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Voorwoord
//e/ is /:/aar £n s/er/:er nog: me/ vee/ genoegen. D// Joor Je /noreng van
mensen J/e er op ne/ y'Mis/e momen/ waren om /e ne/pen a/s //: ne/ n/e/ meer w«/.
/Us eers/e Dr. 71//.A/. //asaarf, copromo/or fies/e 7bm, ye /everJe Je /Jeeën, /eerJe
me scnapen opereren en ar/i"A:e/en scnr/y'ven, en /«ssenJoor oot nog Je
ver/os/:wn Je, zeer vee/ Jan/: /i/ervoor.
Pro/ Dr 7e//e Je //aan, promo/or, £/ /eerJe my waarJer/ng /e ne^oen voor
ne/ we/enscnappe/y'/: onJerzoe/: o/nnen Je op/e/Jing /o/ gynaeco/oog, en creeerJe
voor my Je moge/yjtne/J be/Je /e como/neren. Afyn oprecn/e JanA:.
onJerzoe/: werJ Mi/gevoerJ o/nnen Je Cen/ra/e Proe/J/er
van ne/ fi/o-AfeJ/scn Cen/n/m, waar Je n«/p van ve/en zeer gewaarJeerJ is. A/e/
name w/7 iJk noemen 7oyce 5MV/: en A/aj fios/. Opereren werJ Joor y«///e een
genoegen waar lit me/ vee/ p/ez/er aan /erwg Jen/:. De J/erverzorg/ng werJ
gro/enJee/j verr/c/i/ Joor Frans 5/angen en Pe/er Franssen.
f/i7 6e/g/e, 7os L.//. Van /îeemp/s. fie Jan/:/ voor Je accwra/esse en
ôe/ro/:/:e/jne/J waarmee 7e a/ Je gegevens J/e w7 A/aas/ric/i/ naar fieerje ibvam^/i
oe/ianJe/Je. //e/ vervaarJ/gen en Z?eoorJe/en van Je wee/se/coMpes, samen me/
A/arc //ase/Joncfcr, ne/ .vcnryven i'an Je ar/i^e/en, en ne/ meeJen/:en. Voor Jeze
/aa/.v/e /wee zaAen Jan/: /it 00/: Pro/ Dr A/arce/ Borgers. //erman Van fie//e worJ/
/?eJan/:/ voor ne/ verric/i/e/i van /?epa//ngen /n serwm en //awor cereorosp/na//s en
voor zi/n aJv/ezen in samen gescnreven ar///:e/en. fio& yoossen-Afeyv/s en Lâmèer/
Leyssen worJen fteJan/:/ voor Je /?oe/:verzorg/ng. //: /IOMJ een zeer goeJ gevoe/
over aan Je samenwer/:/ng me/ onze wes/erfcuren.
CAf. /7zermans, s/«Jen/-ass/s/en/e. Ve/e wee/:enJen za/en we in ne/
BA/C Dan/: voor Je n«/p en geze///gne/J /y'Jen.v ne/ e.ïper/men/eren. /rené A/.
/Twipers, A/O oy Je a^/e'/ing Z:/nJergenees/:MnJe. Twisen Je scnapen, op symposia
en congressen maar voora/ ooi in Je wanJe/gangen was er een goeJe
sa/ne/iH'erA:i/ig, waarvoor Jan/:. Dr /ng. CAf. Ver/:es/e, oes/e Car/a. 7e n«/p oy Je
s/a//s//eÀ' was orooJnoJ/g en werJ /en zeers/e gewaarJeerJ. fiovenJ/en was ye er
a//y'J op ne/ women/ Ja/ /ie/ vy/ voor /waa/f was en //: ye op Ja/ momen/ noJ/g
naJ. Dr 7.5.//. V/es, ôes/e //ans. Cb-au/eur en meeJen/:er vana/ne/ eers/e «wr. 7e
/as Je mamiscr/p/en wi/ers/ A:ri7/scn en o/ee/ vo/nowJen Ja/ a//es posi7/e/ oeJoe/J
was. Da/i/:. Dr. //. \'an //«/sse/ing, oes/e //ans. £/nJe/yl' /:reeg //: J/e occ/wJer
erom/jeen; /7eJanit/ voory'e /î«/p oy Je eers/e opera/Zes. De eeoorJe/Zngscomm/ss/e
v^«/i>n/ /o/ voor ne/ v/o/ oe/:ri7/seren van ne/ man«scr/p/. A/e/ name Pro/ Dr.
Car/os £. B/anco, J/e frena/ve /n Je èeoorJe//ngscomm/ss/e 00/: in Je
, op ne/ BMC en m de £//n/dt s//mM/erend werfc/e. Mawr/to C.£.F.
fry de ECG a/ia/yse. Jan G^//^n was a//yd onm/dde//y'A: oere/A:fraar
ca/am//e//en. Pe/er W///em.sen voorÂ:Ham s/or/ngen /n de /j/o^t/gai
. Dr. Fn/s W. Pr/«zen /»V/p Art<?r /î^ f préparerez van de wj/crosp/ieren, en
me/ rfe verwer&mg van re/gegevens «/r a"e gamma-counter. Dr. L.L.//. Pee/ers,
noo// q/7afena"e enr/iOMs/asme en &r/7/scne A:yA: op a"e vve/enscnap
t/y'ven èoe/ena* en /nip/rerena*. A/ea"e a55/5fen/en en ex-a^^w/enfen worsen /jeaanfcf
voor ne/ uaarnemen van myn se/'n a/^ i/t even naar Je scnapen moe^r, en voor a"e
ge?oona*e fte/ang5fe///ng //i ne/ onrfer^ oeA:. DJ7 /aa/5/e ge/a*/ 00& voor a"e 5/a/7ea'en
en secre/aresses van a"e a/a*e//ng Ofe/e/r/e en Gjnaeco/og/e. De verp/eegA:ana'/^ eAi
van ver/oj&amers en a/a"e//ngen rf/e /wi/wer weer feen/'eMwa' waren naar myn
scnapewere/aye. Gera/a* a*e //aan en Leo //o/s/ra, paranym/en, voor ne/ /r/f/sc/i
cfoor/ezen van Anan«5cr/p/en, ge/oonde m/ere55e, en wer^zaamneden rond de
promo/i'e.
/A: danA: myn owders d/e door nwn opvoed/ng en mee/ev/ng zeer vee/
feydroegen. Myn scnoonowders voor nwn n/mmer q/7a/ende aandacn/ en warm/e.
A/5 /aa/5/e noem /it ne/ foe/angry/t^/e: myn //?M/.v/ron/. Myr/ne /naaAr/e de voorÂ:anï
van ne/ èoeAye, da/ nw e/nde/y'A: A:/aar /s. 5/ors, excuses voor myn /eA:or/A:om/ngen
/en opz/c/î/e van JOM /nye eer^/e /evenyaar, /A: za/ da/ z^Aer goed maA:en.
7ens/o//e C>»n/n/a. ZonderyoM H'a^  /it zover n/e/ geA:omen.
gewe/d/g. /A: now va/17'e, a//yd en overa/.
10 Fetal asphyxia, a study in preterm lambs
11
Abbreviations
ATP
BE
CBF
CSF
CTG
ECG
ECoG
FHR
Hb
MBF
min
[Oz]a
Pa
Pv
PCO2
post-1
post-2
SD
SEM
adenosine 5'-tnphosphate
base excess
cerebral blood flow
cerebrospinal fluid
cardiotocogram
electrocardiogram
electrocorticogram
fetal heart rate
hemoglobin
myocardial blood flow
minute
arterial oxygen content
arterial blood pressure
venous blood pressure
carbon dioxide tension
post asphyxia 1 ; time= 90 min
post asphyxia 2; time= 180 min
standard deviation
standard error of the mean
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1.1. Introduction
Perinatal asphyxia is a major concern in obstetrics. The American College of
Obstetricians and Gynecologists liability survey in 1992 shows that 79.4% of members
have been sued at least once: 32.6% of the litigations involved brain-damaged infants,
12.8% stillbirth or neonatal death, and 12.0% other major infant injury (1). Also in
Europe the scene regarding the legal aspects of malpractice in association with the
consequences of perinatal oxygen shortage is changing. Perinatal asphyxia is definitely
not the main cause for neurologic disability (2,3,4), but it is a cause theoretically
preventable. To prevent asphyxia and optimize perinatal care the fetus is monitored with
a variety of methods.
12. Fetal surveillance
Fetal surveillance is performed using cardiotocography (CTG), in combination
with fetal blood sampling, or with recording of fetal body movements and breathing
activity. Recently measurement of fetal blood flow velocity waveforms has gained
clinical interest.
Soon after its introduction, electronic fetal heart rate (FHR) monitoring in
combination with uterine activity recording became widely used in an effort to reduce
perinatal mortality and morbidity (5,6). To the description of FHR decelerations,
accelerations and changes in basal heart rates, the concept of variability was added, and
the ominous significance of decreased variability was established (7). Initial results were
hopeful: variable and late decelerations were associated with an increased incidence of
low Apgar scores (8) and fetal and neonatal release of catecholamines (9). More
recently however, it is shown that FHR patterns poorly correlate with fetal acid-base
balance (10). A normal CTG pattern may be regarded to represent fetal well-being and
normoxemia, but the occurrence of afcMorwra//7/V.s in CTG patterns does not necessarily
signify that the fetus is in danger. Use of the CTG is associated with unnecessary
operative intervention (11), whereas still children are born damaged by unrecognized
asphyxia (12,13). In a large randomized controlled trial CTG monitoring was compared
with intermittent auscultation. Neonatal outcome was similar for both groups, except for
seizures that were more often present in the intermittent auscultation group (14). These
seizures however were not indicative for cerebral palsy during childhood: reassessment
of the children when aged 4, showed that in both groups 3 children had cerebral palsy.
An even more important finding was that 16 (=78%) of the 22 children with cerebral
palsy at age 4 had not shown any clinical sign suggesting asphyxia at birth (15).
Monitoring of all deliveries with CTG compared with monitoring only fetuses at high
risk resulted in increased rates of cesarean section because of fetal distress, without
improving perinatal outcome in the 34,995 pregnancies monitored (16). Therefore,
research is performed to detect parameters with a diagnostic value superior to the CTG.
Serial sampling of micro-amounts of blood from the fetal presenting part
enables the obstetrician to divide cases with abnormal CTG traces in fetuses with and
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fetuses without acidemia (17). In the presence of normal FHR variation however, the
role of fetal blood sampling is limited (18). Although this technique has gained wide
acceptance, its limitations are obvious: membranes have to be ruptured, dilatation is
needed, and the presenting part has to be engaged and has to be free from maternal
blood and excessive fetal hair. Furthermore, it is a somewhat laborious, invasive
technique, considered unpleasant by patients.
Maternal perception of spontaneous fetal movement may be a suitable
complementary method to assess fetal well-being, although maternal reporting at times
is biased (19). Fetal breathing movements are specific fetal movements, which occur in
periods, associated with different stages of activity /« wtero (20,21), and are present
when the fetus shows rapid eye movements and low voltage electrocortical activity
(22). A clear relationship is established between lack of fetal breathing movements and
fetal asphyxia (23). However, since fetal breathing movements can only be detected
ultrasonographically, long periods of observation are necessary. Furthermore, fetal
breathing movements diminish or are even absent during labor (24), reducing their
usefulness to predict fetal well-being and outcome.
Recently, Doppler measurements were introduced for fetal surveillance. After
description of the technique of combining a linear array transducer with a pulsed
Doppler system at a fixed angle (25,26) normal values for blood velocities in the
descending aorta and the umbilical vein of human fetuses during the third trimester of
pregnancy have been produced (27). Initially, a strong association has been suggested
between fetal oxygen shortage in growth retardation and mean blood velocity in the
fetal aorta (28). However, the same group concluded several years later that accurate
estimation of the fetal acid-base balance is not possible with Doppler studies (29). No
significant correlation was found between fetal oxygen content and the umbilical artery
pulsatility index or between umbilical artery systolic/diastolic ratio and the fetal pH,
PCO2, or PO2 (30). However, in fetuses beyond 25 weeks of gestation, in which zero
flow was repeatedly determined, fetal hypoxemia was practically always present (31).
In animal experiments changes in the pulsatility index during fetal hypoxemia
were not correlated with placental vascular resistance (32). Progressive embolization of
the placenta in fetal lambs resulted in hypoxemia and a progressive acidemia that lasted
for days, without a proper correlation with the umbilical artery pulsatility index (33).
Therefore, it can be concluded from animal experiments as well as from human studies
that there is no simple correlation between fetal blood flow velocity parameters and fetal
acid-base balance. Clinical decisions should not be made on the base of Doppler
assessment of blood flow in pregnancy (34).
In conclusion, accurate determination of fetal well-being and prediction of fetal
outcome remains troublesome, in spite of the variety of methods available for fetal
surveillance.
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13. Neonatal monitoring at birth
At birth, asphyxia has to be recognized as soon as possible to start
adequate cardiorespiratory resuscitation of the neonate. Clinically, a number of
parameters are used to diagnose and evaluate asphyxia, including acid-base
balance of arterial blood at birth, and at 30 and 60 minutes after birth, Apgar score,
meconium loss, and neonatal neurologic symptoms. Biochemical abnormalities in
serum and CSF may give supportive evidence of an asphyxiai period.
Severe fetal oxygen shortage will result in anaerobic metabolism,
production of lactate, and fetal acidemia. Due to decreased placental gas exchange
the PCO2 will increase, resulting in a mixed metabolic and respiratory acidemia.
Determination of the acid-base balance from umbilical cord blood immediately
after delivery identifies fetuses normally oxygenated during delivery. However, it
is shown in a variety of studies that there is a poor correlation between the fetal
acid-base balance at birth and the neurologic development of the newborn. None
of the neonates with a pH <7.00 and a 1 minute Apgar score >3 had either seizures
or hypotonia. Conversely, among those with pH values >7.00 and a 1 minute
Apgar score <3 seven (=14%) had hypotonia and two (=4%) had seizures (35).
Neurologic abnormality at its turn was not related to acidemia at birth either
(36,37,38). In conclusion, pH values between 7.00 and 7.20 have no correlation
with any immediate or long-term neonatal morbidity. Most fetuses born with an
arterial pH <7.00 will not suffer evidence of perinatal brain damage either.
Conversely, such acidemia itself offers no adequate evidence to establish that the
observed injury has occurred during labor (39), but will only give supportive
evidence for possible intrapartum etiology.
Next to assessment of the umbilical cord acid-base balance, clinical
observation of the newborn may provide signs of peripartal oxygen shortage.
Although the Apgar score was described originally as a systematic way to evaluate
neonatal condition at birth (40), it soon was used as an international standard of
perinatal asphyxia (41). Gestational age, maternal medication, infection,
congenital disorders affecting the neuromuscular system, and the neonatal
cardiopiilmonary condition at birth are but a few of the factors that can lead to a
low Apgar score without the presence of asphyxia. The sensitivity and the positive
predictive value of a low 5 minute Apgar score (<7) to determine adverse
neurologic outcome were 12% and 19%, respectively (38). Of the children with
cerebral palsy 26% had an Apgar score <3 at one minute, yet 55% had a score >7.
Persistance of a low Apgar score at 10, 15, or 20 minutes, despite resuscitative
efforts indicates an ongoing insult that could affect, or further affect, outcome, and
is associated with an increased mortality and long-term morbidity (41). In a
multivariate analysis of children with cerebral palsy, asphyxia played a role in 9%
of children at the maximum (2). Most infants who had an Apgar score <3 at 20
minutes and survived were neurologically impaired. Rapid improvement in scores
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by 5 to 10 minutes indicates that it is unlikely that the prior insult has been
sufficiently severe to result in permanent deficit (41,42).
Presence of meconium has also been suggested indicative for severe or
prolonged intrauterine stress. The type of meconium (thick or thin, heavy or light)
and time of passage (early or late in labor) seemed to be the most significant
factors affecting fetal outcome (43). However, expulsion of meconium during
labor was present in as much as 18% of all deliveries, whereas it did not predict
neonatal outcome (44). A history of meconium a/one did not prove that a term
infant experienced a degree of asphyxia sufficient to account for later neurologic
sequelae (45).
In conclusion, a variety of factors may suggest perinatal oxygen shortage
in the newborn. However, none of them can be regarded as absolutely diagnostic
of preceding oxygen lack, since they may reflect other prenatal or intrapartum
events or even more fundamental problems of prenatal origin, as, e.g., congenital
abnormalities. Although short term morbidity after perinatal asphyxia is important,
the golden standard to evaluate perinatal care is long term morbidity, mainly
reflected by neurological sequelae.
1.4. Biochemical parameters of asphyxia in CSF
There is a large body of literature showing that hypoxanthine is a sensitive
indicator of oxygen shortage, maybe even a more specific marker than lactate,
base excess, or pH, since it reflects the intracellular energy status (46,47). Levels
of hypoxanthine in serum are not very sensitive for brain damage, since the main
part of hypoxanthine released during asphyxia originates from the fetal heart and
liver (48). However, since neuronal damage leads to the release of intracellular
substances into interstitial fluid and into CSF, the level of lactate, hypoxanthine,
and xanthine in CSF may give an idea of the severity of the insult and even of
neurological prognosis. This was shown after marked hypoxia in cats where peak
CSF lactate concentration distinguished animals without brain damage from those
that developed cerebral damage with 100% accuracy (49). Lactate however easily
crosses the blood-brain-CSF barrier: during and after asphyxia a net influx of
lactate into the cerebrum was observed in exteriorized fetal lambs (50). CSF
lactate levels may therefore represent serum lactate levels instead of being
indicative for cerebral anaerobic metabolism. Although the specificity of these
measurements in CSF may be good, the sensitivity in detecting asphyxiai brain
damage is low, since infection, infarction and many other processes may elevate
the level of these parameters (51). The latter is also true for the elevated levels of
hypoxanthine and xanthine in CSF (52). These nucleosides gain importance in the
period following asphyxia, since during reoxygenation of the brain hypoxanthine
and xanthine act as substrate for oxygen derived free radical formation that
aggravates neuronal damage (47).
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1.5. Conclusions
Accurate detection of compromized fetuses remains a major problem in
perinatology. Fetal surveillance led to increased obstetrical intervention without
improved neonatal outcome. Several parameters are indicative for perinatal
asphyxia, but there is not one single test proving that damage observed in the child
is due to asphyxia. Knowledge of cardiovascular mechanisms and electrocardial
activity during fetal asphyxia is still incomplete, and as a result there remains an
inadequate understanding of factors determining neonatal outcome after fetal
asphyxia.
1.6. Objectives of the study
Review of the literature (chapter 2) gives rise to several unanswered
questions. To what extent are certain parameters indicative for fetal condition
during and after asphyxia? Can levels of nucleosides or lactate in CSF be used to
predict neonatal morbidity? Why is a certain degree of asphyxia lethal to one
fetus, causes brain damage in another, and does not seem to have a single negative
impact in a completely recovering subject? The factors determining the narrow
margin between lethality after asphyxia and survival without signs of histologie
damage (53) remain unclear. The questions we addressed after induction of
asphyxia in the fetus were:
(I) What is the effect of asphyxia on cardiovascular parameters? (chapters 4, 5
and 7)
(II) Are certain cardiovascular parameters indicative for fetal recovery and/or
survival after asphyxia? (chapters 4,5 and 7)
(III) Can the fetal ECG be used as an indicator for fetal well-being? (chapter 7)
(IV) Does the composition of CSF change during asphyxia, and are certain
parameters indicative for cerebral brain damage or fetal survival? (chapters
6 and 8)
(V) Does this degree of asphyxia lead to histologically confirmed brain
damage? (chapter 6)
(VI) Are certain drugs effective in preventing fetal death or histological damage
after asphyxia? (chapters 4 and 5)
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2.1. Definition and incidence
Asp/zyjc/a is etymologically derived from a Greek word meaning pulseless.
Clinically it refers to the condition after impaired exchange of respiratory gases.
Biochemically, asphyxia indicates the combination of oxygen lack with acidemia.
Oxygen lack without an accompanying acidemia is called hypoxia (low oxygen
tension) or hypoxemia (low percent saturated hemoglobin) (1). Biochemically,
asphyxia is described by the degree of acidemia, hypoxemia, hypercapnia, and
base excess. Although asphyxia can be exactly defined with these parameters, the
clinical presentation of a child born biochemically asphyxiated varies
considerably. Several signs and symptoms are associated with asphyxia, but none
of them is characteristic for the asphyxiated neonate. This discrepancy between
biochemical and clinical asphyxia accounts for misunderstanding and sometimes
even for mismanagement of newborns. Furthermore, it does not facilitate
comparison of studies in the literature.
In adults, the normal pH of arterial blood is 7.40, while the pH of venous
blood and of interstitial fluids is approximately 7.35, because of extra quantities of
carbon dioxide that form carbonic acid in these fluids (2). Compared with adults
most fetuses are born with a mixed respiratory and metabolic acidemia, despite a
completely normal intrapartum course. In a series of 899 newborns, mean
umbilical artery pH was 7.20 (SD ± 0.08) with a mean base excess of -8.3 mM
(SD ± 4.0) (3). In a series of 2,738 singleton live births at term complicated by
either cesarean section, forceps delivery, meconium passage, oxytocin stimulation
of labor, or abnormal FHR pattern the incidence of asphyxia was 0.6%, 2.8% and
6.0%, when asphyxia was defined as umbilical artery pH values <7.00, pH <7.10,
and pH <7.15, respectively (4). When a blood base excess of -12 mM was taken as
a criterion for fetal asphyxia, the prevalence of intrapartum asphyxia was 2% in
the term fetus (5), and 6% in preterm fetuses less than 2000 g (6).
22 . Etiology
Fetal asphyxia is caused by impaired placental gas exchange. This may be
of fetal or maternal origin, or caused by placental malfunctioning. Fetal causes are
umbilical cord compression, myocardial decompensation and forward failure, or
anemia. Maternal causes include uterine hyperactivity, congestive heart diseases
with forward failure, and severe anemia. All these processes lead to an insufficient
uterine perfusion and an impaired placental gas exchange. Placental reasons for
fetal asphyxia are abruptio, and an inadequate function of the placenta due to
impaired placentation, infection, or infarction.
23 . General pathophysiology of fetal asphyxia
23.1. Hemodynamic pathophysiology
The effect of asphyxia on the fetal cardiovascular system is extensively
investigated in animal experiments. The main part of this research is performed in
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fetal sheep, in which species asphyxia is induced either by reduction of maternal
uterine perfusion, by umbilical blood flow restriction, or by maternal inhalation of
a hypoxic gas mixture.
The common fetal cardiovascular response to acute oxygen shortage is
hypertension and bradycardia (7,8). Fetal arterial blood pressure usually increases
slowly over several minutes, the rise being more rapid and marked when oxygen
shortage is severe (7,8). The association of bradycardia and hypertension suggests
the bradycardia being the result of a baroreflex response to hypertension. This
hypothesis was supported by studies in fetal sheep, in which umbilical cord
occlusion resulted in bradycardia with arterial hypertension (9). Before the
baroreceptors are functionally active the peripheral chemoreceptors (aortic and
carotid bodies) have been demonstrated to mediate the bradycardic response to
acute oxygen shortage (10). These chemoreceptors co-activate parasympathetic
and sympathetic pathways, as is shown in Figure 2.1.
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Figure 2.1. The effect of acute oxygen shortage on the fetal cardiovascular system.
When sympathetic efferents are transsected at Thl2 level, hypoxemia no
longer produces a rise in arterial blood pressure, but the fall in FHR persists since
vagal influences are intact (11,12). The same is observed after pharmacologie
blockade of the alpha-adrenergic system during reduced uterine perfusion in sheep
(13). During oxygen shortage alpha-adrenergic activity promotes vasoconstriction
of the peripheral, mesenteric, splanchnic, renal, and splenic vasculature (7).
Increased beta-adrenergic activity supports the FHR and maintains placental blood
flow (14). When chemoreceptors are subjected to ascending aortic blood PO2
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values <2.4 kPa, bradycardia will result (15). After sinoaortic denervation
sympathetic mechanisms dominate, leading to a tachycardie response during
hypoxia, while cardiac output and fetal blood flow distribution remain unchanged
(16). Both the chemoreflex and the baroreflex induced bradycardia are mediated
through vagal stimulation (17).
When oxygen shortage persists, fetal catecholamines are released from the
adrenal glands, leading to tachycardia (18). This tachycardia may also be due to a
concomitant hypercapnia, which reduces the vagal activity and thereby enhances
sympathetic increment of the FHR (19). Hemodynamic adjustments during
prolonged fetal oxygen shortage are summarized in Figure 2.2.
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Figure 22. The effect of chronic oxygen shortage on the fetal cardiovascular system.
Dramatic changes in the distribution of cardiac output take place. During
oxygen shortage the increased blood flow to the myocardium, brain and adrenal
glands, called cenfra/Zzaf/on of fetal blood (20), occurs at the expense of reduced
perfusion of liver, kidney, gastro-intestinal tract, muscle, carcass and skin.
Perfusion of the placenta remains unchanged (21). This redistribution of the fetal
circulation occurs rapidly (22), and in the absence of progressive metabolic
acidemia the sheep fetus can maintain these protective circulatory adjustments for
up to 48 hours (23). Next to this redistribution of cardiac output, well-oxygenated
blood from the ductus venosus is preferentially directed across the foramen ovale
to provide the myocardium and the brain with an increased proportion of the most
oxygenated blood during periods of asphyxia (17,24).
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. Metabolic pathophysiology
The main metabolic response to oxygen shortage is anaerobic glycolysis.
Classic studies in fetal lambs demonstrate a linear relationship between survival
after asphyxia and the size of the glycogen stores in liver and myocardium (25).
Anaerobic glycolysis implies an inefficient use of energy supplies in comparison
with aerobic metabolism. During normal oxidative metabolism one molecule of
glucose leads to 36 molecules of ATP, whereas anaerobic metabolism only leads to
formation of lactate, NAD"*", and two molecules of ATP (2). Obviously, anaerobic
glycolysis is a short-term rescue mechanism that produces accumulation of lactate
in tissues and blood (26). The gradually increasing concentration of lactate leads to
metabolic acidemia (25). Increased fetal plasma lactate concentrations become a
more important source of substrate for the placenta, and may even reduce placental
glucose consumption (27).
The inability of anaerobic glycolysis to maintain ATP regeneration results
in usage of the energy-rich intracellular phosphates. This process is quantitatively
reflected in an augmented plasma level of hypoxanthine (28,29). The origin of
serum hypoxanthine in asphyxiated lamb fetuses is multiple: a dominant release
from liver and skeletal muscle early during asphyxia, at a more severe stage of
asphyxia followed by release from the myocardium, and only at the most severe
stage of asphyxia a release from the central nervous system (30,31).
2.3.3. Cerebral pathophysiology
Theoretically two adaptations can maintain cerebral oxygen consumption
during asphyxia: (I) the brain may extract more oxygen from the delivered blood,
or (II) cerebral blood flow may increase. Although both in immature fetal lambs
(32) and in newborn lambs (33) fractional oxygen extraction increases during
oxygen shortage, the brain largely relies on blood flow increment. The rise in
cerebral blood flow has a twofold effect: first, maintenance of tissue oxygen
delivery, defined as the product of arterial oxygen content and blood flow, and
second, decreasing the arteriovenous oxygen difference across the brain, thereby
increasing capillary oxygen tension, which is the driving force for oxygen
diffusion. Additional adaptations in situations with chronic oxygen shortage are
elevated Hb concentrations (34) and an increase of the number of capillaries in
muscles (34,35).
Cerebral reaction mechanisms to asphyxia can be divided in two major
stages. The first stage occurs initially, before oxygen shortage has become too
severe, and is characterized by mechanisms to keep up oxygen supply to the brain
and maintain aerobic cerebral metabolism. As described above, blood flow to the
brain is augmented (7,21), and additionally cerebral blood is redistributed
providing the highest flow to phylogenetically older brain structures as thalamus,
cerebellum and medulla oblongata (21,36,37). The second stage is reached when
oxygen delivery to the brain is insufficient. Cerebral oxygen shortage severe
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enough to produce irreversible tissue injury is always associated with major
disturbances in the energy status of the brain (38,39). The main energy consuming
processes in the brain are (I) turnover of membrane lipids and proteins and (II)
maintenance of the membrane potential. Turnover is energy consuming due to the
magnitude of the nervous system: some axon terminals are at one meter distance
from its cell-body. Furthermore, the brain largely consists of lipids: 75% of myelin,
55% of white matter, and 35% of grey matter is of lipid origin (40). Membrane
lipids contain mainly unsaturated fatty acids that are sensitive for oxidation, a
process easily occurring in the adequately oxygenated brain. Maintenance of the
membrane potential is essential for neuron functioning, since communication
between neurons is dependent on depolarization and repolarization.
Table 2.1. Relative concentration differences between extracellular and
intracellular (neuronal) ions
ion
Na+
K+
Ca2+
extracellular
14
1
10,000
intracellular
1
30
1
During physiological conditions, a stimulation opens specific sodium and
calcium channels, and due to concentration differences (summarized in Table 2.1)
ions enter the neuron. Because of these ion shifts, the membrane potential
increases from -60 mV to approximately 0 mV: depolarization. The next step is
closure of these channels, opening of potassium channels, efflux of potassium and
restorage of the membrane potential: repolarization. After these events the
concentration differences are actively built up again with aid of the ATP consum-
ing Na^/K^-pump (40). These processes are schematically shown in Figure 2.3.
Reduction of uterine blood flow to 25% of normal results in generalized
vasoconstriction of fetal cerebral and myocardial vasculature (41). If the latter
condition persists this may lead to fetal decompensation. The cerebrum catabolizes
the high-energy phosphate compounds of the cells, and severe impairment of the
electrical function of the neurons takes place. Spontaneous electroencephalograpic
activity has already ceased (42), but at this stage also the cortical evoked potentials
vanish (30). This disruption of neurophysiological activity during asphyxia is
related to various events. Synaptic transmission is impaired because of reduced
synthesis and release of excitatory transmitter substances such as noradrenaline
and dopamine (43). Energy lack leads to reduced Na"7K"7ATP-ase activity with an
incapability of the neuronal cell membrane to maintain electrical stability. Leakage
of potassium ions into the extracellular space of the brain and of calcium ions into
the cytosol of the neurons and into mitochondria takes place (Figure 2.3) as the
ultimate result of cellular energy crisis (44,45).This was confirmed in the micro-
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Figure 23 . The depolarization-repolarization cycle. During normoxemia ion pumping
after repolarization leads to normal concentrations of ions on both sides of the neuronal
membrane. During energy shortage this normalization cannot be achieved and the
membrane remains depolarized.
scopic studies of Brown and Brierley (46), indicating that the earliest morphologic
alteration of the neuron arising from oxygen shortage is a dilation of mitochondria.
To reduce cellular acidosis, hydrogen ions are exchanged for sodium ions, which
further increases the amount of intracellular sodium. As a result there is a water
influx into the neuron, leading morphologically to cytotoxic cerebral edema.
Alterations in intracellular ion concentrations, intracellular edema, and in cell lysis
lead to pnwary H?wrona/ <fea//j, referring to irreversible loss of neurons during the
insult itself. Other processes do not lead to neuronal loss for some considerable
time after the insult. This secondary /jewro«a/ deaf/j may be a result of
inappropriate activation of programmed cell death, the so-called o/jopro.y/s (47), of
activation of inflammatory cells (48), and of changes in the neuromodulatory
system (49) leading to excitotoxicity (50) and activation of oxygen derived free
radicals. At the final stage of oxygen shortage, immediately before death, the
blood-brain barrier function decreases, resulting in more cerebral edema. Figure
2.4 shows a schematic representation of a neuron demonstrating the processes
important during lack of oxygen.
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Figure 2.4. Schematic representation of a neuron suffering from oxygen shortage. Ionic
and transmitter fluxes are discussed in the text.
2.3.4. Hormonal pathophysiology
Several hormones and vaso-active compounds are released during sustained
oxygen shortage (Figure 2.2). During the stress of normal vaginal birth the fetus reacts
with a release of catecholamines (51). The level of catecholamines reaches values
many times higher when the neonate has been the subject of perinatal asphyxia (52). In
animal research evidence is collected that fetal circulatory and hormonal responses to
asphyxia are partly due to a rise in plasma catecholamines (18,27,53). Fetal sheep
depend on intact beta-adrenoreceptor mechanisms to be able to cope with asphyxia of
a moderate degree (54).
Acute reductions in uterine blood flow in pregnant sheep are associated with a
very large and transient increase in fetal plasma adrenocorticotropin hormone (ACTH)
concentrations coincident with the degree of acidemia (55). Since the fetal adrenal
cortex becomes progressively more sensitive to the stimulatory effects of ACTH in the
last part of gestation, glucocorticoid levels rise during gestation and undergo a
dramatic upsurge 1 to 2 days before parturition (56). Severe acidemia induced by
intravenous infusion of H"*" in fetal sheep leads to increased levels of ACTH and
cortisol, but does not alter fetal plasma renin activity or fetal blood pressure (57). More
severe oxygen shortage however does increase plasma renin activity (58). Renin
converts angiotensin I to angiotensin II, which is a potent vasoconstrictive hormone.
The rise in vasopressin observed during induced acidemia (57) and during
hypoxemia causes bradycardia and a circulatory centralization (59).
Endogenous opioids are a group of naturally occurring peptides that are
involved in the regulation of cardiovascular and other physiological functions. The
endogenous opiate system acts by modulating the vasoconstiction in fetal carcass and
kidneys induced by vasoconstrictor substances, released as a response to asphyxia (60).
In this regard, it has been reported that endogenous opioids decrease the release of
vasopressin from the neurohypophysis (61) and of catecholamines from the adrenal
medulla (62). Finally beta-endorphins, a subgroup of endogenous opiates, lead to
tachycardia and an increased cardiac output (63).
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24. Pathophysiology of the myocardium during asphyxia
24.1. Myocardial blood flow and metabolism
Under normal physiological conditions oxygen supply to the fetal lamb is
approximately twice the value necessary to maintain an adequate fetal oxygen
uptake and a normal fetal base excess (64). When uterine blood flow is decreased
to 75% of baseline, combined fetal ventricular output and regional blood flows are
not different from normal (41). More severe reduction of uterine perfusion will
result in fetal asphyxia. To maintain oxygen delivery to the most vital organs
during asphyxia, the fetus resorts to physiologic mechanisms that cause a
preferential redistribution of the well-oxygenated blood to sustain the heart, brain,
and adrenal glands, and maintain blood flow to the placenta (17,21). At modest
degrees of oxygen shortage it has been shown in the myocardium and the brain
that the increase in blood flow matches the reduced oxygen delivery, resulting in a
constant oxygen uptake by these v/ta/ organs (65,66). Moreover, fetal oxygen
consumption during severe asphyxia decreases, which is presumed to reflect a
reduced uptake of oxygen in the vasoconstricted organs and areas (27,64,67). The
increase in blood flow to myocardium, brain, and adrenals is primarily regulated
by direct local vascular effects (16). When the fetal pH reaches 7.00 combined
ventricular output decreases. If the pH further decreases and reaches values around
6.86, redistribution of fetal blood fails, the perfusion of placenta, heart and brain
decreases, and cardiovascular collaps will occur (68). Severe reduction of uterine
perfusion (25% of baseline) leads to decreased fetal myocardial blood flow prior
to cardiovascular collapse (41 ).
2.42. Adenosine
It goes beyond the scope of this thesis to discuss all hormonal and para-
crine substances produced during asphyxia. Due to its beneficial effects after
asphyxia an exception is made for adenosine. Whenever there is a mismatch in the
myocardium between energy supply and energy demand, nucleotides (tf.g., ATP,
ADP, AMP) are rapidly degraded by consecutive dephosphorylation (69,70). The
amount of nucleotides catabolized is directly related to the duration of ischemia
and may reach 40% to 50% within 30 minutes of normothermic myocardial
ischemia in dogs (71). Adenosine accumulates in the myocardial interstitium
where it can exert its function, or can be catabolized in either the endothelial cell
or in the vascular lumen (70). This is summarized in Figure 2.5.
Accumulation of adenosine within the interstitium of the myocardium is
transient because of its rapid metabolism in endothelial cells (72). Production and
release of adenosine in response to oxygen shortage may be an important natural
defense system in the myocardium (and probably also in other vital organs, such
as the brain and kidneys).
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Figure 2.5. Formation and metabolism of adenosine (ADO) in the myocardium. Oxygen
shortage leads to AMP accumulation in the myocyte. Cytosolic dephosphorilation may
lead to intracellular formation of adenosine, which leaves these cells by diffusion (D).
More probably, interstitial fluid (/5F) adenosine originates from extracellular nucleotides
(AMP from myocytes, ATP from nerve endings or endothelial cells). In the ISF adenosine
has access to several targets on the surrounding cells. Whereas some adenosine may reach
the lumen of the microvasculature through clefts between endothelial cells (£C), the
majority of adenosine is taken up in these cells via diffusion, facilitated by the nucleoside
transporter (7"), and extensively catabolized. Reproduced with permission (72).
Pretreatment with similar repeated brief periods of ischemia trigger adaptive
changes that protect the myocardium from the effects of a subsequent, prolonged
ischémie insult, and reduce infarct size (73). In this /sc/iem/c preco/id/V/ow/'ng a
central role for adenosine is presumed (73,74). The latter was confirmed after
prolonged ischemia in dogs, where intracoronary administation of adenosine, after
reperfusion, improved regional ventricular function in the ischémie zone (75). This
benefit is explained by a range of pharmacological properties: (I) Adenosine is an
important coronary vasodilator (76). An enlarged diameter of microvessels may
allow passage of microemboli that may contribute to the MO-r^ /7ovv phenomenon in
the ischemic/reperfused myocardium (77). (II) Adenosine inhibits the release of
catecholamines (78), and modulates the effect of catecholamines (79), and
therefore reduces the nutrient and oxygen demand of the myocardium. (Ill)
Adenosine inhibits platelet aggregation (80). Infusion of adenosine antagonists
during hypoperfusion in dogs led to a rapid decrease in coronary blood flow,
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attributed to thromboembolism (81). (IV) Leukocytes, infiltrated in the myocar-
dium during hypoxia-ischemia, are activated. These leukocytes may physically
obstruct the microvessels during reperfusion or may even release oxygen derived
free radicals and a whole array of proteolytic enzymes (82). Adenosine is known
to inhibit these processes (83). (V) Furthermore, adenosine is used as an anti-
arrhythmic agent, known to terminate paroxysmal supraventricular tachycardias,
and therefore protects the heart against excessive energy demands (84).
2.4-3. Fetal electrocardiography
The human fetal ECG can be recorded since 1906 (85). After improve-
ment of analyzing and recording equipment the fetal ECG gained clinical interest.
The human fetal ECG was studied during increased asphyxia in induced abortions
(86). A few years later the first recordings during labor are reported, and it was
postulated that fetal ECG changes could be due to impaired fetal oxygénation (87).
In his study concerning the changes of the ECG of the dying fetus, Hon focuses on
PR interval changes, on widening QRS complexes, and on S-T segment depres-
sions (88). Also the electrical axis of the fetal heart is suggested as a criterion for
fetal condition (89). However, a clear relationship between fetal condition and
certain ECG parameters could not be established.
The fetal ECG regained interest in clinical obstetrics when appropriate
baseline noise filters and signal processing became available (90). In response to
hypoxia the ratio of the T wave height to the QRS complex height (T/QRS ratio)
increases in studies in fetal lambs (91,92,93). This increment of the T/QRS ratio is
considered to represent a change to anaerobic myocardial metabolism (91),
secondary to beta-adrenergic stimulation (92). However, in the studies mentioned
above oxygen shortage does not lead to anaerobic fetal metabolism and acidemia.
This is peculiar, because // the T/QRS ratio is ever going to be used in fetal
surveillance, experiments with severely asphyxiated fetuses should have been
performed. Especially, since the severity of asphyxia is associated with the level of
neonatal morbidity and mortality (94,95).
Recent clinical studies on the T/QRS ratio are not unequivocal. None of
the neonates born in a poor condition (one minute Apgar score s3) or with
evidence of acidemia had a mean T/QRS ratio significantly different from the
normal range (99). A raised T/QRS ratio had a considerably lower detection rate
for fetal acidemia than a pathological CTG (97). A weak correlation is found
between the T/QRS ratio and umbilical artery acidemia (98). Other results are
promising: in a large randomized trial the combination of CTG with T/QRS ratio
analysis did not lead to neonates born in a better condition, but was associated
with a 50% reduction of operative deliveries for fetal distress (99,100). Regarding
this 50% decrease it should be kept in mind that introduction of fetal surveillance
with CTG led to a 50% increase of operative deliveries for fetal distress, even
when the CTG was complemented by selective fetal blood sampling and acid-base
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balance assessment (101,102,103). It is obvious that fetal ECG monitoring is
restricted to surveillance during labor, since an electrode placed directly on the
fetal presenting part is a prerequisite for a technically acceptable recording. But
even with an optimal recording extensive research needs to be directed toward
severely asphyxiated fetuses to elucidate the value of the ECG in fetal
surveillance.
2.5. Pathophysiology of the brain during asphyxia
2 J . I . Acidemia
Many studies are designed to investigate the effects of hypoxia on fetal
variables. Reduced placental perfusion however not only leads to hypoxia, but
moreover complicates the release of carbon dioxide from the fetus, resulting in
respiratory acidemia. Anaerobic glycolysis leads to a gradual accumulation of
pyruvate and lactate and to the development of a non-carbonic, metabolic
acidemia. Intrauterine asphyxia therefore constitutes of a mixed metabolic-
respiratory acidosis. Increased severity of asphyxia in fetal sheep leads to
deterioration of fetal cerebral activity, measured with evoked potentials. The
combination of oxygen shortage with a normal pH does not seriously affect the
evoked potentials (104). Fetal acidemia itself, induced by infusion of lactic acid to
achieve arterial pH levels around 6.88, did not lead to severe deterioration of
cerebral function in the absence of concomitant hypoxia (105).
2.5.2. Glucose levels
During oxygen shortage hyperglycemia leads to the formation of high
levels of lactate that reduce the tolerance of the brain during this event. The latter
has been demonstrated in a variety of animal models: hyperglycémie rhesus
monkeys produced more lactate during complete ischemia by means of circulatory
arrest, and had a more pronounced deterioration of cerebral functions than their
normoglycemic and hypoglycémie controls (106). This phenomenon is confirmed
in experiments with hyperglycémie cats exposed to severe oxygen shortage, who
underwent a neurologic deterioration in the hours following reoxygenation (107).
The latter was correlated with inhibition of mitochondrial respiration, increased
tissue lactate levels and decreased energy state (108). Conversely, hypoglycemia
(in experiments with adult rats that fasted shortly before incomplete brain
ischemia) resulted in lower cerebral lactate levels and better cerebral outcome
compared with animals that were pretreated with intravenous glucose (109).
Also in humans the level of serum glucose during oxygen shortage is
correlated with neurologic sequelae. After cardiac arrest, comatous patients with a
marked hyperglycemia have a greater risk to develop permanent severe deficits
(110). Women with fasting hyperglycemia are at greater risk for fetal death (111).
In a study of 766 newborns who weighed >4,500 g perinatal mortality was 7%,
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16% were severely depressed at birth, and 11% had severe neurological
complications. Macrosomia itself and the related birth injury could not explain the
adverse outcome observed (112). On the other hand also growth-retarded fetuses
appeared to be more susceptible to asphyxia than adequately grown fetuses, both
in clinical studies (113) and in animal experiments (114). Within the intrauterine
growth retarded (IUGR) group, the disproportionate (low Pondéral index) IUGR
group has higher neonatal morbidity (hypoglycemia, perinatal asphyxia, hypo-
thermia, fetal distress and meconium aspiration) than the proportionate IUGR
group (113,115). Since anaerobic myocardial metabolism during asphyxia is
dependent on glycogen stores (25), it is suggested that the group of disprportionate
IUGR fetuses has a reduced ability to adapt during asphyxia, simply because of
lower metabolic reserves (113).
In conclusion, during intrauterine asphyxia hyperglycemia will lead to
increased production of lactate, whereas chronic hypoglycemia may result in lower
metabolic reserves and a decreased functioning of compensatory mechanisms.
Both glycémie states are therefore associated with worse cerebral outcome
compared to normoglycemic fetuses.
2.53. Arterial blood pressure
Increased extracellular volume increases blood volume and filling
pressure, which increases the venous return to the heart, leading to increased
cardiac output and elevated arterial blood pressure. When tissue is perfused by an
excessive amount of blood, local vasoconstriction decreases blood flow to normal
values. This phenomenon is called awforegw/flf/ew, which means regulation of
blood flow by the tissue itself (116). Between the pressure limits of 60 and 140
mm Hg acute changes in arterial blood pressure will not lead to changes in
cerebral blood flow. In patients with hypertension this cerebral blood flow
autoregulatory range shifts to even higher pressure levels, up to as high as 180 to
200 mm Hg (116).
If the arterial blood pressure falls below the limit of autoregulation,
cerebral blood flow becomes severely compromized. This is confirmed in preterm
fetal lambs: cerebral blood flow is linearly related to mean arterial blood pressure
from 18-45 mm Hg, constant between 45-80 mm Hg, and again linear from 80-90
mm Hg (117). In midgestational sheep fetuses with a mean arterial blood pressure
less than 30 mm Hg during oxygen shortage (i.e., below the limit of auto-
regulation), serum lactate concentrations were elevated to excessive high values
and, more important, brains were markedly damaged (118). In asphyxiated fetal
lambs neuronal damage was strongly associated with the percentage decrease in
blood pressure during the insult (119). In cats exposed to 25 minutes of marked
hypoxia, animals that maintained their blood pressure were cerebrally undamaged,
whereas hypotensive animals showed severe neuronal necrosis (120).
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If the arterial blood pressure rises above the upper limit of autoregulation,
cerebral blood flow rises rapidly (117) and can cause severe overstretching of
cerebral blood vessels, sometimes resulting in serious brain edema (2) or
hemorrhages (121). Intermittent increases of intravascular pressure in combination
with asphyxia indeed caused hemorrhages in the germinal layer of the fetal sheep
brain (122).
Following prolonged asphyxia local cerebral recirculation may not be
restored upon reoxygenation. This effect has been described as the no-re/7ow
p/iertomerto/î. Cytotoxic edema due to asphyxia is thought to collapse capillaries
and thus impede reperfusion (123,124). An elevated blood pressure observed after
a variety of insults may be necessary to open collapsed capillaries and facilitate
reperfusion (125).
2.5.4. Cerebral blood flow
Next to severe arterial hypertension and hypotension, a variety of factors
can affect cerebral blood flow (Figure 2.6). The question remains how this multi-
tude of factors precisely regulates brain blood flow under various conditions (126).
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Figure 2.6. Factors playing a role in the regulation of cerebral vascular tone and blood
flow. Reproduced with permission (126)
During hypoxemia oxygen delivery to the brain is generally maintained by
increment of cerebral blood flow, although some variability in responses between
various experimental protocols is reported (127). Blood flow to different regions
within the brain also varies. Flow to phylogenetically older areas as medulla
oblongata, pons, and subcortex is increased compared with cortical flow. This
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distribution remains intact during oxygen shortage (23). However, if cerebral
oxygen delivery decreases, normal cerebral oxygen consumption is maintained
due to a proportional increase in cerebral fractional oxygen extraction, both in
immature fetal lambs (32) and in neonatal lambs (33). Although not resembling
pathophysiology of human intrauterine asphyxia, an experimental design was
developed which combined oxygen shortage with decreased cerebral perfusion.
Unilateral carotid artery ligation in rats in combination with inhalation of a
hypoxic gas mixture led to significantly more damage in the ischémie cerebral
hemisphere (128). Recently this model is modified for fetal sheep. Ligation of the
vertebral-carotid anastomosis and inflation of occluder cuffs around both carotid
arteries for 30 minutes results in ischémie encephalopathy (129). The effect of
unilateral cerebral ischemia can be evaluated due to the morphologic differences
between both hemispheres. The major disadvantage of these ischémie models is
the difference from clinical pathophysiology: oxygen shortage normally leads to
acid-base balance changes and increased cerebral blood flow, but in these ischémie
setups fetal metabolic condition does not change, and cerebral blood flow is
reduced.
Excessive brain swelling is thought to occur secondarily to cytotoxic
(intracellular) edema as a result of increased permeability of the capillaries,
leading to accumulation of fluid in the extracellular space (124). This cerebral
edema can increase intracranial pressure to the point of impeding cerebral blood
flow. Intracranial pressure reaches a maximum at 36 to 72 hours after a severe
asphyxiai insult in neonates (130).
255. Oxygen derived free radicals
A free radical is an atom or molecule that contains an odd number of
electrons in its outer most orbit. If a radical reacts with a non-radical another free
radical is produced. This characteristic enables free radicals to participate in chain
reactions, which may be thousands of events long. During normal oxidative
processes a small proportion of the oxygen utilized is converted into free radicals:
the superoxide ion (O2), the related hydrogen peroxide (H2O2), and the hydroxyl
radical (OH). These potentially destructive agents are extremely reactive, may
damage membrane structures, and may also lead to direct injury of the cellular
DNA (131). During normal oxidative metabolism, defense mechanisms against the
potential damaging effect of oxygen derived free radicals are provided by
endogenous scavengers, including enzymes (superoxide dismutase, catalase, and
peroxidase), cholesterol, vitamin E, vitamin C, and glutathione (39). These
scavengers prevent the accumulation of high concentrations of oxygen derived
free radicals that would lead to tissue damage and to the formation of the most
highly reactive radical, the hydroxyl radical (132,133) (Figure 2.7).
Oxygen derived free radicals are formed during arachidonic acid
metabolism (see ad. 2.5.6), but also in the period following asphyxia. During
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asphyxia energy rich nucleotides are rapidly catabolized (134), which results in the
accumulation of hypoxanthine and xanthine both in circulating blood and in
tissues, including the brain (30). When oxygen is added to a system rich in
hypoxanthine and xanthine, oxygen derived free radicals are formed in large
quantities, provided the enzyme xanthine-oxidase is available (135). This enzyme
is generally not present but can be transformed from xanthine-dehydrogenase. This
transformation takes place in the liver (136) and in endothelium of brain
capillaries (137), is induced by oxygen shortage and by an increase of intracellular
calcium ion concentrations, which in turn is caused by the lack of oxygen
(138,139). Instead of being beneficial, the elevated arterial oxygen content in the
period after asphyxia leads to formation of superoxide radicals and hydrogen
peroxide. In the presence of the catalyzing free iron these two compounds react to
form the hydroxyl radical. Endogenous CSF contains enough free iron for this
process (140). In the brain oxygen derived free radicals are hold responsible for
vascular wall damage and cerebral blood flow abnormalities (133). This was
confirmed in neonatal lambs, where cerebral hypoperfusion after asphyxia was
observed as a result of oxygen derived free radical production (141).
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Figure 2.7. Chemical reactions leading to the formation of the hydroxyl radical and the
pathways catalyzed by some endogenous oxygen derived free radical scavengers.
25.6. Calcium
Lack of oxygen results in energy failure, leading to impeded ATP-
dependent Na^/K^-transport. The ensuing decrease in membrane potential opens
voltage-dependent calcium channels. Additionally, the decrease of the
transmembrane sodium gradient diminishes outward calcium transport. The result
is an intracellular influx of calcium, which is considered an important factor in the
mechanism of cell death (142). The intracellular calcium concentration is normally
maintained near 0.1 /<M, which is 10,000 fold less than the extracellular calcium
concentration (143). Overloading of neurons with calcium ions takes place as a
result of the rapid break down of the normal calcium gradient across the cell
membrane (Figure 2.3). This occurs within a few minutes of complete lack of
oxygen, resulting in a 200-fold increase of intracellular concentrations of free
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calcium (45,144,145). Calcium activates Upases, proteases, and endonucleases:
enzymes that degrade the cell structure (146). In the brain, influx of calcium or its
release from intracellular stores, could be responsible for the extreme vulnerability
of some neuronal populations for oxygen shortage (147). The susceptibility of
these cells cannot be ascribed to vascular factors, and it is tempting to assume that
these cells are vulnerable because they contain a high density of calcium channels,
creating /iof spors of calcium accumulation in their dendritic domains. Indeed
during hypoxia-ischemia in adult rats, important calcium shifts could be
demonstrated cytochemically, mainly at excitatory presynaptic sites. The ion
dissipated during the early recovery period (148). There is no doubt that calcium is
a co-factor in the activation of xanthine-oxidase and phospholipase. The latter
facilitates the production of arachidonic acid out of membrane phospholipids. Part
of the complex metabolic and biochemical events that cause neuronal damage after
oxygen shortage are summarized in Figure 2.8.
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Figure 2.8. Metabolic and biochemical events causing neuronal death due to oxygen
shortage, and steps possibly useful to pharmacologie intervention. (1) Calcium channel
blockers, (2) Oxygen derived free radical scavengers, (2.1) Allopurinol, (2.2) Superoxide
dismutase, (2.3) Catalase, (3) Excitatory amino acid antagonists, (4) Arachidonic acid
cascade inhibitors, (5) Indomethacin and other cyclo-oxygenase inhibitors, (6) Seizure
suppressants. Reperfusion temporarily aggravates the condition of the nervous system.
Arachidonic acid is the precursor for highly active compounds as
thromboxane A2 and prostacyclin. These substances have opposite functions:
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vasoconstriction versus vasodilation, platelet aggregation versus inhibition of
aggregation. Normally the production of these compounds is adequately balanced.
During lack of oxygen however, prostacyclin synthesis is inhibited and
thromboxane A2 synthesis increases, stimulating vasoconstriction and platelet
aggregation. This vasoconstriction keeps thromboxane A2 locally, but during
reoxygenation the resulting vasodilation spreads thromboxane A2 over a larger,
and probably healthy, cerebral area (38). This is called the oxygen paradox:
reoxygenation aggravates the cerebral condition. Moreover, oxygen results in
formation of free radicals due to metabolism of hypoxanthine and xanthine (see
ad. 2.5.5). There remains even a third negative impact of oxygen, since during
reoxygenation the accumulated arachidonic acid serves as a substrate for two
different oxidative enzymatic pathways. The lipo-oxygenase pathway on the one
hand metabolizes arachidonic acid to the leukotriene system that effectively
contributes to the generation of more oxygen derived free radicals (149). These
radicals tend to perpetuate a chain reaction since they accelerate the formation of
arachidonic acid via phospholipid degradation and lipid peroxidation. The cyclo-
oxygenase pathway on the other hand contributes to the formation of a host of
prostaglandins. The net vascular effect of prostaglandin formation in the brain will
be vasoconstriction, since the postasphyxiai brain has only a low capacity to
synthesize the vasodilator prostacyclin (38), while the production rate of the potent
vasoconstrictor thromboxane A2 is high (150). The resulting postischemic
hypoperfusion could indeed be prevented by pretreatment with indomethacin, an
inhibitor of cyclo-oxygenase activity (151).
2.5.7. Excitatory neurotransmitters
Maintaining brain function requires a delicate balance between excitatory
and inhibitory neurotransmitter activity. Well-established excitatory
neurotransmitters include acetylcholine, dopamine, norepinephrin, and serotonin,
whereas inhibitory neurotransmitters include gamma-aminobutyric acid and
glycine. More recently the functioning of glutamate has been elucidated (152).
Membrane receptors can be activated by glutamate, followed by opening of
channels through which ions can pass independent of the electrochemical (voltage)
gradient across the plasma membrane (153). Glutamate toxicity is considered a
major factor in the production of hypoxic-ischemic injury of selectively vulnerable
neurons, /.e., those nerve cells predominantly innervated by glutaminergic neurons
(154). The so-called exc/fo/ojt/c fry/wtf/iesw of neuronal death (153) implicates that
oxygen shortage depolarizes neuronal membranes causing the synaptic discharge
of the excitatory neurotransmitter glutamate. Glutamate opens the voltage
dependent, N-methyl-D-aspartate specific receptor, allowing calcium to
accumulate in the neuron (155). Although experiments are reported in which N-
methyl-D-aspartate antagonists reduced brain damage after stroke or
hypoglycémie coma, a unifying hypothesis for the role of calcium causing cell
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dysfunction and cell death has not yet been provided (153). Recently however, it is
suggested that calcium activates an oxygen dependent neuronal nitric oxide
synthetase, which oxidizes arginine to produce nitric oxide when oxygen is
readmitted to the cerebrum during reoxygenation. Nitric oxide reacts with the
oxygen radical superoxide and powerful cytotoxic oxidants (as, e.g., the hydroxyl
radical) are formed (156). This hypothesis is consistent with available evidence on
the protective action of N-methyl-D-aspartate blockers /« v/fro (157) and /n v/vo
(158). Due to its role in the control of cerebral perfusion after oxygen shortage,
nitric oxide may elevate the level of oxygen derived free radicals and thus induce
part of the secondary neuronal damage (159). Most experiments however were
conducted in ischémie conditions, entirely different from intrauterine asphyxia
where cerebral blood flow increases until the moment that cardiac output falls.
Moreover, it should be noted, that two amino acids that inhibit synaptic
transmission are also released. Both gamma-aminobutyric acid and taurin in high
concentrations tend to counterbalance the hyperstimulation of postsynaptic
neurons induced by the excitatory neurotransmitters, and may therefore play a role
in prevention of neuronal damage.
2.6. Significance of maturity of the fetal brain
Evidence that the immature animal has a greater tolerance to suffocation
than the mature animal was already provided in 1670. Newborn rat pups were
enclosed in a jar with an adult rat and a burning candle. After the candle had
expired the young animals survived longer than the adult animal (160). That the
immature brain can withstand longer periods of oxygen shortage compared with
the mature brain can be explained by differences in structure, differentiation and
basal energy demands. The immature brain has smaller and less branched
neurones with fewer synapses, and has therefore smaller energy demands than the
adult brain (161,162). During oxygen shortage immature rats can preserve cerebral
circulation and maintain their energy metabolism for a longer period.
Histological damage after cerebral oxygen shortage is also different in
premature infants compared with term infants. Although at microscopic level
neuronal or myelin necrosis is the main phenomenon observed, the localization of
the lesions varies according to conceptional age at the time of the injury. This
appears to be due to a different distribution of blood supply during gestation (163).
In preterm infants the main lesion observed is periventricular leukomalacia, often
occurring in the white matter region that involves the myelinated fibers descending
from the cortical pyramidal cells to innervate mainly the legs, but also the arms
and hands (164). Thus, spastic diplegia appears to result of periventricular
leukomalacia in premature infants who survive the neonatal period. In children of
more than 35 weeks' gestational age, the cortical neurons of the cerebrum, basal
ganglia, brainstem, and Purkinje cells of the cerebellum appear to be more
vulnerable. The precise reason for this change of susceptibility is not known,
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although for the cerebellum there is a relative lack of blood vessels to the outer
layers, containing the Purkinje cells ( 121 ).
A final remark concerns the plasticity of the brain: although individual
neurons may be irreversibly damaged by a previous event, other neurons may
recover and take over the function of the dead neuron. This plasticity is
demonstrated after antenatal hypoxia in rats: with maturation abnormal behaviour
disappears (165).
2.7. Histologie evaluation of brain damage
Morphology has the advantage that cellular changes cannot only be
visualized and quantified, but also exactly localized. Histology is important in
research directed toward the occurrence of damage, in experiments with
cerebroprotective drugs, but also postmortem to verify or reject whether asphyxia
resulted in brain damage, a matter increasingly important due to medicolegal
aspects associated with it.
In chapter 2.6 the distribution of lesions according to the gestational age at
the time of asphyxia has been described. Preterm occurring lesions are localized
periventricular, whereas at term, the cortex, basal ganglia, brainstem, and Purkinje
cells of the cerebellum are affected. Brown and Brierley divided the changes after
hypoxia-ischemia into four main categories, which they called in ascending order
of severity, microvacuolation, ischémie cell change, severe cell change, and finally
cell loss (166). The microvacuoles seen could be identified as severely swollen
mitochondria (46). However, it is far from easy to recognize whether the observed
empty space is constituted of a swollen neuronal process or a hydropic astrocyte,
especially since phagocytosis eliminates damaged cerebral cells. These cells are
then replaced by proliferating hematogenous and glial cells and hence do not leave
an empty space at all (167). Two types of cerebral cell changes remain dominant
and are reproducable to recognize after hypoxia-ischemia: coagulative cell
changes, restricted to the neuronal compartment, and edematous cell changes,
mainly occurring in the astrocytic compartment (168). The type of change and the
extent of damage seems to be determined not only be the original oxygen shortage,
but also by factors such as additional acidemia (168), high density of calcium
channels (147,148), and the number of glutamate receptors (148,150). Many of the
observed changes are fully reversible in conditions of reoxygenation (168). The
large variability in models, experimental setups, and methods of morphologic
evaluation of tissue, does not facilitate interpretation and comparison of histologie
data.
2.8. Neonatal outcome
Substantial or prolonged perinatal asphyxia of the full term infant,
sufficient to result in permanent neurologic damage, essentially always produces
manifestations of neurologic dysfunction during the early days of life. Conversely,
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an infant who does not show neurologic dysfunction in the early nursery period
has not suffered from perinatal oxygen shortage severe enough to result in
neurological deficits (169,170). The American College of Obstetricians and
Gynecologists and the American Academy of Pediatrics have recently defined
criteria that must be present when perinatal asphyxia occurs that has the potential
for resultant neurologic deficits. A// of the following must be present: (I) profound
umbilical artery metabolic or mixed acidemia (pH <7.00), (II) persistence of an
Apgar score of 0 to 3 for longer than 5 minutes, (III) neonatal neurologic sequelae
(e.g., seizures, hypotonia, coma), and (IV) multiorgan system dysfunction (171).
The presence of only one of these factors at birth is considered insufficient
evidence to substantiate that asphyxia led to the neurologic deficit observed in
childhood. This agrees with experimental data (172). Severe asphyxia causes
injury to tissues other than the central nervous system: abnormalities of renal
function with oliguria or elevated creatine levels, pulmonary hypertension,
meconium aspiration, hepatic dysfunction, necrotizing enterocolitis, thrombo-
cytopenia, disseminated intravascular coagulopathy, and even myocardial
dysfunction may provide supporting evidence of prior asphyxia and its severity
(173,174).
Since cerebral damage accounts for significant morbidity after asphyxia,
chapter 2.8 will be limited to the brain. Oxygen shortage sufficient to result in
brain dysfunction will produce encephalopathy. The manifestation of this
encephalopathy varies with severity and duration of the insult, with degree of
development and maturity, and with presence or absence of underlying deficits in
brain substrate. Severity of the encephalopathy can clinically be scored according
to Sarnat (175) (Table 2.2). Scoring and evolution in days is important because the
score has a prognostic value. Newborns with evidence of mild encephalopathy
(Sarnat stage 1) had a normal neurologic outcome, 80% of those with moderate
encephalopathy were neurologically normal, and a// of the children with severe
encephalopathy (Sarnat stage 3) died or had neurologic sequelae (176). This
agreed with the original data from Sarnat: infants who did not enter stage 3 and
had signs of stage 2 less than 5 days appeared normal in later infancy. Persistance
of stage 2 for more than 7 days or failure of the EEG to revert to normal was
associated with later neurologic impairment or death (175). In conclusion, the
neonatal course appears to give additional evidence of degree and duration of the
prior oxygen shortage insult and offers information of prognostic importance
(177,178).
Cerefera/ pa/sy is a term used to describe a group of diverse nonpro-
gressive syndromes that affect the brain and are associated with impaired motor
function. The onset is presumed to be either before or at the time of birth, or in
early childhood (179). The most frequently used catagories of cerebral palsy
include diplegia (or paraplegia), a form where the legs are primarily affected;
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Table 2.2. Scoring of encephalopathv
Level of
consciousness
stage 1
mild
hyperalert
Neuromuscular control
- muscle tone
- posture
- strech reflexes
- myoclonus
Complex reflexes
- suck
- Moro
- oculovestibular
- tonic neck
Autonomie function
- pupils
- heart rate
- bronchial and
salivary
secretions
- gastrointestinal
motility
Seizures
Electroencephalo-
gram findings
Duration
normal
mild distal
flexion
overactive
present
weak
strong; low
threshold
normal
slight
generalized
sympathetic
mydriasis
tachycardia
sparse
normal or
decreased
none
normal
(awake)
< 24 hours
according to Sarnat
stage 2
moderate
lethargic or
obtunded
mild hypotonia
strong distal
flexion
overactive
present
weak or absent
weak; incomplete;
high threshold
overactive
strong
generalized
parasympathetic
miosis
bradycardia
profuse
increased.
diarrhea
common; focal
or multifocal
early; low voltage.
delta and theta,
later: periodic
pattern
Seizures; focal
1 to 1.5 Hz, spike
and wave
2 to 14 days
(175)
stage 3
severe
stuporous
flaccid
intermittent
decerebration
decreased or absent
absent
absent
absent
weak/absent
absent
both systems
depressed
variable;
unequal; poor
light response
variable
variable
variable
uncommon.
decerebrated
early: periodic
pattern with
isopotential
phases, later:
totally iso-
potential
hours to weeks
Extrapyramidal (or dyskinetic) types of cerebral palsy include choreoathetosis and
ataxia. Cerebral palsy affects 2 in 1,000 children in the USA (180). Historically,
asphyxia during labor and delivery has been implicated as a major cause of
cerebral palsy (181). In the last decade however, a number of large population
studies have revealed that asphyxia probably accounts for only a relatively small
proportion of cerebral palsy cases. The National Collaborative Perinatal Project
studied prospectively the outcome of over 40,000 live births in the USA between
1959 and 1966. From neonates with an Apgar score <3 at 5 minutes, more than
95% did not develop cerebral palsy (182). In a multivariate analysis of 189
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children with cerebral palsy studied up to the age of 7 years, maternal mental
retardation, birth weight below 2001 g, and fetal malformations were the leading
predictors for cerebral palsy. Breech presentation was also a predictor, but breech
delivery was not. The proportion of cerebral palsy that could be attributed to
asphyxia was between 3% and 13% (183). This is in accordance with the
prospective study of more than 43,000 patients undertaken to determine the causes
of cerebral palsy, where only 6% of all cerebral palsy patients had suffered from
birth asphyxia (184). Western Australian data support these findings: only in
about 8% (15/183) of children cerebral palsy was possibly attributable to
intrapartum asphyxia (185). Other reasons for cerebral palsy are trauma,
developmental abnormalities, infections (toxoplasmosis, congenital herpes, cyto-
megalovirus, beta-hemolytic streptococci), radiation, maternal toxemia,
intrventricular or subarachnoid hemorrhage and hemolytic disease of the newborn,
leading to kernicterus (179). The critical period for development of brain damage
underlying cerebral palsy was considered the 26'^ to 34'^ week of gestation in
particular. This implies that in infants born at term damage occurs during late
intrauterine life, while in most preterms damage is established in early neonatal
life (186).
In conclusion, most cases of cerebral palsy originate from causes other
than asphyxia. Moreover, the majority of even quite severely asphyxiated babies
suffer no detectable neurologic or intellectual sequelae. The latter findings are
based on epidemiologic observations and suggest that resuscitative efforts in
mature newborn infants ought not be too quickly abandoned for fear of late
sequelae. Finally, when neurologic symptoms are present, the first days to weeks
of life are of prognostic importance.
2.9. Treatment
The condition of a neuron after hypoxic-ischemic energy shortage is
fragile. The cell membrane is weak and due to activation of catabolic enzymes
partly damaged, and mitochondria are suffering from internal elevated calcium
levels. Finally, when the enzymes of cellular metabolic pathways denaturate due
to elevated calcium concentrations, cell death results. It is impossible to revitalize
neurons in which energy providing systems are absent. Therefore, treatment has to
be concentrated on the penumbra, the area surrounding the primarily affected
area. Neurons in the penumbra are still functioning, but may also get damaged
when, during reperfusion or reoxygenation, oxygen derived free radicals,
glutamate and thromboxane A2 are released. Research on treatment of neuronal
damage after oxygen shortage is mainly focused on protection of the penumbra.
In medicine we do not induce asphyxia, but diagnose it. We are not
informed about the lag-period between the occurrence of asphyxia and the
moment it is diagnosed, or about its severity. Asphyxia long before birth has
already led to irreversible damage. Therefore, the window for treatment is
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hampered by unknown variables. Pretreatment of fetuses at risk for asphyxia
implicates over-treatment of the normally oxygenated fetuses.
The damaging effect of perinatal asphyxia, recognized at birth, seems to
be, at least in part, preventable by various drugs (187). A drug, effective against
the damaging action of oxygen lack in the brain has to fulfill at least three
important criteria (188): (I) Hemodynamically: the drug should possess
antivasoconstrictive activity, without causing systemic vasodilation or impairment
of autoregulation. Cardiac depression should be absent, and preferably the drug
should be brain vessel selective. (II) Pharmacokinetically: the drug should easily
be able to cross the blood-brain barrier and remain bioavailable once penetrated.
(HI) The drug should increase the tolerance to lack of oxygen, and be effective not
only />e/oré> but, more important, a/ter the period of oxygen shortage.
Possible intervention to reduce neuronal damage after oxygen shortage is
indicated in Figure 2.8. Calcium channel blockers, oxygen derived free radical
scavengers, anticonvulsants, excitatory neurotransmitter antagonists, neurotrophic
growth factors, and gangliosides are discussed in more detail. Most of these drugs
meet the criteria to be used against the damaging action of oxygen lack (188).
Calcium channel blockers may limit the influx of calcium into neurons
and therefore reduce the amount of primary neuronal death after asphyxia.
Flunarizine is a lipid soluble calcium channel blocker that crosses the blood-brain
barrier well (189), and has minimal cardiac depression. Rats, pretreated with
flunarizine before a hypoxic-ischemic insult, had less brain damage than untreated
controls. Detailed histological analysis confirmed that in all cerebral areas
significant protection was achieved (190,191). A benefit of the calcium blocker
nimodipine was shown in patients with symptomatical clinical cerebral vasospasm
or with severe angiographie vasospasm: secondary ischémie brain damage was
reduced (192). Not all studies on calcium channel blockers showed beneficial
effects: a dramatic decrease of blood pressure and skin perfusion in severely
asphyxiated neonates was observed after administration of nicardipine, and
therefore continuation of the study was not warranted (193).
Free radical scavengers ( 194) or drugs that control cerebral edema ( 195)
may have neuroprotective actions, at least in mature animals. Pretreatment of
newborn sheep with superoxide dismutase and catalase, enzymes that promote the
breakdown of H2O2 to inactive compounds, prevented the secondary hypoper-
fusion of the brain following asphyxia (141). The xanthine-oxidase inhibitor
allopurinol, administered before hypoxia-ischemia in 7 day old rats showed reduced
cerebral edema and reduced histological brain damage (196). Calcium channel
blockers and oxygen derived free radical scavengers are considered important in the
prevention of primary neuronal damage. Experimental treatment is generally started
fo/ore the asphyxiai event (141,190,191,196), although a combination of oxygen
derived free radical scavengers with magnesium administered in 1 week old rat
pups during resuscitation q/ter asphyxia also showed protection (197).
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Seizures are regarded as a result of neuronal damage, but moreover,
seizures may aggravate cerebral damage. The use of anticonvulsants is proposed to
reduce post-insult epileptiform activity and the secondary neuronal death related to
this overexcitability of neurons. Treatment may therefore be started a/ter the
insult. Intense epileptiform activity leads to spreading depolarization in the
neocortex (198), edema, and cell death /'/i v/rro (199). In adult rats epileptiform
activity for more than 30 minutes can cause rapid neuronal death (200,201), and
the onset of postischemic convulsions was closely related with the delayed death
of cortical neurons (202). In clinical studies, onset of seizures immediately after
asphyxia and prolonged seizures are early predictors of infants who will die or
have significant neurologic sequelae (203,204,205). In an effort of postasphyxiai
therapy barbiturates have not shown consistent benefit either experimentally or in
humans (206,207). Classic anticonvulsants (as, <?.#., diazepam) are often
ineffective in treating seizures after asphyxia in neonates (208,209). The reason for
this could be activity of excitatory neurotransmitters (210).
Recently, it has been postulated that cerebral oxygen shortage may
interfere with normal neuronal development and thus induce brain damage.
Normally suppressed programmed cell death (apopfo.s/.y) may be activated.
Neuronal hyperexcitability induces a marked rise of /leurofrapto/c /actors. These
factors appear to be endogenously protective and may play a role in repair/-
recovery processes after oxygen shortage. Insulin-like growth factors and their
binding proteins fibroblast growth factor (211) and calcitonin generated peptide
(212) are neurotrophic m v/fro (213), m v/vo (214), and after asphyxia (215).
Administration of these growth factors can improve outcome when given after the
insult, showing the importance of trophic factors (215,216). As apoptosis normally
occurs in neurons that fail to make connections to trophic support, it is tempting to
speculate that additional trophic support, provided by growth factors, may
overcome the inappropriate activation of the programmed cell death cascade (217).
Finally, also gangliosides are described in protecting the cerebrum against
hypoxic-ischemic injury. Gangliosides are a family of glycosphingolipids that are
endogenous components of the plasma membrane. Pretreatment with a
monosialoganglioside in near term fetal sheep showed improved recovery of
cerebral edema, reduced epileptiform activity, and reduced histological damage
after hypoxia-ischemia (218).
In conclusion, cerebral outcome after severe oxygen shortage varies
considerably depending on a multitude of known and unknown factors. The
diversity of pharmacologie treatment is a reflection of the various pathways
leading to neuronal damage. Moreover, this range of different drugs indicates lack
of complete insight into pathophysiology as well as ineffectiveness of therapy.
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3.1.Surgery s K ^;-
Surgery was performed in 47 Dutch Texel sheep of known mating dates
between 110 and 128 days gestation (mean ± SD = 120.0 ± 2.8 days, term = 147
days).
General anesthesia was induced with intravenous pentobarbital and
maintained with 1% halothane in a 2:1 mixture of nitrous oxide and oxygen. Ewes
were placed in left tilted Trendelenburg position to avoid compression on the
inferior vena cava and the associated uterine hypoperfusion. Legs were fastened
upon the operating table. Before surgery ewes received intravenous 1 g of
ampicillin. Abdomen and left flank of the ewe were shaved, cleaned, and twice
rinsed with an iodine solution. The ewe was covered with sterile drapes except for
the lower abdomen in the midline.
Under sterile conditions, a paramedian abdominal incision was made. The
uterus was lifted out of the pelvis for a maximum period of 3 minutes, since this
maneuver interferes with uterine circulation. The distal aorta of the ewe ends in a
trifurcation: the external iliac arteries provide mainly hindlimbs, genitals, and
udders with blood and the common internal iliac artery, which divides in two
branches (usually 0.5 to 3.0
cm distal from the trifurcation)
and supplies mainly both
uterine horns. The vascu-
larization pattern of the main
pelvic organs is summarized in
Figure 3.1.
abdominal aorta
internal spermatic artery
M- caudal mesenteric artery
external iliac artery^-genitals
^udders
common internal artery
cranial gluteal artery
umbilical artery
median uterine artery
cranial vesical artery
caudal vesical artery
caudal uterine artery
Figure 3.1. Vascularization
pattern of the main pelvic organs
in Dutch Texel sheep.
Reproduced with permission (1).
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The retroperitoneal space over the trifurcation of the aorta was opened and
the vessels were exposed by sharp and blunt dissection. An inflatable balloon
occluder was placed around the maternal common internal iliac artery and secured
with a linen tie. If the occluder could not be placed within the maximum period of
3 minutes, this procedure was repeated after 3 to 5 minutes. In contrast to
primates, sheep have thin uterine musculature and a cotyledonous placenta. The
uterus was incised in an area free of cotyledons. The incisional site was chosen to
be able to extract at first the cranial part and afterwards the caudal end of the fetus,
through the same aperture. Polyvinyl catheters used had an outer diameter of 1.6
mm and an inner diameter of 0.8 mm (Talas B.V., Ommen, the Netherlands). Fetal
instrumentation involved:
- insertion of a polyvinyl catheter in the axillary artery, the tip advanced to the
level of the brachiocephalic trunk.
- placement of isolated fine multistranded stainless-steel wires (AS 632, Cooner
Sales Co., Chatsworth, California, USA) over the dura of the parietal cortex
through burr holes 1 cm lateral from the midline and a reference electrode fixed
subcutaneously in the midline between both parietal electrodes, for recording of
the fetal electrocorticogram (ECoG).
- placement of a polyvinyl catheter in the spinal cavity to obtain CSF. A midline
incision was made in the dorsal surface of the fetal neck, and the epidural cavity
was opened (2). Epidural fat, containing small veins, was carefully swept away
with a cotton-tipped applicator and the spinal cavity was opened with a needle.
The catheter was inserted through the puncture hole into the spinal cavity and
advanced 1.0 to 2.0 cm cranially until adequate CSF sampling was possible.
The catheter was fixed with tissue glue and sutured to the fetal skin. Its tip was
located in the spinal cistern. CSF that appeared after opening of the spinal
cavity was sampled with a 1 mL syringe.
- placement of electrodes, made of stranded silver plated copper wire isolated
with extruded Teflon, subcutaneously at the level of the cardiac apex and at the
upper part of both forelegs for recording of the fetal ECG.
- insertion of a polyvinyl catheter in the femoral artery, the tip advanced to the
level of the descending aorta.
- insertion of a polyvinyl catheter in the femoral vein with the tip advanced into
the inferior vena cava.
- insertion of a polyvinyl catheter in the trachea.
- insertion of a polyvinyl catheter in the amniotic cavity.
After fetal instrumentation lost amniotic fluid was replaced by warm
(39°C) saline and the uterus was closed in two layers. Catheters and wires were
exteriorized through a small incision in the ewe's flank. A small pouch attached to
the ewe's flank protected catheters and electrodes during the recovery period.
Finally, the abdominal wall of the ewe was closed.
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After surgery ewes were housed in individual cages with free access to
food and water (Figure 3.2) and were allowed to recover for at least 3 days before
experiments were started. A continuous slow infusion (1 mL/hour) of heparin in
saline (10 U/mL) was used to maintain patency of fetal arterial and venous
catheters. Guidelines for care and use of animals as approved by the local Animal
Medical Ethics Committee were followed.
Figure 3.2. The cage in which the ewe recovered from surgery, and some equipment used
for data recording and analyzing.
32 . Measurements
Pa and Pv, trachéal pressure, and amniotic pressure were determined with
the zero point at the level of the ewe's spine. These signals, together with the fetal
ECG, the fetal ECoG and the FHR, derived from the pulsatile signal of the femoral
artery, were fed into bioelectric amplifiers (Hewlett Packard 8800 series, Andover,
Massachusetts, USA), displayed on a monitor, recorded on an eight-channel strip
chart recorder, stored on magnetic tape, and digitized and analyzed with a
computer. An example of a tracing obtained is shown in Figure 3.3.
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venous blood pressure
fetal heart rate
arterial blood pressure
amniotic pressure
fetal breathing activity
electrocortical activity
electrocardial activity
1/100 minute 1 minute
Figure 3.3. Registration of a fetus during the baseline period. Parameters measured are
indicated. The left part of the figure is recorded at 3 m/min, the right part at 3 cm/min.
Regional blood flow was measured with radioactive microspheres. With
this technique microspheres with various energy spectra are injected into the heart.
The left ventricle acts as a mixing chamber. Well-mixed spheres will subsequently
be carried by the arterial system to various organs and tissues, and due to their
diameter of 15 urn the microspheres will be trapped in the microcirculation during
their first passage. The total amount of injected microspheres will be distributed in
proportion to the blood flow to each organ, presuming even distribution of the
spheres in the arterial blood (3). In random order, one out of five available
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microspheres (^Scandium, ^Niobium, '^Ruthenium, "*Tin,and '^'Cerium) was
injected. Aggregation of microspheres was prevented by adding 0.05% Tween 80
to the injection medium. After homogenization in an ultrasonic waterbath at 39°C
(Bransonic 5200, Soest, the Netherlands) for 20 minutes, approximately 0.5x10^
microspheres were stirred on a vortex agitator. The 0.5x10^ microspheres formed a
volume of 0.5 mL, which was mixed with approximately 2.0 mL of fetal blood,
withdrawn from the inferior vena cava. After mixing, the 2.5 mL volume was
infused over a period of 1 minute into the inferior vena cava (3). Reference
sampling (1.80 mL/min) (Harvard Apparatus Ltd., Kent, England) was started
from the brachiocephalic arch 30 seconds before infusion, continued during
infusion, and stopped 1 minute after infusion. The rationale for reference sampling
is to mimic a fetal organ from which the perfusion rate is exactly known. By
comparing radioactivity in the reference sample with radioactivity in fetal organs,
organ blood flow can be calculated. The precision of the radioactive microsphere
technique depends mainly on the number of microspheres in reference samples
and organs studied, and not on the amount of radioactivity, since counting
accuracy can be improved by longer counting times if the count rate is very low. If
however, small numbers of microspheres lead to marked random variability of
their distribution to different organs, no degree of counting accuracy will correct
the error (4). At least 400 microspheres in each reference and tissue sample are
considered necessary for reliable measurements (4). Since the microspheres act as
emboli, obstructing the vessel and causing cellular damage distal from the site of
entrapment, the number of spheres injected must be chosen carefully: too much
will lead to ischémie tissue damage whereas too little will give rise to inaccuracy.
Blood gas values and pH from the fetal aortic arch were measured with an
automated analyzer (AVL or AVL 995, Radiometer, Copenhagen, Denmark) and
corrected for 39°C. The percentage of saturation of Hb was measured (OSM2
Hemoximeter, Radiometer). Measurement of the arterial PO2 alone might lead to
erroneous results, since retention of CO2 induces a respiratory acidosis, which due
to the rightward shift of the oxygen dissociation curve tends to result in an oxygen
tension being maintained despite a substantial drop in arterial oxygen content
([C^Ja) (5). Therefore, a more valid measure of oxygen amount in arterial fetal
blood is the [C^Ja, calculated as follows:
[Cya (mM) = Hb level (mM) x Hb oxygen saturation (%/100) + POj (mm Hg) x 0.0031.
In this calculation the freely dissolved oxygen is represented by (PO2 x
0.0031). This additional factor accounts for a small amount of oxygen and is not
mentioned any further in [C^Ja calculations.
After the microsphere injection, 2 mL of blood were withdrawn from the
axillary artery and centrifuged (3 minutes at 13,000 revolutions/min). Serum was
frozen in liquid nitrogen and stored at -73°C. After all experiments had ended
serum lactate concentrations were determined in these samples.
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CSF obtained during surgery and during the experiment was withdrawn
with a 1 mL syringe, centrifuged (3 minutes at 13,000 revolutions/min), frozen in
liquid nitrogen, and stored at -73°C. Levels of nucleosides and purine bases in
CSF were determined with high performance liquid chromatography, discussed in
chapter 8.
3-3 Experiments
Gestational age during experiments varied between 113 and 132 days
(mean ± SD = 123.5 ± 3.0 days). Baseline values for FHR, Pa, and Pv were
obtained during a control period of at least 2 hours. Fetal acid-base balance was
analyzed every 15 minutes. The amount of blood sampled during the entire
experiment was less than 30 mL (which is less than 10% of the initial fetal blood
volume). Since the experiments lasted for a prolonged period this is not considered
to result in major alterations in fetal cardiovascular functioning or metabolic
condition: the fetus will rapidly return its blood volume to normal by increasing
plasma renin activity, arginin vasopressin, and norepinephrine levels (6).
Individual gestational ages, treatment and survival, as well as the chapter
in which each fetus is used, are depicted in Table 3.1. The experimental set-up for
all 47 instrumented fetuses is comparable and shown in Figure 3.4.
surgery
-5 to -3 days
baseline
*
-180 -120
occlusion
-- -^
severe
asphyxia
*
-60 0 60
recovery
* *
120 180 240
time in minutes
fixation
^-
+3 days
Figure 3.4. Experimental protocol. Astem/cs indicate fetal blood flow measurements and
fetal serum sampling.
Animals received either flunarizine (chapter 4), the adenosine transport
inhibiting drug R-75231 (chapter 5) or the inert solvent of both drugs (10% 5-OH-
propyl-B-cyclodextrine) at various moments during the experiment. Detailed
information on administration, pharmacology, and effects of these drugs is
described in the chapters mentioned above. Each experiment started with a
baseline period of at least 2 hours. During this baseline period radioactive
microspheres were administered to determine fetal blood flow to various organs.
When fetal metabolic condition was considered abnormal (pH <7.32, or BE <-6.0
mM) experiments were not performed.
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Fetal asphyxia was induced by stepwise inflation of the balloon occluder
around the maternal common internal iliac artery. Several methods have been
described to induce fetal asphyxia: umbilical cord occlusion, maternal hypoxemia,
and restriction of uterine perfusion. Fetal cardiovascular responses to various types
of stress are clearly different (7). Umbilical cord occlusion results in immediate
cardiovascular reactions as hypertension and bradycardia and resembles variable
fetal decelerations during uterine contractions. Prolonged severe umbilical blood
flow obstruction will lead to fetal asphyxia but is associated with fetal
cardiovascular changes, since occlusion leads to an acute increase in systemic
resistance. Maternal inhalation of a hypoxic gas mixture is associated with
maternal hyperventilation, discomfort, release of maternal catecholamines, and
disturbances in recording of fetal signals. Therefore, this method may not be
preferable. Restriction of uterine perfusion does not lead to maternal discomfort
and is closely resembling acute fetal oxygen shortage. Therefore, we preferred this
method to induce fetal asphyxia.
During the experiment the preductal aortic fetal acid-base balance and
blood gases were determined every 15 minutes. To maintain the fetus in a stable
hemodynamic condition, uterine blood flow was gradually reduced over a period
of 60 to 90 minutes, until fetal [C^Ja reached a value of approximately 35% of
baseline level and/or fetal pH <7.15. In human literature a pH of 7.15 is
approximately the mean - 2 SD (8,9). The total duration of occlusion could not be
standardized. Apparently the collateral blood supply to the pregnant uterine horn
varies considerably between animals. The time necessary to reach an [Cya of 35%
of baseline varied, especially since we aimed for a stable FHR, /.*>., without a
reflex bradycardia. An [C^Ja of 35% of baseline was considered the start of fetal
asphyxia, and therefore called time= 0 min. The [C^la was maintained at the same
level for 1 hour, during which the arterial pH decreased further. At the end of this
period of severe asphyxia, microspheres were again administered to determine
fetal blood flow. Uterine blood flow obstruction was then discontinued by
emptying the balloon occluder. This moment corresponds with time= 60 min. Fetal
blood flow was determined again at time= 90 and 180 min, corresponding with 0.5
and 2 hours after release of the occluder. Fetal recovery was monitored, and after
disconnecting the fetus from the amplifiers fetal Pa was checked regularly to
determine survival interval. During the disconnected period, no blood gas analysis
was performed.
3.4. Fixation procedure and histologie evaluation
Three days after fetal asphyxia (/.?., 6 to 8 days after instrumentation) a
relaparotomy was performed under general anesthesia. The fetus was completely
heparinized by 15,000 U intravenous heparin. The fetal heart was approached by
median thoracotomy. A blunt steel catheter was inserted in the left ventricle. The
right atrium was opened, and 500 mL of isotonic and buffered isocolloidal fluid
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Table 3.1. Characteristics of the 47 fetal
animal
number
8902
9002
9003
9005
9006
9007
9008
9009
9013
9014
9015
9016
9017
9018
9020
9023
9025
9026
9027
9028
9101
9103
9106
9107
9108
9109
9110
9112
9113
9114
9115
9116
9117
9119
9120
9126
9128
9204
9206
9207
9210
9214
9218
9303
9305
9306
9308
gestational age at:
surgery
121
117
116
118
115
120
116
123
118
121
121
124
123
128
110
120
118
119
120
120
122
120
120
119
120
118
120
124
120
121
119
123
123
118
118
119
119
120
120
121
119
123
119
124
119
123
120
experiment
125
121
120
123
119
124
120
126
121
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129
128
132
113
124
121
123
123
124
126
125
124
122
124
120
123
128
123
126
123
125
126
123
123
122
122
122
123
124
122
125
122
128
121
126
122
lambs used
treatment
flunarizine
flunarizine
solvent
solvent
solvent
flunarizine
flunarizine
solvent
flunarizine
solvent
solvent
solvent
solvent
flunarizine
solvent
flunarizine
flunarizine
flunarizine
flunarizine
R-75231
R-75231
R-75231
flunarizine
flunarizine
R-75231
R-75231
R-75231
R-75231
R-75231
R-75231
R-75231
solvent
solvent
solvent
R-75231
solvent
solvent
solvent
R-75231
solvent
R-75231
R-75231
solvent
R-75231
R-75231
solvent
solvent
used in
chapter no.
7
4.7
4.7
4,7
4,7
4,7.8
4,7,8
4.7.8
4,7,8
4.5,7
4,7,8
43,7
4.5,7
7,8
5,7,8
7.8
4,7
7
7,8
7,8
5.6.7,8
7.8
4,7
4,7
5.6,7,8
5,6,7,8
5,6,7
5,6,7
5,6,7,8
7
5,6,7.8
5.7,8
5,7.8
5.7
7
7
7.8
7
7
7
7,8
7.8
7
7
7
7
7.8
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(Haemaccel) at 39°C was infused into the left ventricle. The descending aorta was
clamped. When the fluid leaking from the right atrium was colorless, the fetal
brain was preserved by replacing the Haemaccel by Karnovsky's fixative (2%
formaldehyde and 2.5% glutaraldehyde in phosphate buffer 0.1 mol/L, pH 7.40),
approximately 1 L at room temperature. The time lag of 3 days between asphyxia
and histologie fixation is necessary to allow delayed neuronal cell death to become
histologically manifest (10). Subsequently, fetuses were removed and weighed,
and correct catheter placement was confirmed at autopsy after 3 days or earlier in
case of fetal death. After perfusion and 1 day immersion fixation in Karnovsky's
fixative the fetal brain was removed from the skull and was sampled for CBF
determination and histologie analysis.
Histologie analysis was performed according to a stereotaxic atlas of the
ovine fetal brain (11). After scintillation counting, vibratome sections (200 /<m)
were cut from eight cerebral areas: frontal cortex, parietal cortex, temporal cortex,
striatum, hippocampus, cerebellum, thalamus and medulla oblongata. Sections
were post-fixed in 2% osmium tetroxide, buffered with barbital acetate (0.05
mol/L, pH 7.40), dehydrated in graded series of ethanol, and routinely embedded
in Epon. Light microscopic evaluation was performed on 2 //m sections stained
with toluidine blue. Fixation quality was scored on a 10-point scale (12) in which
two characteristic types of hypoxic cell changes were evaluated: edematous cell
changes, mainly involving the glial compartment, and coagulative neuronal cell
changes. These cell changes were also scored on a 10-point scale (12).
3.5. Calculations and data analysis
FHR, Pa, and Pv were corrected for amniotic pressure, and averaged over
10 seconds periods by computer. Five of these epochs were averaged to calculate
mean Pa and Pv. Perfusion pressure (Pa-Pv) was calculated every 15 minutes.
The fetus was dissected to perform fetal blood flow measurements and
histology. Tissue samples were weighed (± 1 g), put into test tubes, and
additionally preserved in Karnovsky's fixative solution. For reasons of accuracy,
MBF was calculated from the mean flow of three samples out of left ventricular
base, middle, and apex of the fetal heart. The fetal cerebrum was dissected in the
eight anatomical entities mentioned before. The energy spectra of all isotopes used
in each animal were counted simultaneously. Radioactivity in tissue and blood
samples was measured with a gamma scintillation counter and sample changer
system (analyzer model 45, Molsgaard Medical, Horsholm, Denmark). Fetal blood
flow was calculated with an ND680 programmable analyzer/computer system
(Nuclear Data GmbH, Frankfurt, Germany). Since fetal myocardium and brain are
well-perfused organs, the amount of microspheres injected was sufficient to find at
least 400 microspheres in each sample, which is considered the minimum
necessary for accurate measurements (4).
For the ECG analysis the tape recorded fetal ECG was run through a
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commercially available cardiotocograph and ECG-analyzer (ST-analyzer, Cinventa
AB, Môlndal, Sweden), and analyzed with the aid of a microprocessor system
supplied by the same company. Filtering and signal processing used in this
analysis are described in chapter 7.
3.6. Statistics
Whenever groups are compared with each other, the two-tailed Mann-
Whitney U test is used. Differences within groups are compared with the
Wilcoxon matched-pairs signed-ranks test or with the Friedman two-way analysis
of variance, with time as the repeated measure. Occasionally Log rank-tests and
paired t-tests are used. To investigate the correlation between ECG-changes and
changes in pH and [Cya Pearson correlation coefficients are determined. A
p<0.05 is accepted as level of statistical significance.
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Abstract
Afeuroprotecr/ve propernV^ 0/ rne ca/ciwm c/ianne
/wve i»ee« re/jor/ec/ q/ïer /i^poxic-wcAe/n/c ini«/w in /mmafMre, in/anr,
raw. //owever, irs e//ecr on/<?to/ reg/ona/ cerefera/ è/ooc/y/ou' (CBFj an
ft/oorf pressure q/fer severe aip/iyjr/a is nof ^AIOIV/I. /u /5/e/a/ /awès (5 ro 5 days
a/rer surgery ; gesrafiona/ age a/ rfce experimen/ 723.2 ±2.5 a"aysj arteri'a/ oxygen
con^n/ was progress!ve/y re^ Mcea" fo 50% èy res/ricfion o/Mfer/ne 6/ooa'y7ow wiVn
an in/7ara6/f &a//oon occ/Ma*er arowna" f«e ma/erna/ common in/erna/ i//ac ar/ery.
7ne regiona/ CBF was measurea" wi/n raaVoactt've microspneres ar oase/me
cona"i'//on, a/fer 7 «our 0/severe asp/iyxia, ana" a/ 50 ana" 720 m/«Mfes in //ie
recovery p/iase. /mmed/are/y a/fer rne ena" 0/ rfce OCC/MSIO« per/oa*/e/«ses
rana"om/y receivea" ei7ner /fMnar/zine or i7s so/venf f0.5 mg/Â:g esr/ma/ea* /e/a/
wei'gnr). /Vo a"i//erences in regiona/ CBF cnanges oerween growps were observed
dKr/ng and q/rer aspnyjc/a. Cnanges in arreria/ b/ood pressure or/era/ nearr rare,
due /o y7MAiar/z/ne, co«/d no/ be ràovcn e/rner. On/y /ïve /erwses f=5i%j survived
rnis degree o/aspnyjc/a /onger rnan 72 nowrs./oMr 0/rne//«narizine-rrearedgroup
and one o/fne con/ro/ growp. 7f is Mn/i/:e/y rnar rnis possib/e prorecr/ve property 0/
rne drug is caused by 1rs i'n/7«ence on regiona/ CSF, on arfena/ b/ood pressure, or
on/e/a/ nearr ra/e in rne pnase immediafe/y q/'er aspnyjcia.
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Introduction
Brain damage due to perinatal asphyxia is a clinically relevant target of
research (1). In this respect important results have been obtained in neonatal and in
adult rats in which calcium channel blockers have shown structural and functional
brain protective properties in various experimental setups. Newborn and infant
rats, pretreated with the class IV calcium channel blocker flunarizine (2) and
submitted to hypoxic-ischemic insults, had less brain damage as compared to non-
treated controls (3-5). Flunarizine treatment after induction of cortical damage in
adult rats improved brain function and reduced infarct size (6). Regarding blood
flow, flunarizine decreased the rate of the stimulated calcium influx into vascular
smooth muscle cells of the rat tail and rabbit ear and, therefore, inhibited the
peripheral vasoconstriction and vasospasm evoked by tissue anoxia (7). After 10
minutes of complete ischemia in the adult dog, the brain protective effect of
nimodipine, a class II calcium channel blocker (2), was attributed to a nearly
doubled cerebral blood flow (8).
The fetus reacts to hypoxia with an increase in cerebral blood flow to
maintain cerebral oxygen delivery (9). The effect of flunarizine on fetal regional
CBF and on fetal cardiovascular parameters is not known. To mimic treatment
after fetal pathophysiology, we chose to administer flunarizine after a period of
severe asphyxia. The lack of oxygen results in energy failure, which leads to
impeded ATP-dependent Na^/K^-transport. The ensuing decrease in membrane
potential opens voltage-dependent calcium gates. Additionally, the decrease of the
transmembrane sodium gradient diminishes outward calcium transport.
Intracellular influx of calcium is an important factor in the mechanism of cell
death (10). The intracellular calcium concentration is normally maintained near
0.1 //M, which is 10,000 fold less than the extracellular calcium concentration
(11). Calcium shifts occurring with ischemic-anoxic energy failure are responsible
for massive calcium overload in neurons, leading to activation of phospholipases.
This results in accumulation of free fatty acids, and in swelling and edema of
neurons. The latter further compromises oxygen supply (12).
Flunarizine, a possible neuroprotective drug, was studied in the chronic
fetal sheep model, which allows accurate measurements of regional CBF, FHR,
Pa, and Pv during and after severe fetal asphyxia. The hypothesis tested was that
flunarizine improves regional CBF in the phase immediately after asphyxia and
that this may lead to improved fetal outcome after severe asphyxia.
Material and methods
Surgery
Surgery was performed in 15 pregnant Dutch Texel sheep. Gestational age
varied between 115 and 124 days (mean ± SD = 119.2 ± 2.3 days, term = 147 days).
General anesthesia was induced with pentobarbital i.v. and maintained
with 1% halothane in a 2:1 mixture of nitrous oxide and oxygen. Before surgery,
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the ewes received 1 g of ampicillin i.v. Instrumentation was performed as
described previously (13). Briefly, a paramedian abdominal incision was made,
and an inflatable balloon occluder was placed around the maternal common
internal iliac artery. Catheters were inserted in the fetal axillary and femoral artery,
and the tips were advanced to the level of the brachiocephalic trunk and
descending aorta, respectively. In addition, fetal catheters were placed in the
femoral vein, the tip advanced into the inferior vena cava, and in the amniotic
cavity. Electrodes were placed to record the fetal ECG and ECoG, and a catheter
in the spinal cistern allowing sampling of CSF. Catheters and wires were
exteriorized to the ewe's flank.
Ewes were housed in individual cages, had free access to food and water
and were allowed to recover from surgery for at least 3 days before experiments
were started. A continuous slow infusion (1 mL/hour) of heparin in saline (10
U/mL) was used to maintain patency of fetal arterial and venous catheters.
Guidelines for care and use of animals as approved by the local Animal Medical
Ethics Committee were followed.
Measurements
Regional CBF was measured by means of radioactive microspheres with a
diameter of 15 /<m. At random, one out of four available microspheres (^Nb,
H^Ru, ii3<j,^ ^nd '*'Ce) was injected. Aggregation was prevented by adding
0.05% Tween 80 to the medium. After homogenization in an ultrasonic 39°C
water bath (Bransonic 5200, Soest, the Netherlands) for 20 minutes, approximately
0.5x10^ microspheres were stirred on a vortex agitator and infused gradually over
a period of 1 minute into the inferior vena cava (14). Reference sampling (1.80
mL/min) was started from the brachiocephalic arch, 30 seconds before infusion,
continued during infusion, and stopped 1 minute after infusion, using a variable
speed peristaltic pump (Harvard Apparatus 1210, Edenbridge, England).
Pa, Pv, and amniotic pressure were determined with the zero point at the
level of the ewe's spine. These signals, together with the FHR derived from the
pulsatile signal of the femoral artery, were led to a bioelectric amplifier (Hewlett-
Packard 8800 series, Andover, Mass., USA), displayed on a monitor, recorded on
an eight-channel strip chart recorder, stored on magnetic tape, and digitized and
analyzed with a computer.
Immediately after microsphere injection, 2 mL of blood were withdrawn
from the axillary artery and centrifuged (3 minutes at 13,000 revolutions/min).
Serum was frozen in liquid nitrogen and stored at -73°C, to determine lactate
concentrations. Blood gas values and pH from the fetal aortic arch were measured
with an automated analyzer (AVL, Radiometer, Copenhagen, Denmark) and
corrected for 39°C. Hb saturation was measured with an hemoximeter (OSM2
Hemoximeter, Radiometer). The [O^la was calculated as follows: [O^Ja (mM) =
Hb concentration (mM) x Hb oxygen saturation (%/100).
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Experiments
Gestational age at the beginning of experiments varied between 119 and
129 days (mean ± SD = 123.2 ± 2.5 days). Baseline values were obtained during a
control period of 2 hours. Fetal acid-base balance was analyzed every 15 minutes.
baseline occlusion recovery
• ^ •
severe
asphyxia
*
—I 1 1 1
-180 -120 -60 0 60 120 180 240
time in minutes
Figure 4.1. Experimental protocol. Asteris&s indicate regional CBF measurement. The last
two measurements correspond with post-1 and post-2 in the text. Treatment consisted of
either flunarizine or its solvent.
Figure 4.1 shows the experimental protocol. After measurement of
regional CBF in the baseline control period, severe asphyxia was induced by
gradual reduction of maternal uterine blood flow by stepwise inflation of the
balloon occluder around the common internal iliac artery. To maintain the fetus in
a stable hemodynamic condition, uterine blood flow was gradually reduced over a
period of 90 to 120 minutes until fetal [C^Ja was reduced to approximately 30% of
the baseline value. This latter asphyxiai condition was maintained for 1 hour. At
the end of this period, at time= 60 min, regional CBF was remeasured ( « . * r / i in
Figure 4.1). Uterine blood flow obstruction was then discontinued by emptying the
balloon occluder. At this moment the animals were randomized and treatment was
started; seven fetuses received flunarizine (0.5 mg/kg estimated fetal weight),
whereas the control group consisted of eight fetuses receiving the solvent, 10% 5-
OH-propyl-6-cyclodextrine. To avoid possible side effects such as systemic
hypotension and tachycardia, we administered flunarizine or the solvent in 2
dosages over a period of 1 hour infused in the axillary artery. The first dosage was
given immediately after the period of severe asphyxia, the second infusion started
at time= 180 min. In the first animals fetal serum levels of flunarizine were
determined during various moments in the experiment. The regional CBF was
again determined at time= 90 min (post-1, which is during the first treatment) and
at time= 180 min (post-2, just before the second treatment).
The experiment was ended when either the fetus had died or, in case of
fetal survival, after 3 days. Then the ewe was killed by an overdose of pento-
barbital, the fetus was removed and weighed, and correct catheter placement was
confirmed. The fetal cerebrum was dissected into eight different anatomical
entities: frontal cortex, parietal cortex, temporal cortex, striatum, hippocampus,
cerebellum, thalamus, and medulla oblongata.
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Calculations and data analysis
Different tissue samples were weighed (± 1 g), put into test tubes, and
preserved in fixative containing a 2% formaldehyde and 2.5% glutaraldehyde
solution. All four isotopes were counted simultaneously. Radioactivity in the eight
cerebral entities and in the reference samples was measured with an automatic
gamma counter and sample changer system (analyzer model 45, Molsgaard
Medical, Horsholm, Denmark). The CBF was calculated with an ND680 program-
mable analyzer/computer system (Nuclear Data GmbH, Frankfurt, Germany).
FHR, Pa, and Pv, corrected for amniotic pressure, were averaged over 10
seconds periods using a computer program. Five of these epochs were averaged to
calculate mean values. Data obtained at several moments in the experiment within
one group were compared with a Friedman two-way analysis of variance, with
time as the repeated measure. Differences between the flunarizine-treated group
and the control group were tested with the two-tailed Mann-Whitney U test. A p
<0.05 was taken to represent statistical significance.
Results
Infusion of flunarizine resulted in fetal serum levels well within the
therapeutic range, /.e.,>200/*g flunarizine/L serum (15).
Table 4.1 summarizes the fetal acid-base balance at the four moments of
blood flow measurement. [O^Ja (mM), pH, PCO2 (kPa), BE (mM) and serum
lactate concentration (mM) are expressed at baseline condition, at the end of the 1
hour period of severe asphyxia (time= 60 min), at post-1, and at post-2 for both the
flunarizine-treated group and the control group. Uterine blood flow restriction
resulted in a reduction of the [O^la to about 30% of baseline level. After 1 hour of
severe asphyxia the mean pH had decreased to 7.08 and 7.09 in the flunarizine-
treated group and the control group, respectively. In the recovery phase, the mean
oxygen saturation did not return to baseline values. This resulted in an [C^Ja
significantly below baseline levels at post-1 and post-2, whereas pH and BE
increased only slightly. Serum lactate concentrations at post-1 and post-2 are in the
same range as in the period of severe asphyxia.
Table 4.2 shows the weight specific regional CBF in mL/min xlOOg
during baseline, asphyxia and post asphyxia, for eight cerebral areas. The amount
of microspheres used was sufficient, as all of the dissected tissues and samples
contained more than 400 microspheres (16). Adequate mixing was proven by the
absence of significant differences between the amount of microspheres in left and
right kidney. Baseline levels of blood flow in phylogenetic older structures as
cerebellum, thalamus and especially medulla oblongata were higher compared
with younger structures as cortices (Mann-Whitney U test, p <0.05). Blood flow
tonearly all parts of the brain more than doubled in response to asphyxia. At post-
1, during the first treatment, mean CBF decreased compared with asphyxia but had
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Table 4.1. Fetal acid-base balance
Flunarizine group
[C>2]a (mM)
PH
PCO2 (kPa)
base excess (mM)
lactate (mM)
Control group
[O2]a (mM)
pH
PCO2 (kPa)
base excess (mM)
lactate (mM)
Baseline
3.86
7.37
4.79
-3.5
1.5
±
±
±
±
±
0.44
0.02
0.28
0.9
0.3
Baseline
3.38
7.36
4.61
-3.5
1.8
±
±
±
±
±
0.34
0.03
0.24
1.0
0.2
Asphyxia
1.13
7.08
6.78
-15.4
11.2
±
±
±
±
±
0.24*
0.01*
0.49*
1.1*
2.6*
Asphyxia
1.14
7.09
5.96
-17.0
9.6
±
±
±
±
±
0.11*
0.03*
0.45*
0.7*
0.8*
Post-
2.64
7.13
5.52
-14.8
9.4
±
±
±
±
±
1
0.46*
0.02*
0.26*
1.4*
0.2*
Post-1
1.86
7.12
4.82
-16.8
9.0
±
±
±
±
±
0.29*
0.03*
0.23
1.3*
0.4*
Post-2
2.48
7.27
5.75
-9.7
10.8
± 0.73*
± 0.04*
± 0.41
± 2.4*
± 2.5*
Post-2
1.56
7.15
5.71
-13.3
11.9
± 0.32*
± 0.07*
± 0.70
± 2.6*
± 2.5*
Values are expressed as mean ± SEM. Asphyxia is at time= 60 min, post-1 is at time= 90 min,
and post-2 is at time= 180 min. n=8 for the control group and n=7 for the flunarizine group,
except at post-2, when n=7 and n=6, respectively.
*: p<0.05 (asphyxia, post-1, or post-2 versus baseline; Friedman two-way ANOVA.
not yet returned to baseline values. At post-2, CBF in the flunarizine-treated group
returned to baseline values, whereas CBF in the control group remained
significantly higher compared with baseline. However, no differences were
demonstrated between both groups, except for cerebellar flow, which was higher
in the control group at post-2.
Fetal cardiovascular parameters at the four moments of regional CBF
measurement are summarized in Table 4.3. During the experiment FHR increased,
whereas Pa and Pv did not change. Perfusion pressure (Pa-Pv) in individual
animals was calculated and did not change during the experiment. No differences
between groups could be demonstrated.
In Figure 4.2 the time course of FHR, Pa, [C^Ja, and pH for both
experimental groups is depicted. The time scale on the ordinate is the same as in
Figure 4.1. No significant differences between the groups in any of the four
parameters were demonstrated (two-tailed Mann-Whitney U test).
The entire experiment resulted in a mean fetal blood loss of 28.5 mL. This
consisted of approximately 25 x 0.1 mL for the various determinations of the fetal
acid-base state, added to 4 x 2.5 min x 1.80 mL/min for CBF measurements, added
to 4 x 2.0 mL for fetal serum analysis.
Fetal survival after severe asphyxia was poor: 10 animals (seven of the
control group versus three of the flunarizine-treated group) died during the first 12
hours. In each group one animal survived a very short period, reducing the number of
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animals to n=7 and n=6 at post-2 for the control group and the flunarizine treated
group, respectively. In both groups one fetal lamb died between 1 and 3 days. The
last three fetuses, all of the flunarizine-treated group, survived and were killed
after 3 days.
Table 4.2. Regional cerebral blood flow
Flunarizine group
Frontal cortex
Parietal cortex
Temporal cortex
Striatum
Hippocampus
Cerebellum
Thalamus
Medulla oblongata
Control group
Frontal cortex
Parietal cortex
Temporal cortex
Striatum
Hippocampus
Cerebellum
Thalamus
Medulla oblongata
Baseline
110
117
126
138
142
192
210
265
±
±
±
±
±
±
±
±
32
28
39
32
42
71
61
102
Baseline
114
101
89
148
120
161
201
196
±
±
±
±
±
±
±
±
25
20
18
30
21
32
29
41
Asphyxia
225
217
203
265
247
350
452
558
±
±
±
±
±
±
±
±
34*
43*
44*
51*
51*
47*
80*
76*
Asphyxia
275
260
221
341
289
422
501
578
±
±
±
±
±
±
±
±
50*
46*
41*
77*
65*
64*
89*
92*
Post-1
184
187
165
190
161
293
329
385
±
±
±
±
±
±
±
50
62
57
17
59
68
85
±123
Post-1
188
179
151
223
173
325
320
361
±
±
±
±
±
±
±
±
34*
24*
27
27
37
43
48
53
Post-2
124
121
122
139
149
201
229
292
±
±
±
±
±
±
±
±
20
19
23
21
23
330
39
70
Post-2
183
164
152
211
200
307
334
377
±
±
±
±
±
±
±
±
18*
14*
15
29*
21*
22*#
23*
39
Values are expressed as mean ± SEM (mL/minxlOOg). Asphyxia is at time= 60 min, post-1
is at time= 90 min, and post-2 is at time= 180 min. n=8 for the control group and n=7 for
the flunarizine group, except at post-2 when n=7 and n=6. respectively.
*: p<0.05 (asphyxia, post-1, or post-2 versus baseline: Friedman two-way ANOVA).
#: p<0.05 (flunarizine-treated group versus control group: two-tailed Mann-Whitney U test).
Discussion
To rationalize the use of calcium channel blockers in the treatment of
brain ischemia-anoxia, two major theories are developed. The first theory is the
augmentation of cerebral oxygen delivery. The mechanisms considered reponsible
are inhibition of calcium influx into vascular smooth muscle cells, thus relieving
the vascular spasm originating from anoxia (7). Another mechanism involved is
the inhibition of calcium influx into red blood cells, causing the erythrocyte
deformability to remain intact (17). Studies on the impact of calcium channel
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Table 4J. Fetal cardiovascular
Flunarizine group
FHR (beats/min)
Pa (mm Hg)
Pv (mm Hg)
Pa-Pv (mm Hg)
Control group
FHR (beats/min)
Pa (mm Hg)
Pv (mm Hg)
Pa-Pv (mm Hg)
parameters
Baseline
172
46.2
6.2
45.0
±
±
±
±
7
2.2
1.6
5.0
Baseline
180
51.6
4.5
47.2
±
±
±
±
12
2.5
0.9
3.4
194
45
5
39
221
48
4
43
\sphyxia
5
5
1
±
±
±
±
22*
3.7
1.5
3.9
Asphyxia
2
8
5
±
±
±
±
13*
3.8
3.8
3.6
Post-1
210
44.7
6.0
41.0
±
±
±
±
Post-1
212
48.2
7.5
40.7
±
±
±
±
13*
3.4
1.6
4.1
12*
3.7
1.0
3.4
Post-2
194
42.5
5.9
35.7
± 17*
± 4.3
± 1.4
± 4.8
Post-2
206
47.3
6.7
42.3
±31*
± 3.4
± 1.1
± 4.4
Values are expressed as mean ± SEM. Asphyxia is at time= 60 min, post-1 is at time= 90 min,
and post-2 is at time= 180 min. n=8 for control group. n=7 for flunarizine group, except at
post-2 when n=7 and n=6. respectively.
*: p<0.05 (asphyxia, post-1, or post-2 versus baseline; Friedman two-way ANOVA).
blockers on CBF and neurologic recovery after cerebral ischemia in adult dogs
have yielded conflicting outcomes. Results varied from considerable benefits to
total absence of improvement (8,18,19). The second theory is that calcium channel
blockers would directly reduce calcium entry into neurons, thereby enhancing
resistance to injury. Flunarizine proved to be a potent blocker of low-threshold
calcium channels (20). Maintaining low intracellular concentrations of calcium is
an important modality in the prevention of cell death (10,12). Van Reempts ef a/
(21) observed a reduced infarct size after photochemically induced thrombosis in
spontaneously hypertensive rats and postulated based on histologie findings that
flunarizine might contribute to preservation of the integrity of endothelial cell
membranes (reduction of platelet adhesion and vasogenic edema formation), of
neuronal cell membranes (inhibition of calcium overload), and of glial cell
membranes (prevention of cytotoxic edema formation). More recently, flunarizine
enhanced neuronal survival in lumbar sensory ganglia from newborn rats after
axotomy (22). The researchers suggested that this effect was caused by unknown
intracellular acting mechanisms, distinct from blockade of voltage-dependent
calcium channels.
Before considering the use of calcium channel blockers in the treatment of
perinatal asphyxia, extensive animal research on the effects of these drugs on fetal
brain circulation, metabolism, and function are needed (1). The present study not
only focuses on the effect of flunarizine on the fetal regional CBF after asphyxia
but also analyzes the effect on FHR and fetal systemic blood pressure. Flunarizine
is a highly lipophylic substance, easily crossing the blood-brain barrier. In humans
it is used to treat neurologic disorders varying from migraine and vertigo to
epilepsy (16). To mimic treatment in a clinical pathologic condition, we chose to
start the infusion of flunarizine after a profound and prolonged period of asphyxia.
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Oxygen delivery to the brain depends on both the [O^Ja and the regional
CBF. The CBF varies with gestational age. Baseline values in the present study
correspond with those reported by others (23,24). No differences in CBF changes
between both groups, either in the baseline period or asphyxia period, or in the
phase immediately after severe asphyxia during which flunarizine was adminis-
arterial blood pressure (mm Hg)
5.0-
4.0-•
3 .0-
2.0-•
1.0"
0
arterial oxygen content (mM)
1^
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time in minutes
Figure 4.2. Time course of FHR. Pa. [O^la. and pH (mean ± SEM). Time -180 to -120
min= baseline period; time -120 to 0 min= progressive reduction of uterine blood flow;
time 0 to 60 min= 1 hour period of severe asphyxia; time 60 to 240 min= recovery period.
F///«/ /na/ig/eî represent the flunarizine-treated group, open c/rc/e^ represent the control
group.
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tered, were observed. The [C^Ja in both groups was comparable during baseline and
asphyxia. Also, in the post asphyxiai phase, the [C^Ja between groups was not
statistically different. It can only be speculated that the nonsignificant slightly higher
[C^la in the flunarizine-treated group might be caused by better brain functioning,
improved myocardial performance, and placental perfusion, or by coincidence. At
post-2, CBF in the control group is still elevated compared with baseline, whereas
CBF has normalized in the flunarizine-treated group. Therefore, the net result of
oxygen delivery is the same in both groups. The increased regional CBF in animals
suffering from hypoxia or asphyxia is in agreement with literature (9).
Reduction of maternal uterine blood flow with a balloon occluder around
the common internal iliac artery resulted in severe asphyxia in all animals. An
immediate effect of occlusion was a transient bradycardia with arterial
hypertension. These cardiovascular parameters soon stabilized, resulting after 1
hour of severe asphyxia in tachycardia and normal blood pressure in both groups.
This is in agreement with data from others (24). The change from bradycardia to
tachycardia and hypertension to normotension might be secondary to a sustained
release of catecholamines (25), in combination with hypercapnia, which reduces
vagal inhibition and thereby enhances sympathetic stimulation of the FHR (26).
The degree and duration of asphyxia have their influence on cardiovascular
reaction patterns (27,28). One possible explanation for the final decompensation
after severe asphyxia is hypoxic myocardial failure, which is accompanied by an
elevation in central venous pressure and the development of hypotension (28).
Cardiovascular reaction patterns were not influenced by the infusion of
flunarizine, as can be seen from the FHR and Pa data in Figure 4.2. When
asphyxia becomes too severe, oxygen delivery to vital organs can no longer be
maintained (29). The ensuing anaerobic metabolism increases the amount of serum
lactate in the fetus (28). In the present study, lactate concentrations increased to
approximately 10 mM during asphyxia and remained at this level at least 2 hours
after the period of severe asphyxia. Although the [C»2]a failed to recover to
baseline values and the acid-base state did not normalize, fetal cardiovascular
function in the first 3 hours after asphyxia appeared to be adequate, as is suggested
by a normal Pa and Pv. Perfusion pressure (Pa-Pv) also remained unaltered during
the experiment in both groups.
The mean fetal blood loss of approximately 28.5 mL per animal in the
present study did not result in a decrease in fetal Hb levels or even in fetal anemia.
This is in accordance with the study of Brace and Cheung (30) who removed an
average of 120.3 ±5.1 mL of blood (30.8% of the initial blood volume) in a period
of 2 hours in fetal lambs. Complete restitution of fetal blood occurred in only 3
hours, demonstrating that the dynamic fetal fluid system can accurately regulate its
blood volume. Therefore, it is unlikely that the mortality, which was as high as
67% (10 of 15 animals) within the first 12 hours after the experiment, is caused by
fetal hemorrhage resulting from the experimental protocol. The dead fetuses did
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not develop anemia before death. This strengthens the idea of ongoing pump
failure during severe asphyxia, leading to insufficient placental perfusion,
prolonged hypoxia, and progressive decompensation of both the metabolic and
cardiovascular equilibrium. Most animals did not recover and died within 12
hours. Of the five animals completely recovering from asphyxia and surviving
longer than 12 hours, four were treated with flunarizine. With these low numbers,
only speculations can be made on protective properties of flunarizine. It also
remains questionable to what extent fetal brain damage has contributed to the high
percentage of early fetal demise.
In summary, the present data show that flunarizine, given after a period of
severe asphyxia of 1 hour in preterm fetal lambs, does not influence regional CBF
in the immediate post asphyxiai period, and does not affect FHR, Pa, or Pv.
Mortality after such a long period of asphyxia is high; the effect of flunarizine on
survival remains to be elucidated.
It is concluded that a possible beneficial effect of flunarizine on the fetal
brain after asphyxia cannot be ascribed to an altered CBF, to its effect on systemic
Pa or Pv, or to its influence on FHR.
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Abstract
VWien /ne £«£/•#}> Jema«rf ejtce«</.s //ie energy supp/y, anaerobic
me/abo/ism rajt^i over #«</ /ne A7P ca/aZ?o/i/e cufe/ioft/ie is gen^ra/erf. A^nojj/ie
a* a coronary vasorf/7ator, /nereèy increasing /ne oxygen swpp/y /o /ne near/,
poten/ia/, nowever, « poor/^ exp/oi7eJ rfue to ej:ren5/ve cafafto/j'sm. /?-75237
/ran.spor/ o/ arfenos/ne in/o enrforne//a/ ce//s, vvnere ù is ca/a^o/i'ze<i,
resw//ing in an e/evalion o/inlers/i/ia/ a^enosi'ne concentrations, /n 74 /era/ lamfo,
(3 to 5 a"a_ys a/rer surgery, gesfart'ona/ age 724.7 ±7.7 rfa^j, seven/elwses were
/?refrea/erf wi7n 7?- 7523 7 (0.7 mg/ftg esf/mafea'/era/ wei'gnr as a 6O/HS in/ec?ion in
/ne in/eri'or vena cavaj, wnereas ?ne ofner seven servea" as con/ro/s. A/ter 7 nowr o/
severe as/j/iyxia, inrfucea" è}' rgsfrichon o/«/enne e/ooa'/Zon', fnose/etases rrea/ed
wf'/n 7?-75237 snovvea* a/asfer nornia//za//on o/aorra/ /?// ana", in confras/ ?o /«e
con/ro/ grow/?, aïa" nor a"eve/op racnycarcfia. 7ne percenfage increase in myocarJ/a/
ft/ooa'/Zow (/«ring aspnyxia, measwrea" wi'fn radioac/ive m/crospneres, was
signi/icanl/}' n/g/ier in r/ie 7Î-75237-rrea/erf groi/p comparea" ?o /ne con/ro/ grow/?
f437 ana* 254%, res/?ec//ve/y). 7n /ne con/ro/ grow/;, on/y /nree/e/ivses recovered
ana* SMrvi'vea", wnereas in /ne 7?-75237 group a// seven ani'ma/s recovered a//er
severe aspnvxia. 7/ is conc/ua'ea' /na//e/a/ Zanies pre/rea/erf wi'/n 7Î-7523/ /?e/ore
//?e onse/ o/severe asp/ryxia nave an ennancea" increase in myocara'/a/ Z7/ooa"/7ow
a"Mn"ng aspnyxia, recover/as/er ana" survive /onger.
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Introduction
It is well documented that lack of oxygen accelerates the catabolism of
ATP in the myocardium, due to lack of rephosphorylation of ADP and AMP (1).
This results in the formation of adenosine. Because of its many interesting phar-
macological properties (coronary vasodilation, anti-adrenergic effects, inhibition
of platelet and leukocyte activation) (2), the production of adenosine can be
regarded as a natural defense system. After 2 hours of partial myocardial ischemia
in dogs, ventricular function was improved by intracoronary administration of
adenosine (3).
Extensive catabolism of adenosine in endothelial cells and the concomi-
tant short half-life does not facilitate adenosine therapy (4). Continuous infusions
of high doses of adenosine would be necessary, giving rise to systemic vasodila-
tion and unwanted side effects in various organ systems. To avoid these problems,
we pretreated fetal lambs with R-75231, a potent and specific adenosine transport
inhibiting drug with unique pharmacokinetic properties (5). During asphyxia,
myocardial workload increases and adenosine is released. Adenosine transport
inhibition has two major advantages. First, R-75231 will show an effect only if,
and as long as, adenosine is produced; and second, the action will be restricted
only to the area where adenosine is produced. Thus, cardiac effects of adenosine
are enhanced, whereas side effects in other organs are avoided.
We hypothesized that an increased myocardial concentration of adenosine
during severe asphyxia leads to an enhanced MBF, better cardiac functioning
during and after asphyxia, and an improvement in fetal survival. To test this
hypothesis we studied fetal lambs, pretreated with R-75231, during and after
asphyxia. We measured cardiovascular parameters as FHR, Pa, and Pv and MBF.
Material and methods
Surgery
Surgery was performed in 14 Dutch Texel sheep of known mating dates
between 110 and 124 days gestation (mean ± SEM = 120.5 ± 1.0 days, term = 147
days).
General anesthesia was induced with intravenous pentobarbital and
maintained with 1% halothane in a 2:1 mixture of nitrous oxide and oxygen.
Before surgery the ewes received intravenously 1 g of ampicillin. Under sterile
conditions, a paramedian abdominal incision was made, and an inflatable balloon
occluder was placed around the maternal common internal iliac artery. Fetal
instrumentation involved insertion of catheters in the axillary and femoral artery,
the tips advanced to the level of the brachiocephalic trunk and descending aorta,
respectively. In addition, catheters were placed in the femoral vein with the tip
advanced into the inferior vena cava, the trachea and the amniotic cavity. Fine
stainless steel wires (Cooner Sales Co., Chatsworth, California, USA) were placed
over the dura of the parietal cortex for recording of the fetal ECoG. A poly vinyl
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catheter was placed in the spinal cisterne to obtain CSF. Electrodes were
subcutaneously implanted at the level of the cardiac apex and at both forelegs for
recording of the fetal ECG. Catheters and wires were exteriorized to the ewe's
flank.
Ewes were housed in individual cages with free access to food and water
and were allowed to recover from surgery for at least 3 days before the
experiments were started. A continuous slow infusion (1 mL/hour) of heparin in
saline (10 U/mL) was used to maintain patency of fetal arterial and venous
catheters. Guidelines for care and use of animals as approved by the local Animal
Medical Ethics Committee were followed.
Measurements
Pa, Pv, trachéal pressure, and amniotic pressure were determined with the
zero point at the level of the ewe's spine. These signals, together with the fetal
ECG, the fetal ECoG and the FHR, derived from the pulsatile signal of the femoral
artery, were fed into bioelectric amplifiers (Hewlett Packard 8800 series, Andover,
Mass., USA), displayed on a monitor, recorded on an eight-channel strip chart
recorder, stored on magnetic tape, and digitized and analyzed with a computer.
MBF was measured with radioactive microspheres with a diameter of 15
/<m. In random order, one out of four available microspheres (^Nb, '^Ru, "-^Sn,
and '^'Ce) was injected. Aggregation of the microspheres was prevented by
adding 0.05% Tween 80 to the injection medium. After homogenization in an
ultrasonic waterbath at 39°C (Bransonic 5200, Soest, the Netherlands) for 20
minutes, approximately 0.5x10*" microspheres were stirred on a vortex agitator and
infused over a period of 1 minute into the inferior vena cava (6). Reference
sampling (1.80 mL/min) (Harvard Apparatus Ltd., Kent, England) was started
from the brachiocephalic arch 30 seconds before infusion, continued during
infusion, and stopped 1 minute after infusion.
Blood gas values and pH from the fetal aortic arch were measured with an
automated analyzer (AVL, Radiometer, Copenhagen, Denmark) and corrected for
39°C. The percentage of saturation of Hb was measured (OSM2 Hemoximeter,
Radiometer). The [O^la was calculated as follows: [C»2]a (mM) = Hb concentration
(mM) x Hb oxygen saturation (%/100).
Immediately after the microsphere injection, 2 mL of blood were with
drawn from the axillary artery and centrifuged (3 minutes at 13,000 revolu-
tions/min). Serum was frozen in liquid nitrogen and stored at -73°C. After all
experiments had ended, serum lactate concentrations were determined in these
samples.
Experiments
Gestational age during experiments varied between 113 and 129 days
(mean ± SEM = 124.1 ± 1.1 days). Baseline values for FHR, Pa and Pv were
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obtained during a control period of at least 2 hours. Fetal acid-base balance was
analyzed every 15 minutes.
During the baseline period, MBF was determined. Fifteen minutes
thereafter seven of the 14 lambs received an intravenous bolus of R-75231 (2-
(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-[5,5-bis(4-fluorophenyl)-
pentyl]-l-piperazineacetamine) in a dose of 0.1 mg/kg estimated fetal weight.
Estimation of fetal weight was performed during instrumentation.
Severe fetal asphyxia was induced by stepwise inflation of the balloon
occluder around the maternal common internal iliac artery. During the occlusion
period, every 15 minutes the aortic fetal acid-base balance was determined. To
maintain the fetus in a stable hemodynamic condition, uterine blood flow was
gradually reduced over a period of 60 to 90 minutes, until fetal [Oija reached a
value of approximately 30% of baseline level and/or the fetal pH had decreased to
a value less than 7.15. This condition was considered the start of fetal asphyxia
and occlusion was kept at the same level for 1 hour. At the end of this period,
MBF was remeasured. Following, the uterine blood flow obstruction was
discontinued by emptying the balloon occluder. MBF was determined again at 30
and 120 minutes after release of the occluder. Fetal recovery was monitored, and
when the fetal condition did not improve 3 to 5 hours after asphyxia, the fetal
lambs were disconnected from registration and fetal Pa was checked regularly to
determine survival interval. During the disconnected period, no blood gas analysis
was performed. After 3 days of survival a relaparotomy was performed. Under
general anesthesia, fetal blood was replaced /'« v/vo by Karnovsky's fixative
solution (a mixture of 2.5% glutaraldehyde and 2.0% formaldehyde) to allow
further histologie evaluation of the fetal brain. Subsequently, fetuses were
removed and weighed, and correct catheter placement was confirmed at autopsy
after 3 days or earlier in case of fetal demise.
Calculations and data analysis
FHR, Pa, and Pv, corrected for amniotic pressure, were averaged over 10
seconds periods by computer.
For reasons of accuracy, MBF was calculated from the mean flow of three
samples out of left ventricular base, middle, and apex of the fetal heart. The
samples were weighed (± 1 g), put into test tubes, and additionally preserved in
Karnovsky's fixative solution. Radioactivity in tissue and blood samples was
measured with a gamma scintillation counter and sample changer system (analyzer
model 45, Molsgaard Medical, Horsholm, Denmark). MBF was calculated with an
ND680 programmable analyzer/computer system (Nuclear Data GmbH, Frankfurt,
Germany). All data are expressed as mean ± SEM. For statistical analysis within
groups the Wilcoxon matched-pairs signed-ranks test was used, whereas
differences between the R-75231-treated and the control group were tested with
the two-tailed Mann-Whitney U test. A p-value <0.05 was considered significant.
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Linear regression analysis was performed for FHR and pH in the post occlusion
period. Slopes of the lines of individual animals were compared by means of a
two-tailed Mann-Whitney U test to determine differences between groups. The
Log rank-test (7) was used to compare survival in both groups.
Results
In Figure 5.1 the time course of mean [C^la, pH, and BE for both
experimental groups is depicted. The magnitude of metabolic acidosis and BE
decrease is comparable in both groups, but a significant difference existed in LO?]a
during the period of severe asphyxia (time 0 to 60 min). In the R-75231-treated
group the [C^la remained higher. The pH after 1 hour of severe asphyxia,
however, was 6.99 and 7.06 for the R-75231-treated and the control group,
respectively (p=0.08). Values below -17.5 mM were reached for the BE in both
experimental groups. To analyze the speed of recovery, mean linear regression
lines for pH against change in time in both groups were calculated over the post
occlusion period, beginning at time= 60 min, when the occluder was released.
Comparison of the 14 individual slopes of these regression lines (mean slope 1.88
± 0.36 versus 0.76 ± 0.39, whereas r= 0.87 and 0.89, both slopes and r-value for
the R-75231-treated and the control group, respectively) of these lines with a two-
tailed Mann-Whitney U test, showed that the pH in the R-75231-treated group
normalized faster (p<0.05) toward baseline levels compared with the control
group.
Time course of FHR, Pa, and Pv is shown in Figure 5.2. Administration of
R-75231 before the onset of occlusion did not induce any changes in either FHR,
Pa, or Pv in six out of seven treated animals. In one animal a transient bradycardia
(from 145 to 110 beats/min) of 15 seconds was observed, without simultaneous
changes in Pa or Pv. In the post occlusion phase, starting at time= 60 min, linear
regression lines for FHR against change in time in both groups were calculated.
Comparison of the slopes of these lines (mean slope is -0.15 ± 0.12 versus 0.13 ±
0.10, whereas r=0.53 and 0.62, slopes and r-values for the R-75231-treated and the
control group, respectively) with a two-tailed Mann-Whitney U test showed the
development of a tachycardia (recovery period compared with baseline) in the
control group, versus the absence of this tachycardia in the R-75231-treated group
(p<0.05). During the occlusion (approximately from time= -75 to 60 min) Pa in
the control group was elevated compared with baseline levels (Wilcoxon matched-
pairs signed-ranks test, p<0.05), whereas Pa remained unchanged in the R-75231-
treated group. At two moments in the occlusion period (time= -75 and -45 min)
differences between groups reached significance. Pv remained unaltered in both
groups during the entire experiment.
MBF was measured at four conditions in the experiment. At these moments,
serum lactate levels were determined as well. The individual MBF data of all 14
animals are shown in Figure 5.3, whereas the means and percentage of increase are
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Figure 5.1. Time course of [Oila. pH and BE (upper, middle and lower panel,
respectively), expressed as mean ± SEM. F///ed fna/ig/es represent the R-75231-treated
group, open c/rc7e.v the control group. Mean linear regression lines for the R-75231-treated
group (A™/ied (me) and the control group (so/W /me) in the post occlusion phase are drawn
for pH against change in time. The slopes of these lines are significantly different (Mann-
Whitney U test, p<0.05). Time -180 to -100 min= baseline period; time -100 to 0 min=
progressive reduction of uterine blood flow; time 0 to 60 min= 1 hour of severe asphyxia;
time 60 to 180 min= post occlusion period. R-75231 was administered approximately at
time= -120 min. Differences between groups (two-tailed Mann-Whitney U test, p<0.05)
are indicated with an
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Figure 5.2. Time course of FHR, Pa and Pv (upper, middle and lower panel, respectively),
expressed as mean ± SEM. F/7/ed /r/a/i#/t\y represent the R-75231-treated group, open
the control group. Mean linear regression lines for the R-75231-treated group
/me) and the control group (.TO/K/ //we) in the post occlusion phase are drawn for
pH ugainst change in time. The slopes of these lines are significantly different (Mann-
Whitney U test, p<0.05). Time -180 to -100 min= baseline period; time -100 to 0 min=
progressive reduction of uterine blood flow; time 0 to 60 min= 1 hour period of severe
asphyxia; time 60 to 180 min= post occlusion period. R-75231 was administered
approximately at time= -120 min. Differences between groups (two-tailed Mann-Whitney
U test, p<0.05) are indicated with an
summarized in Table 5.1. During asphyxia, the percentage of increases in MBF was
significantly higher in the R-75231-treated group than in the control group (p<0.05).
In contrast to the R-75231 treated group, MBF remained significantly increased
(p<0.05) in the control group at 120 minutes after release of the occluder.
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Figure 5.3. MBF of all 14 animals at four moments in the experiment (baseline, after 1
hour of severe asphyxia, and 30 and 120 min after release of the occluder). fï//«/ ma/ig/es
represent the R-75231 -treated group, ////ed c/rc/es the control group without recovery
(n=4), and o/?en c/>c/es the control group with recovery (n=3).
Table 5.1. Fclal MBF and fetal lactate levels
R-75231 group
MBF(mL.min-l.lOOg-l)
MBF (% of baseline)
lactate IrnM)
Control group
MBF(mL.min-'.IOOg')
MBF(9h of baseline)
lactate (mM)
253
1
347
1
Baseline
± 50
100
8 ± 0.5
Baseline
± 44
100
8 ± 0.2
Asphyxia
1029 ± 210*
437 ± 40«#
14.7 ± 0.6*
Asphyxia
991 ± 225*
284 ± 60*#
12.6 ± 1.5*
30
518
236
14.4
30
539
164
12.0
minutes
±
±
±
89*
57*
0.6*
minutes
±
±
±
50*
20*
1.4*
120
500
188
11.5
120
750
223
12.8
minutes
±
±
±
175
50
0.7*
minutes
±
±
±
120*
32*
1.8*
Values are expressed as mean ± SEM, n=7 for both groups. R-75231 is administered after baseline measuremen'
MBF was determined after I hour severe asphyxia and 30 and 120 min after release of the occluder.
*:r«0.05 (asphyxia. 30 or 120 min vcra/.t baseline. Wilcoxon matched-pairs signed-ranks test)
#:p<0.05 (R-75231 group «-raw control group, 2-tailed Mann-Whitney U test)
Table 5.2 summarizes the survival interval of all individual animals and
the cause of fetal death. All animals of the treated group recovered well after
asphyxia. Unfortunately, one ewe bit a fetal arterial catheter and the lamb bled to
death 30 hours after asphyxia. From a twin gestation, the instrumented (and
treated) animal recovered, but a second (and untreated) lamb was not monitored.
The treated lamb recovered well, but died during parturition 22 hours after the
experiment. When the lambs were born, it was clear that the other lamb had died
much earlier (probably during the experiment). This intrauterine death may have
been the cause of preterm labor. Animals surviving longer then 72 hours were
killed for cerebral histology. Because of a logistical problem in the laboratory, one
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animal out of the control group was killed after only 24 hours. Survival in the R-
75231 treated group was better than in the control group (Log rank-test, p<0.05).
In this test, a correction has been made for the three animals described above.
Table 5.2. Fetal survival (in hours) and cause of fetal death
for both experimental groups
animal-
number
1.
2.
3.
4.
5.
6.
7.
animal-
number
1.
2.
3.
4.
5.
6.
7
survival-
interval
72
72
72
±30
22
72
72
survival-
interval
5
5
24
3
72
72
20
cause of fetal death
(R-75231 -group)
killed for histology
killed for histology
killed for histology
good fetal recovery, but catheter
accident, fetus bled to death
ewe in labor, fetus died during
parturition
killed for histology
killed for histology
cause of fetal death (control group)
no recovery after asphyxia
no recovery after asphyxia
killed for histology
no recovery after asphyxia
killed for histology
killed for histology
no recovery after asphyxia
Discussion
Depletion of nucleotides has been regarded as a major cause of
irreversible damage and malfunctioning of the heart (8). High concentrations of
adenosine have been documented to protect against the damage from myocardial
ischemia in isolated hearts from rats (9) and rabbits (10). Most convincing
evidence for cardioprotection however, has been gathered in a series of
experiments in closed-chest dogs, in which adenosine has been infused in the
coronary artery during the P' hour of reperfusion after periods of regional
ischemia lasting 40 minutes (11), 90 minutes (12), 2 hours (3) or 3 hours
(13).When compared with control animals, adenosine treated dogs had a much
better functional recovery and a considerable reduction in infarct size. The benefit
from adenosine was lost when the ischémie period was extended to 3 hours. This
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limitation may be due to the extensive catabolism of adenosine in endothelial cells
and the rapid washout during reperfusion (4). Nucleoside transport inhibitors
prevent the uptake of adenosine into endothelial cells. In this way, deamination is
inhibited, leading to elevated interstitial adenosine levels. This mechanism was
demonstrated after pretreatment with the nucleoside transport inhibitor mioflazine
(14), and recent pharmacologie studies on R-75231 were even more promising (5).
R-75231 has recently been proposed as a highly effective concept for long-term
preservation of donor hearts (15).
In the present study, restriction of uterine blood flow resulted in an
increase of fetal Pa compared with baseline values (Wilcoxon matched-pairs
signed-ranks test, p<0.05) in the control group (Figure 5.2). The absence of this
hypertension in the R-75231-treated group, and the significant differences between
both groups (at time= -45, -75 and 135 min) may be explained by the vasodilatory
effect of adenosine in fetal sheep (16). Levels of adenosine are still expected to be
elevated during the post occlusion phase, as R-75231 has a long duration of action
(4). The differences between groups in FHR (at time= 150, 195 and 210 min) may
therefore be caused by the negative chronotropic activity of adenosine (17), or by
inhibition of the tachycardie effect of catecholamines (18). On the other hand,
these FHR differences can also be explained by a better oxygénation and higher
pH in the R-75231-treated group, leading to normalization of myocardial
performance.
During baseline measurements, MBF varies considerably between
animals. This is in agreement with the literature (19,20,21). MBF was measured at
the peak of asphyxia, at time= 60 min. The [C^Ja at this moment was significantly
lower in the control group compared with the R-75231-treated group. Oxygen
delivery to heart, brain and adrenal glands is maintained by an increase in MBF
when [O2]a decreases (19). Therefore, we expected the increase in MBF in the
control group, />., the group with the lowest [O2]a, to be larger than the increase
in the R-75231-treated group. Although the absolute values of MBF were very
similar in both groups during asphyxia, the percent increase in MBF was
significantly higher in the R-75231 treated group (Table 5.1). As is shown in
Figure 5.3, these means of approximately 1,000 mL.min''.100g'' do not equal the
maximum coronary blood flow that can be reached. The larger percentage of
increases in MBF in the R-75231-treated group may very well be explained by the
coronary vasodilative effect of adenosine (22). In the post asphyxiai period, an
enlarged diameter of vessels may allow passage of microemboli, originating from
hypoperfused tissues during asphyxia (23), and, as a result, coronary micro-
embolization can be prevented. During the post occlusion period MBF decreased
in both groups compared with the asphyxiai period. After 120 minutes in the post
occlusion period MBF in the control group remained elevated compared with
baseline, whereas MBF in the treated group was normalizing and not elevated
compared to baseline. We suggest that this difference is explained by an impaired
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oxygénation in the control group during this phase (mean [0->]a ± SEM is 2.91 ±
0.45 and 1.87 ± 0.30 for the R-75231-treated and the control group, respectively,
Mann-Whitney U test, p<0.05). Three out of four non-survivors in the control
group have an augmented MBF (as can be seen in Figure 5.3), thus elevating mean
MBF considerably.
Physiologic circulatory compensation during asphyxia, causing a
preferential redistribution of blood, is available for a limited time only (24).
Considering the magnitude and duration of asphyxia in the present study,
inadequate recovery of four out of seven animals (Table 5.2) in the control group
in the first 24 hours after asphyxia is not surprising. A plausible explanation for
this mortality is cardiovascular failure. After severe asphyxia, a transient
tachycardia precedes progressive hypotension and death.
We suggest that pretreatment with the adenosine transport inhibiting drug
R-75231 leads to an enhanced increase in MBF during severe fetal asphyxia. This
leads to better myocardial functioning after asphyxia, indicated by a faster
normalization of pH and an absence of fetal tachycardia in the post occlusion
period. Finally, this results in better survival.
As summarized elsewhere (5), nucleoside transport inhibition has been
shown to be cardioprotective in a variety of experimental models and in different
species. Because of the high specificity of nucleoside transport inhibition, its
effects can be assumed to be solely due to the prolonged presence of adenosine
within the area where it is produced. In view of its many known activities
(coronary vasodilation= increased blood supply; anti adrenergic= lower demand;
calcium-antagonist= afterload reduction; anti arrhythmic; inhibition of platelet
aggregation= no thrombosis; inhibition of leukocyte activation= no damage from
radicals or proteases), adenosine can be regarded as a multipurpose drug, which
can tackle the many problems arising during myocardial hypoxemia and
reperfusion. From the present experiment, it is not possible to define which of the
activities of adenosine is playing a major role. It is reasonable to assume that all of
them, acting in concert, may contribute to the benefit observed.
In summary, pretreatment with the adenosine transport inhibiting drug R-
75231 resulted in faster recovery and better survival after severe fetal asphyxia.
Enhancement of the increase in MBF during asphyxia probably is one of the
explanatory mechanisms. The actual working mechanism of adenosine transport
inhibition during severe asphyxia in fetal lambs remains to be elucidated.
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Abstract
77je pwrpose was to s/wdy f/ie e/Jfec/ o//e/a/ asp/îyx/a on //je re/ease o/
/lypoxa/j/A/'/je a/ia" ^a/ir/i//ie in cerebrospina/ /7«id f C5FJ am/ on brain nisfo/ogic
cnarac/erisfics. 77?ere/ore, in seven /era/ /awes (J ro 5 days a/fer surgery,
ges/afiona/ age /24J ±2.6 days) aspnytia was induced fey res/ric/ion o/M?erine
/?/ooa'y7ow. Fe/a/ p / / and base excess were redwcea* /o 6.99 ± 0.02 and -/7.6 ± 0.9
mAf, respec/ive/y. Cerebra/ Wood/7ow increased during aspnyjfia and remrned /o
norwa/ in /ne recovery pnase. Afajri/nwrn concen/ra/ions o/C5F nypoxan/nine and
C5F jran/nine were reacned in fne norwojcemic recovery pnase. 7nis rtign /eve/ o/
SMbs/ra/^j during norwojre/nia /aci/i/a/es oxygen derived /ree radica/ /ormafion
and may rnus aggrava/e pos/-aspnyjcia/ brain damage, //is/o/ogic eva/wa/ion o/rne
brain i days a/fer fne ins«// snowed a variab/e degree o/ edewa. Coagu/a/ive
newrona/ cnanges, c/iarac/eris/ic o/irreversib/e ce// dea/n, were on/y occasiona//y
de/ecfed. Tnese cnanges were mos/ obviows in /ne Pwritin/e ce//s o//ne cerebe//wm.
/f was conc/wded fnaf /efa/ aspnyxia induced by «ferine b/ood /7ow resfric/ion is
associated wif/i nign /eve/s o/CSF nypojcanfnine and C5Fxanfnine in /ne recovery
pnase. A/icroscopica//y de/ecfab/e brain damage, a/fnowgn nof ejcfensive, is main/y
/ocafed in fne cerebe//«m.
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Introduction
Fetal distress as a result of progressive fetal asphyxia can, if not corrected
or circumvented, result in decompensation of physiologic responses and lead to
permanent tissue injury or death ( 1 ). At the level of the central nervous system this
damage becomes clinically apparent in seizures, hypotonia, and motor- and
cognitive deficits (2,3).
Several experimental setups have been used to investigate brain damage
after oxygen shortage. Myers (4,5) induced brain injury in neonatal monkeys. The
animals were anesthetized or heavily sedated, and after asphyxia resuscitation was
performed on a neonatal intensive care unit. The majority of monkeys, sustaining
episodes of asphyxia severe enough to lead to widespread cerebral damage, also
had injury to the myocardium, which resulted in death from cardiogenic shock
within the first day or two after the insult (5). Levine circumvented that problem in
adult rats by combining unilateral carotid artery ligation with hypoxic exposure,
thereby increasing the susceptibility for oxygen shortage in the ischémie cerebral
hemisphere (6). In fetal lambs it seemed more difficult to obtain an adequate
survival rate concomitant with an acceptable degree of histologie damage (7). The
narrow threshold between a degree of intrauterine asphyxia associated with no
sequelae, an insult causing persistent cerebral impairment, and an insult resulting
in intrauterine demise was confirmed. Recently, the Lev/n? mode/ was modified
for fetal sheep. Ligation of the vertebral-carotid anastomosis and inflation of
occluder cuffs around both carotid arteries for 30 minutes resulted in ischémie
encephalopathy (8).
However, although most setups described above led to reproducible and
quantifiable brain damage, experimental cerebral ischemia is entirely different
from the primarily hypoxic mechanism encountered in clinical practice. Therefore
the pathophysiological condition of acute fetal asphyxia was mimicked in the
present study by reducing maternal placental perfusion. The objective of the study
was to induce severe asphyxia and evaluate its effect on (I) the fetal cardiovascular
system and cerebral blood flow (CBF), (II) systemic and brain metabolic
parameters (levels of CSF lactate, CSF hypoxanthine, and CSF xanthine), the
latter two are considered substrates in the formation of oxygen derived free
radicals, involved in the induction of post-asphyxial tissue damage (9), (III)
histology of the brain after 3 days survival.
Material and methods
Surgery
Surgery was performed in 7 pregnant Dutch Texel sheep of known mating
dates between 118 and 124 days' gestation (mean ± SD = 120.9 ± 2.0 days, term=
147 days). General anesthesia was induced with intravenous pentobarbital and
maintained with 1% halothane in a 2:1 mixture of nitrous oxide and oxygen.
Before surgery, the ewes received 1 g of intravenous ampicillin. Under sterile
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conditions, a paramedian abdominal incision was made and an inflatable balloon
occluder was placed around the maternal common internal iliac artery. Fetal
instrumentation involved insertion of polyvinyl catheters in the axillary and
femoral artery, the tips advanced to the level of the brachiocephalic trunk and
descending aorta, respectively. In addition, catheters were placed in the femoral
vein, the tip advanced into the inferior vena cava, and in the amniotic cavity. A
polyvinyl catheter was placed in the spinal cisterne to obtain CSF. Catheters were
exteriorized to the ewe's flank.
Ewes were housed in individual cages with free access to food and water
and were allowed to recover from surgery for at least 3 days before the
experiments were started. A continuous slow infusion (1 mL/hour) of heparin in
saline (10 U/mL) was used to maintain patency of fetal arterial and venous
catheters. Guidelines for care and use of animals, as approved by the local Animal
Medical Ethics Committee, were followed.
Measurements
Fetal Pa, Pv, and amniotic pressure were determined with the zero point at
the level of the ewe's spine. These signals, together with the FHR derived from the
pulsatile signal of the femoral artery were led to a bioelectric amplifier (Hewlett
Packard 8800 series, Andover, Mass., USA), displayed on a monitor, recorded on
eight-channel strip chart recorder, stored on magnetic tape, and digitized and
analyzed with a computer.
Regional CBF was measured with radioactive microspheres with a
diameter of 15 //m. At random one out of four available microspheres (^Nb,
'^Ru, "''Sn, and ''"Ce) was injected. Aggregation of microspheres was prevented
by adding Tween 80 to the injection medium. After homogenization in an
ultrasonic waterbath at 39°C (Bransonic 5200, Soest, the Netherlands) for 20
minutes, approximately 0.5x10^ microspheres were stirred on a vortex agitator,
and infused into the inferior vena cava over a period of 1 minute. Reference
sampling (1.80 mL/min) (Harvard Apparatus Ltd., Kent, England) was started
from the brachiocephalic arch 30 seconds before infusion, continued during, and
stopped 1 minute after infusion.
Blood gas values and pH from the fetal aortic arch were measured with an
automated analyzer (AVL, Radiometer, Copenhagen, Denmark) and corrected for
39°C. Hb saturation was measured with an hemoximeter (OSM2 Hemoximeter,
Radiometer). The [C^Ja was calculated as follows: [C»2]a (in mM) = Hb
concentration (mM) x Hb oxygen saturation (%/100). Immediately after a
microsphere injection 2 mL of blood was withdrawn from the axillary artery and
centrifuged (3 minutes at 13,000 revolutions/min). Serum was frozen in liquid
nitrogen and stored at -73°C.
Samples of CSF were withdrawn with a 1 mL syringe from the catheter in
the spinal cisterne, centrifuged (3 minutes at 13,000 revolutions/min) and frozen in
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liquid nitrogen. The catheter deadspace was shortened to approximately 0.2 mL,
the volume of CSF obtained per sample was at least 0.6 mL. After storage at
-73°C, serum and CSF samples from all animals were analyzed together.
Concentrations of lactate were measured, whereas levels of hypoxanthine and
xanthine were determined by high performance liquid chromatography (10).
Experiments
Mean gestational age (± SD) during experiments was 124.3 (± 2.6) days.
FHR, Pa, and Pv, were monitored continuously. Fetal acid-base balance was
analyzed every 15 minutes. To improve myocardial performance after asphyxia
(11), the fetal lambs received an intravenous bolus of the adenosine transport
inhibiting drug R-75231 (2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-
[5,5-bis(4-fluorophenyl)-pentyl]-l-piperazineacetamine, Janssen Pharmaceutica,
Beerse, Belgium) in a dose of 0.1 mg/kg estimated fetal weight in the inferior vena
cava before the onset of occlusion. Estimation of fetal weight was performed
during instrumentation.
After microsphere injection in the baseline period, fetal asphyxia was
induced. To maintain the fetus in a stable hemodynamic condition, uterine blood
flow was gradually reduced by stepwise inflation of the balloon occluder around
the common internal iliac artery, over a period of approximately 120 minutes, until
fetal [C^Ja reached a value of 40% of baseline, in combination with an aortal pH
<7.15. This moment was considered time= 0 min and occlusion was kept at the
same level for 1 hour. At time= 60 min, the peak of asphyxia, microspheres were
injected to calculate CBF. Thereafter the uterine blood flow obstruction was
discontinued by emptying the balloon occluder. The third and fourth dosage of
microspheres were administered in the recovery phase, at time= 90 min and at
time= 180 min, corresponding with 0.5 and 2 hours after release of the occluder,
respectively.
Fixation procedure and histologie evaluation
Three days after the period of asphyxia a relaparotomy was performed
under general anesthesia. The fetus was completely heparinized by 15,000 U
intravenous heparin. The fetal heart was approached by median thoracotomy. A
blunt steel catheter was inserted in the left ventricle. The right atrium was opened,
and 500 mL of isotonic and buffered isocolloidal fluid (39°C) was infused. The
descending aorta was clamped. The fetal brain was preserved by intracardial
perfusion with Karnovsky's fixative (2% formaldehyde and 2.5% glutaraldehyde
in phosphate buffer 0.1 M, pH 7.40), approximately 1 L at room temperature. The
fetus was weighed and correct catheter placement was confirmed. After one day
immersion fixation in Karnovsky's fixative, the fetal brain was removed from the
skull, and was sampled for CBF determination and histologie analysis, according
to a stereotaxic atlas of the ovine fetal brain (12). After scintillation counting,
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vibratome sections (200 (jm) were cut from eight cerebral areas (frontal cortex,
parietal cortex, temporal cortex, striatum, hippocampus, cerebellum, thalamus and
medulla oblongata). Sections were postfixed in 2% osmium tetroxide, buffered
with veronal acetate (0.05 M, pH 7.40), dehydrated in graded series of ethanol and
routinely embedded in Epon. Light microscopic evaluation was performed on 2
pm sections stained with toluidine blue. Fixation quality was scored on a 10-point
scale (13) whereby 10 corresponds with preservation in which no residual
erythrocytes are detected, with open microvessels and without disseminated cell
swelling. A zero corresponded with a morphologic picture, dominated by
collapsed microvessels filled with residual erythrocytes and surrounded by spongy
brain parenchyma. Two characteristic types of hypoxic cell changes were
evaluated: edematous cell changes, mainly involving the glial compartment, and
coagulative neuronal cell changes. Cell changes were also scored on a 10-point
scale, whereby 0 is absence of coagulative changes and 10 is 100% of the tissue
damaged (13).
Calculations and data analysis
The Pa, corrected for amniotic pressure, was averaged over 10 seconds
periods, using a computer program. Five of these epochs were averaged to calculate
mean Pa.
Samples from the eight cerebral areas were weighed (± 1 g), put into test tubes
and preserved in 3% glutaraldehyde solution. Radioactivity in all samples was
determined before histologie evaluation. All four isotopes were counted
simultaneously. Radioactivity in tissue and in reference samples was measured with an
automatic gamma scintillation counter and sample changer system (analyzer model 45,
Molsgaard Medical, Horsholm, Denmark), connected to a ND680 programmable
analyzer/computer system (Nuclear Data GmbH, Frankfurt, Germany).
Parameters during asphyxia and in the recovery period were compared with
baseline values, by means of a Friedman analysis of variance, with time as the repeated
measure. A p<0.05 was taken to represent statistical significance.
Results
The time course of mean [C^la, pH, and Pa is depicted in Figure 6.1. The
[CXja decreased gradually, and was approximately 40% of baseline level during
the period of asphyxia. During the occlusion period the mean pH decreased from
7.36 to 6.99. Release of the occluder resulted in recovery, with a mean pH of 7.22
at 180 min. Pa remained unaltered during the entire experiment.
Table 6.1 summarizes the fetal [C^Ja, pH, pCC^, BE, serum glucose levels
and serum lactate concentrations. Glucose levels remained unaltered during the
experiment, but serum lactate levels rose during asphyxia more than eightfold
compared with baseline levels (Friedman two way analysis of variance, p<0.05),
and remained elevated during the hours monitored in the recovery phase.
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Figure 6.1. Time course of fOi]a (mM), pH and Pa (mm Hg), n=7, expressed as mean
± SEM. Time -180 to -120 min= baseline period; time -120 to 0 min= progressive
reduction of uterine blood flow; time 0 to 60 min= 1 hour period of asphyxia; time 60 to
180 min= recovery period. Bar, period of occlusion.
Table 6.1. Fetal acid-base balance and serum glucose and lactate levels
[O2la
PH
PCO2
BE
serum
glucose
serum
lactate
(mM)
(kPa)
(mM)
(mM)
(mM)
Be
3.31
7.36
5.15
-4.1
1.05
1.8
iseline
± 0.42
±0.01
± 0.20
± 0.8
± 0.14
± 0.5
Asphyxia
1.56
6.99
7.37
-17.6
0.96
14.7
± 0.16*
± 0.02*
± 0.33*
± 0.9*
±0.18
± 0.6*
time =
2.80
7.08
6.14
-15.6
0.96
14.4
±
±
±
±
±
±
: 90
0.41
0.01*
0.19*
0.3*
0.09
0.6*
time
2.91
7.22
5.57
-9.4
1.02
1 1.5
=
±
±
±
±
±
±
180
0.45
0.03*
0.19
1.7*
0.10
0.7*
Values are expressed as mean ± SEM, n=7. Asphyxia is at time= 60 min, at the peak of
asphyxia. Time= 90 min and time= 180 min corresponds with 0.5 and 2 hours after release of
the occluder, respectively.
*: p<0.05 (asphyxia, time= 90 min or time= 180 min verms baseline, Friedman two way ANOVA
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All fetal lambs in this study were succesfully instrumented with a catheter
in the spinal cisterne. It was not always possible to maintain patency of these
catheters, and therefore CSF could be collected in five preparations only. Because
of sampling problems, CSF could not be obtained on standardized moments. The
results of CSF analysis are depicted in Figure 6.2. During the hour of severe
asphyxia concentrations of lactate, hypoxanthine, and xanthine, started to rise,
which continued during the first hours of recovery. Maximum values of hypo-
xanthine and xanthine in CSF were found approximately at 180 minutes.
Thereafter the concentrations returned to normal. CSF lactate levels however,
remained almost unchanged during the 3 hours after asphyxia, at a level of appro-
ximately 9 mM.
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Figure 6.2. CSF levels (n=5) of lactate in mM (upper panel), hypoxanthine in uM (middle
panel), and xanthine in (iM (lower panel) during the experiment. All five individual
animals are represented by a specific symbol. Time -180 to -120 min= baseline period;
time -120 to 0 min= progressive reduction of uterine blood flow; time 0 to 60 min= 1 hour
period of asphyxia; time 60 to 240 min= recovery period, Bar, period of occlusion.
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The weight specific regional CBF (in mL/min x 100g) is shown in Table
6.2. During asphyxia CBF in all anatomical areas increased, whereas normaliz-
ation occurred in the recovery period.
Table 6.2. Regional cerebral blood flow
Frontal cortex
Parietal cortex
Temporal cortex
Striatum
Hippocampus
Thalamus
Cerebellum
Medulla oblongata
Baseline
135
129
133
156
151
234
208
292
+
±
±
±
±
±
20
22
30
23
27
52
34
69
Asphyxia
278
288
295
362
372
546
476
776
±
±
±
±
±
55*
59*
57*
57*
79*
80*
63*
118*
time
143
134
122
156
154
239
252
326
±
±
±
±
±
+
= 90
26
22
23
28
34
50
36
70
time =
154
157
141
202
173
291
281
357
±
±
±
±
±
±
+
±
180
34
42
36
45
57
85
63
94
Values are expressed in mL/min x 100g, and as mean ± SEM. n=7. Asphyxia is at time=
60 min, at the peak of asphyxia. Time= 90 min, and time= 180 min corresponds with 0.5
and 2 hours after release of the occluder, respectively.
*: p< 0.05 (asphyxia IWSM baseline, Friedman two way analysis of variance)
All seven fetuses recovered and were in a good metabolic condition the day after
asphyxia. One ewe developed contractions and the fetus died during labor. The
period between intra-uterine fetal death and birth resulted in a poor quality of
fixation, which made reliable histologie evaluation impossible (Table 6.3; lamb no.
5). Another fetal lamb bled to death because of a catheter accident. The brain of
this animal was immersion fixed; it showed typical morphologic signs of
inadequate fixation (e.g., a high amount of residual erythrocytes, extreme swelling
of the perivascular and perineuronal glial compartment, densification of neuronal
cell bodies and granular appearance of nuclear chromatin (Table 6.3; lamb no. 4)).
It was impossible to differentiate these changes from subtle experimental hypoxic
damage. Five fetuses survived for 72 hours after asphyxia. This 3-day period was
chosen to allow delayed neuronal cell death to become histologically manifest
(14,15). The metabolic condition of these five animals during the whole
experiment did not differ from that of the two animals lost for perfusion fixation
because of labor and hemorrhage. The brains of the five fetuses were adequately
perfused (Figure 6.3; Table 6.3). Structural abnormalities in the brains of these
survivors were scarce. No changes were present that could be attributed to
microsphere embolism. A variable degree of edema was found in white and gray
matter. Coagulative neuronal cell changes, characteristic for irreversible cell death
(13,15) were only occasionally detected in four animals (Table 6.3). These
changes were most obvious in the Purkinje cells of the cerebellum (Figure 6.4).
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Table
lamb
no.
I
2
3
4
5
6
7
6.3. Degree of fixation and histologie
survival
(hours)
72
72
72
24
22
72
72
degree
of
fixation
6.0
5.3
7.7
0.2
np
9.0
7.6
evaluation
edematous cell changes
str
4
3
I
4
np
I
0
ctx
6
2
I
4
np
I
I
thl
6
I
0
4
np
0
0
hip
2
4
I
6
np
np
0
cer
4
4
0
6
np
0
0
med
1
0
0
4
np
0
np
str
0
0
0
• )
np
0
0
coagulative
ctx
0
3
0
• )
np
0
0
thl
0
1
0
0
np
0
0
cell changes
hip
0
0
0
0
np
np
0
eer
0
4
T
4
np
1
0
med
0
0
0
1
np
0
np
Histological cell changes were scored in eight cerebral entities: i/r, striatum; /W, thalamus; /II/J,
hippocampus: cw. cerebellum: m«/, medulla oblongata; whereas m summarizes the results of
evaluation of the frontal, parietal and temporal cortex. np= not performed. Details for the scoring
of the degree of fixation and histologie brain damage (13,15) are provided in the text.
Figure 6.3. Section of adequately fixed fetal cortex 72 hours after a period of severe
asphyxia. Microvessels appear nicely expanded farrovi'5) and are surrounded by a compact
neuropil. Neurons (/V) and glial cells («r/wt'/ieW,) are well preserved as can be derived
from the absence of any coagulative or edematous cell changes (2 um; toluidine blue).
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Figure 6.4. Detail of fetal cere-
bellum 72 hours after a period of
severe asphyxia. Purkinje cells fP)
show characteristic coagulative
cell change with cytoplasmic mi-
crovacuolation (arrow,) and nuclear
pyknosis (arrovv7;c«Jj. Surroun-
ding glial cells are extremely di-
lated (rt.s7frz.vAJ. Granular cell layer
(G/,) and molecular cell layer (ML)
appear unaltered (2 um; toluidine
blue).
g,*'
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Discussion
Reduction of uterine perfusion with an inflatable balloon occluder resulted
in the fetus in a decreased [C^Ja, the onset of anaerobic metabolism, the
production of lactate, and a decrease in pH. Mean Pa was 48.0 ± 0.6 mm Hg and
remained at the same level during and after asphyxia (Figure 6.1). This is in
agreement with previous data (16,17). The Pa gathers importance since
intermittent increases of cerebral intravascular pressure during asphyxia caused
hemorrhages in the germinal layer of fetal sheep brain (18). On the other hand,
also hypotension has been shown to be associated with neuronal damage (7,19).
During asphyxia adenosine is primarily released in the myocardium.
Adenosine is considered as a natural cardioprotector because of its coronary
vasodilative and antiadrenergic effects, and its inhibition of the activation of
platelets and leukocytes (10). Pretreatment with the adenosine transport inhibiting
drug R-75231 therefore preserves the function of the myocardium when the heart
has been compromized by severe asphyxia (11), and was shown to improve
myocardial functioning after heart transplantations in dogs (20). Therefore, we
hypothesized that after pretreatment with R-75231 the degree of asphyxia might be
severe enough to cause cerebral damage without the concomitant fetal death from
cardiogenic injury.
Baseline values of CBF were in agreement with previous results (16) and
literature (21). CBF increased in the period of asphyxia. During asphyxia the
increase in CBF was greater in phylogenetic older structures, such as medulla
oblongata and cerebellum, than in the cortex.
In the current study fetuses remained normoglycemic (Table 6.1) when
compared with literature data on glucose levels (7,22,23). Apparently the fetuses
were able to maintain normal glucose concentrations in spite of severe asphyxia.
Hyperglycemia, shown to reduce the tolerance of the brain toward asphyxia (22),
was not detected in any fetal lamb. The potentially negative impact on the brain of
(experimentally induced) high levels of glucose during oxygen lack was ascribed
to the concomitant tissue acidosis (24). Therefore, in the current study, brain
damage is not explained by an additional hyperglycemia.
After release of the occluder the [C^Ja returned to normal, leading to
recovery of the fetal acid-base balance. The time course of recovery after this
degree of asphyxia is in agreement with data from other investigators (19). CSF
lactate levels still increased during this recovery phase (Figure 6.2). Maximum
concentrations were reached approximately 2 hours after the end of uterine blood
flow obstruction. After this moment there appeared to be a trend toward
normalization. CSF concentrations of hypoxanthine and xanthine (Figure 6.2),
both catabolites of adenosine 5'-triphosphate, started to increase during the hour of
severe asphyxia. At time= 60 min, the start of the recovery period, levels of CSF
lactate, CSF hypoxanthine and CSF xanthine were only slightly elevated.
However, during the recovery period the concentration of these catabolites
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continued to rise. Maximum concentrations (fivefold, fivefold, and fourfold the
baseline levels of CSF lactate, CSF hypoxanthine, and CSF xanthine, respectively)
were reached at approximately time= 180 min. Next to damage to the blood-brain-
CSF compartment barrier, delayed neuronal damage may also partly explain the
increase of hypoxanthine and xanthine in the recovery period (14). During this
phase the [Ooja returned to baseline levels. The enzyme xanthine-oxidase is
released under hypoxic conditions from the liver into the circulation (9), and is
present in the brain (25). This enzyme metabolizes hypoxanthine and xanthine to
excretable uric acid, during which process oxygen derived free radicals are formed
(26,27). High levels of hypoxanthine and xanthine in the brain, in combination
with normal levels of oxygen in the recovery phase, may facilitate oxygen derived
free radical formation and aggravate post-asphyxial brain damage (9). This could
explain the beneficial effect of oxygen free radical scavengers in various
experiments with asphyxiated animals (28,29).
Although in the present study the degree of asphyxia was severe, as
indicated by a mean pH <7.00, serum lactate levels >14 mM, and a BE >-17
mmol/L (Table 6.1; Figure 6.1), extensive histological brain damage was not
observed. Cerebral edema was present in the majority of fetuses. From Table 6.3 it
can be derived that the degree of fixation was inversely correlated with edematous
cell changes. However, the question remains if this edema is a post-mortem effect
after incomplete fixation or if the incomplete fixation is a result of edema induced
by the asphyxiai insult. The latter is supported by combining the CSF
hypoxanthine and CSF xanthine data with the results of histologie studies. Animal
no. 1 (Table 6.3) is depicted in Figure 6.2 with o/w? r/rc/éw; edematous cell
changes at histologie evaluation corresponded with the highest level of CSF lactate
and a long period of elevated levels of CSF hypoxanthine. Animal number 2 is
depicted with //V/eo" c/Vc/es in Figure 6.2. Edematous cell changes are present
throughout the whole cerebrum in the fetus that had the highest amount of CSF
hypoxanthine and CSF xanthine (Figure 6.2). Cerebellar Purkinje cells were
shown to be most sensitive to oxygen deprivation (Figure 6.4). These cells have
highly branched dendritic trees, receiving a huge amount of synaptic input from
axon terminals. During asphyxia these large cells may encounter a nutrient supply
smaller than their minimum needs, resulting in irreversible cell death. The
sensitivity of Purkinje cells for oxygen shortage was confirmed in experiments in
other species. In adult cat brain chronic hypoxia mostly affected the Purkinje cells
located in the deeper portions of cerebellar folia (30). After severe asphyxia and
resuscitation most newborn pigs showed some anoxic cerebellar damage with
scattered necrotic Purkinje cells (31). In the latter two experiments and in the
current study the insult was primarily hypoxic, and damage was predominantly
located in the cerebellum. This is in contrast to brain ischémie experiments, which
primarily result in damage of the parasagittal cortex (8). This cortical area is
considered to be a waters/ied area: an arterial end field in the border zone between
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the territories of major cerebral arteries. During ischemia the relative sparing of
midbrain and hindbrain structures such as the cerebellum, when compared with the
cortex, may reflect preferential perfusion of the residual normoxemic blood flow
to these structures (32).
In sheep various methods were used to reduce fetal oxygen delivery to
induce brain damage; umbilical cord occlusion led to hippocampal brain damage
(33) and common internal iliac artery occlusion led to parasagittal cortex and
striatum damage (19). In the latter study, damage was not extensive: only three of
the 14 surviving fetuses demonstrated >10% damage, and six of the 14 animals
showed no damage at all. The authors presumed that differences in cerebral lactate
concentration could be an explanation of the regional differences in neuronal loss
between the two studies, but neither neuronal nor CSF lactate levels were
measured.
The lack of extensive brain damage reported after various types of
cerebral hypoxia confirms the statement about the existence of a narrow margin
between lethality after asphyxia on the one hand, and survival without signs of
histologie damage on the other hand (34). Finally, adequate perfusion fixation is
an absolute necessity, especially because the brain is extremely sensitive to
postmortem changes and since these changes closely resemble lesions induced by
mild hypoxia (35).
In summary, restriction of maternal uterine blood flow resulted in
increased fetal serum lactate concentrations and severe asphyxia. During asphyxia
animals increased their CBF, remained normotensive and normoglycemic. CSF
concentrations of lactate, hypoxanthine, and xanthine, increased fivefold, fivefold,
and fourfold, respectively. Maximum concentrations of CSF hypoxanthine and
CSF xanthine were reached in the recovery period following asphyxia, and were
associated with edematous cell changes. In the recovery period the [Oija returned
to baseline values. This reoxygenation may facilitate oxygen derived free radical
formation, and may thus aggravate postasphyxiai brain damage. In distinguishing
between histologie damage as a result of asphyxia or as a postmortem artifact,
perfusion fixation appeared to be important. The absence of extensive histologie
brain damage indicates that, under normotensive and normoglycemic conditions,
the fetal brain can tolerate severe asphyxia. Cerebellar Purkinje cells tended to be
most sensitive to asphyxia.
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Abstract
77ie o^yec/ive 0/ rôe prei^nr sfiw/y WYW to </efermine r/ie d/agno5//c power
o/f/ie 77£?/?S rar/o o/r/ie £CG to prerf/c//eto/ we//-bejng. 7nere/ore 1/1 47/era/
(5 to 5 day^ q^er surgery, ge.vtortona/ age 725.5 ± 5.0 days) as/?/ry;c/a wax
were e/?/!er prerreafed w/7/i a/z
a ca/ci'«m c/ianne/ è/ocA:er
=72), or served as cwtfro/s f«=79J. An ar?er/a/ oxygen conïe/i? >7.5 mM a/id/or
>7.75 were c/iosen as //m/tt/or/efa/ we//-^e//ig.
T/ie ar?er/a/ oxygen co«?e«r was reduced^rom 5.5 f± 7.0) to 7.5 f± 0.5)
/, /?r/ decreased to 7.05 f± 0.70). Mor/a/«fy was 55%. Bofn drwgs d/d nor aj^ ecf
we//-fee/n^, swrv/va/, or r/ze 77<2/?5 rario. Max/www T/(27?5 raf/os were reacned a/
/ne peaÂ: o/aspnyjc/a. 5ens/7/v/r>' and spec(//cj'O' o/?ne 77Q7?5 ra//o were 24.0% and
42.6% to pred/cr n^poxew/a, 25.7% and 45.5% to pred/c/ acùfem/a. Pearson
corre/ar/on coe/j^c/en/s/or r/^7?5 raf/o versus oxygen conrenr and versus p / / were
0.769 and 0./92, respec?/ve/>. /r /s conc/uded rnaf: f/) 7n/e/a/ lomfa rne 77g7?S
ra//o/a//ed fo pred/cf n_ypoxem/a or ac/de/ma. (77) 7^e/a/ surv/va/ was nor
corre/ared wt7n rne magn/rude o/rne 7/<27?5 rar/o dur/ng or a/rer aspn>>x/a.
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Introduction :
Soon after its introduction electronic FHR monitoring became widely used
trying to decrease perinatal mortality and morbidity (1). However, after use of
cardiotocography (CTG) for two decades it is clear that FHR patterns poorly
correlate with fetal acid-base balance (2). Difficulty in the interpretation of CTG
patterns during labor can result in unnecessary operative intervention (3) or in
damaged neonates (4). Serial sampling of fetal blood enables division of cases
with abnormal CTG traces in fetuses with and fetuses without acidemia (5). This
technique however is laborious, invasive, and considered unpleasant by patients.
Therefore, research is directed toward non-invasive, patient friendly methods of
fetal surveillance. Recently the combination of CTG with continuous analysis of
the fetal ECG during labor led to reduction of the proportion of operative
deliveries for fetal distress, without differences in neonatal outcome (6).
In animal studies the main interest in the fetal ECG has been focused on
changes in the ST segment and T wave. In response to hypoxia the ratio of T wave
height to QRS height (T/QRS ratio) increased in studies in fetal lambs (7,8,9).
However, in these studies animals were able to recover from hypoxia without the
onset of anaerobic metabolism and the occurrence of acidemia. This differs from
clinical pathophysiology, where severity of acidosis is considered an important
parameter in determination of the degree of fetal distress (10) and the concomitant
fetal morbidity (11).
The current study was designed to induce fetal hypoxemia severe enough
to result in anaerobic fetal metabolism and acidemia, which would inevitably be
associated with fetal death in some animals. The asphyxiai condition was created
in 47 fetal lambs by reduction of uterine perfusion. Animals were treated with
drugs potentially useful in treatment of asphyxiated fetuses: R-75231 (an
adenosine transport inhibitor) (12), flunarizine (a calcium channel blocker) (13), or
with the solvent of both drugs. We evaluated the effect of asphyxia and both drugs
on the T/QRS ratio of the fetal ECG. Thereafter we calculated the diagnostic
potential of the T/QRS ratio to predict fetal hypoxemia or fetal acidemia. To
investigate if a change of the T/QRS ratio within an individual animal was
indicative for its metabolic condition, linear regression analysis was performed for
the T/QRS ratio versus arterial oxygen content and versus pH. Besides the ECG
we were interested in hemodynamic variables as Pa and Pv and perfusion pressure,
possibly indicative for fetal survival.
Material and methods
Surgery
Surgery was performed in 47 pregnant Dutch Texel sheep. Gestational
ages varied between 110 and 128 days (mean ± SD = 120.0 ± 2.8 days, term= 147
days). Instrumentation, handling, and care of the animals were performed as
described previously (12). Briefly, a paramedian abdominal incision was made,
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and an inflatable balloon occluder was placed around the maternal common
internal iliac artery. Electrodes, made of stranded silver plated copper wire isolated
with extruded Teflon, were implanted subcutaneously at the level of the cardiac
apex and at both forelegs for recording of the fetal ECG. Catheters were inserted
in the fetal axillary and femoral artery, the femoral vein, and in the amniotic
cavity. Electrodes and catheters were exteriorized to the ewe's flank.
Measurements
The fetal ECG leads were placed subcutaneously on the left chest wall at
the apex level, and at right and left foreleg. This does not correspond with one of
the standard ECG leads. The chest lead was connected to the positive, the leg leads
to the negative terminal of the electrocardiograph. These leads would identify
changes in the Y-axis, shown to be sensitive in detection of ST waveform changes
(14). The fetal ECG was FM tape recorded continuously during the experiment.
Recording was performed low pass filtered with a 3-db limit of 100 Hz. The over-
all bandwidth was 0.05 to 100 Hz. Analysis of the fetal ECG and determination of
T/QRS ratio was performed after all 47 experiments were finished.
Fetal Pa and Pv and amniotic pressure were determined with the zero
point at the level of the ewe's spine. These signals, together with the FHR derived
from the pulsatile signal of the femoral artery, and the fetal ECG, were fed into a
bioelectric amplifier (Hewlett-Packard 8800 series, Andover, Mass., USA),
displayed on a monitor, recorded on an eight-channel strip chart recorder, stored
on magnetic tape, and digitized and analyzed with a computer.
During baseline, at the peak of asphyxia and twice in the recovery phase
2 mL of blood were withdrawn from the axillary artery and centrifuged (3 minutes
at 13,000 revolutions/min). Serum was frozen in liquid nitrogen and stored at
-73°C to determine lactate concentrations. Blood gas values and pH from the fetal
aortic arch were measured with an automated analyzer (AVL, Radiometer,
Copenhagen, Denmark) and corrected for 39°C. Hb saturation was measured with
a hemoximeter (OSM2 Hemoximeter, Radiometer). The [O^la was calculated as
follows: [O^la (mM) = Hb concentration (mM) x Hb oxygen saturation (%/100).
Experiments
Gestational age at the beginning of experiments varied between 113 and
132 days (mean ± SD = 123.5 ± 3.0 days). Baseline values for FHR, and Pa and Pv
were obtained during a control period of 2 hours. Fetal acid-base balance was
analyzed every 15 minutes.
Asphyxia was induced by gradual reduction of uterine blood flow by
stepwise inflation of the balloon occluder around the maternal common internal
iliac artery. To maintain the fetus in a stable hemodynamic condition, uterine
blood flow was gradually reduced over a period of 90 to 120 minutes until fetal
was reduced to approximately 35% of baseline value. This latter hypoxemic
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condition was maintained for 1 hour, during which the pH dropped. This 1 hour
period is referred to as severe asp/ivjc/a (time= 0 to 60 min). Serum lactate
measurements were performed during baseline condition, at the peak of asphyxia
(time= 60 min), and 30 minutes and 120 minutes after release of the occluder (at
time= 90 min and time= 180 min). Administration of R-75231, flunarizine, or the
solvent of both drugs resulted in the formation of three groups, referred to as group
R (R-75231), group F (flunarizine), and group C (control, animals that received
the solvent). During the baseline period group R (16 fetuses) was treated with an
intravenous bolus of R-75231 (2-aminocarbonyl-N-(4-amino-2,6-dichlorophenyl)-
4-[5,5-bis(4-fluorophenyl)-pentyl]-l-piperazineacetamine} in a dosage of 0.1
mg/kg estimated fetal weight. At random with R-75231, ten fetuses (of group C)
received its solvent, being 10% 5-OH-propyl-B-cyclodextrine, at the same moment
in the experiment. In group F twelve animals were treated with flunarizine in a
dosage of 0.5 mg/kg estimated fetal weight. At random with flunarizine, nine
animals (group C) received the solvent of flunarizine. To avoid possible side
effects such as systemic hypotension and tachycardia, we administered flunarizine
or the solvent in 2 dosages over a period of 1 hour in the axillary artery. The first
dosage was started at time= 60 min, the second dosage was started at time= 180
min. Because the solvent of flunarizine also consisted of 10% 5-OH-propyl-B-
cyclodextrine both solvent groups were taken together and referred to as cwtfro/
group (C). This solvent has proven to be inert in numerous experiments in animals
and man (Janssen Pharmaceutica, personal communication).
The experiment was ended when either the fetus had died or, in case of
fetal survival, after 3 days. When still alive after 3 days a relaparotomy was
performed under general anesthesia. The fetus was /'« v/vo perfused with a fixative
solution to perform histologie analysis of the brain (15).
Calculations and data analysis
FHR, Pa and Pv, corrected for amniotic pressure, were averaged over 10
seconds periods using a computer program. Five of these epochs were averaged to
calculate mean values. Perfusion pressure was determined every 15 minutes by
subtraction of Pv from Pa.
The FM tape recorded fetal ECG was run through a commercially
available cardiotocograph and ECG-analyzer (ST-analyzer, Cinventa AB, Molndal,
Sweden), and analyzed with the aid of a microprocessor system supplied by the
same company. The ST-analyzer employs a system of template matching of the
QRS complex, followed by signal averaging of accepted complexes, provided an
adequate number of complexes are accepted during a set period. Conversion of the
fetal ECG was done at a rate of 500 samples per second and with a resolution
corresponding to 8 bits (14). The average ECG complex was based on 30 ECG
complexes. Filter characteristics and averaging processes were in agreement with
recommendations from literature (9,14).
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The diagnostic potential of the T/QRS ratio, as a test to trace fetal compro-
mise, was determined using an [Cya of 1.5 mM as a cut-off level, repeated by the
same calculation using a pH of 7.15 as a cut-off level. To determine if the T/QRS
ratio during the experiment was an indication of fetal compromise, linear regres-
sion analysis was performed for T/QRS ratio versus [Oija and for T/QRS ratio
versus pH in each individual fetus. Mean slopes and Pearson correlation coeffi-
cients were calculated for all groups.
Because we were interested in parameters possibly influencing fetal
survival after asphyxia, the groups were divided into survivors (R+, F+, and C+)
and non-survivors (R-, F-, and C-), thus forming six different groups. Survival was
established if the fetus was still alive 12 hours after asphyxia. Differences between
groups were tested with the two-tailed Mann-Whitney U test. A p<0.05 was
accepted as level of statistical significance.
Results
Twenty-two of the 47 fetal lambs (47%) survived longer than 12 hours
after asphyxia. Table 7.1 shows the number of animals in all 6 groups, mean
survival time and the range of survival in each group. The limit for survival was
arbitrarily set at 12 hours. Only four animals survived in the range from 6 to 20
hours. Therefore, a change of this limit would not result in major shifts of animals
from one group to another.
Table 7.1. Characteristics of the six experimental groups
Group
R+
R-
F+
F-
C+
c-
Treatment
R-75231
R-75231
flunarizine
flunarizine
control
control
Survival
> 12 hours
yes
no
yes
no
yes
no
Mean
survival
60.5
2.3
51.4
2.5
43.1
3.6
Survival
range
22-72
0.5-11
13-72
1-4.5
12-72
0.2-10
Number of
animals
8
8
7
5
7
12
Division of the 47 fetuses used in the current study according to
treatment and survival.
Mean survival and survival range are expressed in hours.
Chapter 7: The ECG during fetal asphyxia 123
5 "
4 •
3 •
2 •
1 •
n .
u
7.4 "
7.2 •
7.0 "
6.8 •
5 "
o •
-5 "
-10 •
-15 •
-20 •
8 •
6 •
4 •
2 •
- arterial oxygen content (in mM)
• P^
A
| 1 R 1
D & i 0 e g !
i g j
• •
i
• base excess (in mM)
• P(
0 -I
-240
A * A
A
H A I ,
o • 4 E
1
^Og (in kPa)
1
-180
A • i
• •
—1
Agi
-H
-120
• i ;
D 1
à
— i —
* > . .
SI
— i —
—i
-60
I I
8 o
A
• lu
1
i A g û
—1
0
â A
•e
n
! • s
* 4 A
1—
Q O n
J-r*
— i —
• i
— i —
60
6 A O
S °™ D
" • S 1
•
D
• 1 i
1
D • °0 » A
fl • ' •
A
1
A
Mill
— i —
120
o
A o
^ • 1
•
9 Q •
A •
•I
1—
1
_ •
• •
1
H-
180
time
n
a
1
o
n
à
a
1
•
1°
1
240
n minutes
Figure 7.1. Time course of [Oala (mM), pH, BE (mM), and PCO2 (kPa). Values are means
of the six groups: R+ (open fn'a/îg/e.s), R- (////«/ /riang/e.9), F+ (open c/rc/ej), F- (///W
dre/ei), C+ (open 5^Marei) and C- (/î//e</ i^wares). Time (min) is depicted on the X-axis;
time -180 to -120 min= baseline period; time -120 to 0 min= progressive reduction of
uterine blood flow; time 0 to 60 min= 1 hour period of asphyxia; time 60 to 210 min=
recovery period, fiar, period of occlusion.
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The time course of the mean metabolic condition of all 6 groups is
depicted in Figure 7.1. During the occlusion period the [Cya decreased, leading to
acidemia with a mean pH of 7.03 (± 0.10) at time= 60 min. This was associated
with a mean BE of -16.3 (± 3.8) mM. The PCO? did not increase significantly.
After release of the occluder the [C^Ja immediately increased in the surviving
groups (o/^n symbo/s) leading to pH values that returned to baseline and to BE
levels within the normal range. This was in contrast with the non-surviving groups
ym6o/s): release of the occluder only temporarily led to an increase of
, whereas pH and BE did not return to baseline values. No significant
differences between groups were demonstrated before and during occlusion,
whereas from time= 150 min onwards [C^Ja, pH and BE values were higher in the
surviving groups compared with the non-surviving groups (p<0.05, two-tailed
Mann-Whitney U test).
Serum lactate levels increased during asphyxia and remained elevated
after release of the occluder in the non-surviving animals (Table 7.2). This was in
contrast with the surviving fetuses, where a decrease of lactate levels was seen in
the recovery period.
Table 7.2. Serum lactate levels (mean ± SD. mM)
Group
R+
R-
F+
F-
C+
C-
Baseline
1.6
1.3
1.4
1.8
1.4
2.0
±
±
±
±
±
±
1.3
0.4
0.4
0.9
0.6
1.3
Asphyxia
14.2
14.1
14.0
12.1
11.9
12.1
±
±
±
±
±
±
2.0
3.0
3.5
7.0
4.3
3.7
time =
14.2
14.8
11.5
13.4
11.7
11.0
90
±
±
±
±
±
±
min
1.6
3.4
2.8
7.4
4.5
2.9
time=
11.5
12.2
9.2
17.6
9.8
12.0
180 min
± 1.8
(n=l)
± 3.2
± 6.0
± 3.7
± 5.4
Asphyxia is at time= 60 min, at the peak of asphyxia. Time= 90 min and time= 180 min
corresponds with 0.5 and 2 hours after release of the occluder, respectively.
Figure 7.2 shows the time course of fetal cardiovascular parameters.
During asphyxia and recovery the FHR increased slightly in all groups, mean Pa
and Pv did not significantly change, nor did the perfusion pressure (Pa-Pv).
Differences between groups were not significant (two-tailed Mann-Whitney U
test).
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Figure 7.2. Time course of FHR, Pa (mm Hg), Pv (mm Hg), and perfusion pressure (Pa-
Pv, mm Hg). Values are means of the six groups: R+ (o/wvi /r/flngte.ç), R- (/7/W mVjnfltej),
F+ (o/j£'H cm/e.s), F- (/«//«/ c/rc/e.ç), C+ (o/7e>« .v^ wa/^ .v) and C- (////erf n/uar?,?). Time (min)
is depicted on the X-axis; time -180 to -120 min= baseline period; time -120 to 0 min=
progressive reduction of uterine blood flow; time 0 to 60 min= 1 hour period of asphyxia;
time 60 to 210 min= recovery period. Bar, period of occlusion.
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The mean T/QRS ratio for all 6 groups is shown in Figure 7.3. The mean
increased during occlusion, maximum levels were reached at time= 60 min, at the
peak of asphyxia. Standard deviations are depicted for the control groups (C+ and
C-), solely to indicate the large interanimal variation. Due to this variation
significant differences between groups were not reached. The two drugs used in
the present study (R-75231 and flunarizine) did not affect the T/QRS ratio.
Surviving fetuses did not have different T/QRS values compared with non-
surviving fetuses.
Figure 7.3. Time course of the T/QRS ratio. Values are means of the six groups: R+
m't//i#/«\v), R- (////e</ muH.ij/o), F+ («pe/i r/Vc/e.?). F- (/?//«/ c/'reto), C+ (o/w! .s^wares) and
C- (/?//«/ 5^ M«re'.v). Time (min) is depicted on the X-axis; time -180 to -120 min= baseline
period; time -120 to 0 min= progressive reduction of uterine blood flow; time 0 to 60 min=
1 hour period of asphyxia; time 60 to 210 min= recovery period. Bar, period of occlusion.
Standard deviations are depicted for the control group (C+ and C-), only to indicate
interanimal variability.
To determine the diagnostic possibilities of the T/QRS ratio we related all
T/QRS values with their concomitant pH and [C^la value. From the resulting
scattergram, the accuracy could be determined. All T/QRS ratios and pH data for
group C+ are shown in Figure 7.4. The diagnostic potential of the T/QRS ratio was
determined based on the cut-off levels T/QRS<0.25, 0.25<T/QRS<0.50, and
T/QRS>0.50. These cut-off levels created 6 cells (a-f, depicted in Figure 7.4),
which were used to calculate the diagnostic potential of the T/QRS ratio in
predicting fetal hypoxemia ([Oi]a <1.5 mM) or fetal acidemia (pH <7.15). The
results of these calculations are shown in Table 7.3. Calculations were based on
787 data-pairs regarding T/QRS ratio and [O->]a, and on 776 data-pairs regarding
T/QRS ratio and pH. Results were poor; sensitivity and specificity were low,
predictive values moderate, and likelihood ratios for both a positive and a negative
test result were poor.
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Whereas in Figure 7.4 the linear regression analysis of the T/QRS ratio
versus the pH of group C+ is shown (y=-0.767x + 6.011, r=-0.346), the mean
slopes and the Pearson correlation coefficients of all 6 groups are summarized in
Table 7.4. Except for group R- (T/QRS versus pH) all slopes were negative.
Correlation coefficients were low. Differences between groups did not reach
significance. Since differences between groups were not significant all animals
were taken together in the regression analysis of T/QRS ratio versus serum lactate
levels. Lactate was determined at 4 moments during the experiment in 47 animals
(188 samples), whereas in 156 cases an adequate T/QRS ratio was obtained during
sampling. Regression analysis on these 156 data-pairs showed y= 0.008x + 0.267,
r=0.227.
Figure 7.4. Scattergram depicting all available combinations of T/QRS ratio and pH of
group C+. The linear regression line (y=-0.767x + 6.011, r=-0.346) is shown, horizontal
lines indicate cut-off levels for determination of accuracy of the T/QRS ratio. As a result of
these lines six cells are formed (a-f). corresponding with the cells of Table 7.3.
Table 7.4. Regression analysis for the T/QRS ratio versus [C>2]a and of the
T/QRS ratio versus pH
Group
R+
R-
F+
F-
C+
C-
T/QRS versus arterial oxygen content
mean slope
-0.040
-0.029
-0.018
-0.024
-0.026
-0.040
correlation
coefficient
-0.220
-0.152
-0.108
-0.197
-0.091
-0.247
T/QRS versus pH
mean slope
-0.757
0.175
-0.247
-0.133
-0.767
-0.199
correlation
coefficient
-0.446
0.145
-0.185
-0.172
-0.346
-0.150
Values are expressed as mean. Differences between groups did not reach significance.
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Discussion
Reduction of maternal uterine perfusion with an inflatable balloon
occluder resulted in decreased fetal [C^la, the onset of anaerobic metabolism,
production of lactate, and a decrease in pH. BE dropped, and the fetuses kept their
PCO2 reasonably constant. Asphyxia induced in this group of 47 fetuses was
considered severe, as the estimated extracellular fluid BE was always less, and
often far less, than -12 mM (16). Moreover, the severity of asphyxia was indicated
by a mortality within 12 hours after the asphyxiai event of 53% (25 of 47 animals).
During the experiment FHR increased, mean Pa and Pv as well as perfu-
sion pressure remained unaltered.
In previous experiments the beneficial effect of R-75231 on fetal cardio-
vascular functioning after asphyxia was demonstrated (12). Therefore, 16 animals
were pretreated with R-75231 in the current study. The rationale to treat 12 fetuses
with the calcium channel blocker flunarizine is its effect regarding reduction of
cerebral morbidity after hypoxic-ischemic events (17). Calcium shifts occurring
with severe energy failure are responsible for massive calcium overload in
neurons, leading to the activation of phospholipases. This results in accumulation
of free fatty acids and in edema of neurons, which further compromises oxygen
supply (18).
The major finding of the current study was the fact that the T/QRS ratio of
the ECG did not reflect well-being in fetal lambs. This was mainly attributable to
the large interanimal variation (Figure 7.3), not only during asphyxia but also
during the normoxemic baseline period. The trend of the T/QRS ratio in individual
animals may be a better indicator of fetal well-being. Therefore, we performed a
linear regression analysis of T/QRS ratio versus [C^Ja and versus pH. All 47
asphyxiated fetuses were categorized according to treatment and survival in one of
the 6 groups. Pearson correlation coefficients of the 6 groups were low and
differences between groups were not significant (Table 7.4). We conclude that
within a particular animal a change of T/QRS ratio did not correlate satisfactorily
either with its metabolic condition or with its survival.
Recently, a new CTG monitor was designed to combine the CTG with an
on-line calculation of the T/QRS ratio during labor (19). The first randomized trial
of this ST waveform analysis during labor seemed promising. The rate of
operative deliveries for fetal distress was reduced by 53% and the use of cesarean
section and rotational forceps was reduced by 74%, without changes in neonatal
outcome (6). However, also recent literature is not unequivocal. None of the
neonates born in a poor condition (one minute Apgar score <3) or with evidence of
acidemia had a mean T/QRS ratio significantly different from the normal range
(20). A raised T/QRS ratio had a considerably lower detection rate for fetal
acidemia than a pathological CTG (21), and a weak correlation was found between
the T/QRS ratio and umbilical artery acidemia (22).
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Table 7 J . Diagnostic
T/QRS ratio
>0.50
<0.25
0.25 5 T/QRS < 0.50
value of the T/QRS ratio
ICbla
< 1.5 mM
58 (a)
89 (c)
95 (e)
Positive predictive value
Negative predictive value
Sensitivity
Specificity
False positive rate
False negative rate
Accuracy
Prevalence
Likelihood ratio for a
Likelihood ratio for a
= a / (a + b)
= d / (c + d)
= a / (a + c + e)
= d / (b + d + 0
= b / (b + d + 0
= c / (a + c + e)
= (a + d) / (a + b
= (a + c + e ) / (a
positive test result
|O2la
i l . 5 mM
88 (b)
232 (d)
225 (f)
+ c + d + e + f)
+ b + c + d + e
(=sensitivity/false positive rate)=
negative test result
(=false negative rate/ specificity )=
pH <
75 (
102
122
+ n
7.15
a)
(c)
(e)
hypoxemi
= 39.7%
= 72.3%
= 24.0%
= 42.6%
= 16.1%
= 36.8%
= 36.8%
= 30.7%
1.49
0.86
pH a: 7.15
68 (b)
216 (d)
193 (f)
a acidemia
52.4%
67.9%
25.1%
45.3%
14.3% •
34.1%
37.5%
38.5%
1.76
0.75
The diagnostic value of the T/QRS ratio as determined in all fetal lambs (n = 47)
irrespective of their treatment. The diagnostic value was determined for fetal hypoxemia
and for fetal acidemia with cut-off levels for [O2la < 1-5 mM and for pH < 7.15. respec-
tively. The numbers in the 6 cells (a-f) reflect the number of times a particular T/QRS
ratio was associated with a certain metabolic condition.
Increment of the T/QRS ratio in animal experiments was suggested to
represent a change to anaerobic myocardial metabolism (7), secondary to beta-
adrenergic stimulation (8). The T/QRS ratio may therefore be a parameter by
which myocardial adaptation to hypoxia, or a compromized fetus, could be
identified. However, no severely asphyxiated fetuses were observed in the latter
two animal studies. Moreover, these studies were performed using reduction of the
maternal inspired oxygen concentration to induce fetal oxygen shortage. The
correlation between elevation of the T/QRS ratio and the rise of plasma lactate
levels was based on 5 mildly hypoxic fetal lambs (7). This correlation was not
confirmed in the 47 severely asphyxiated fetuses of the present study (r= 0.227).
Another difference in experimental setup is the gradual induction of fetal asphyxia
in the current study, maintaining a normal fetal heart rate and a stable blood
pressure. This is in contrast with the bradycardia and marked hypertension
observed after maternal occlusion for 60 seconds, which was associated with an
increased T/QRS ratio in mature as well as in immature lambs (9). The cause of
the raised T/QRS ratio during this cardiovascular instability remains unclear. The
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degree of asphyxia, the cardiovascular stability, and the number of animals studied
are the main differences with the present experiments. These severely asphyxiated
fetuses represent the group of major interest since this group is highly susceptible
for the development of neurologic sequelae (II).
Mean (± SD) values for the T/QRS ratio of the fetal ECG during human
labor have been reported as 0.20 (± O.I I) (23) and as 0.10 (± 0.05) (24). The
normal range in fetal sheep was reported below 0.30 (7). In the current study the
diagnostic potential of the T/QRS ratio was determined based on the cut-off levels
recommended: T/QRS < 0.25, 0.25 < T/QRS < 0.50, and T/QRS > 0.50. These
levels were also used in a large randomized trial of CTG alone or with ST
waveform analysis (6) and in sheep experiments (25). Figure 7.4 depicts all
available combinations of T/QRS ratio and pH of group C+, the group that had
one of the best correlation coefficients observed (r=-0.346). To increase the power
of the T/QRS ratio in predicting fetal acidemia the number of observations in cell
"a" and cell "d" has to be as large as possible, in cell "b" and cell "c" as small as
possible. However, observations are equally spread in the scattergram. Neither a
change of T/QRS ratio cut-off levels, nor a change of the pH= 7.15 or [O?]a= 1.5
mM cut-off level will lead to more values in cell "a" and cell "d". Therefore, a
change of these cut-off levels will not have a major impact on the power of the
test, During decelerations induced by umbilical cord compression in fetal sheep
the T/QRS ratio was tested in predicting fetal acidemia (pH <7.15): sensitivity and
specificity reached 100% and 76.5-87.5%, respectively. Calculations however
were based on 22 data-pairs in 5 chronically instrumented animals only, whereas
the effect of the deceleration itself remained unclear (25).
The ST-analyzer used in the present study was identical with the one used
in recent investigations (6,21,22). Filter and processing characteristics were as
recommended (9,14). Cut-off levels used for calculations were selected according
literature, and a change of these levels would not induce major improvements of
the test. The main differences between studies promoting the T/QRS ratio as a
sensitive detector of fetal compromise and the present study are the severity of
acidemia. the amount of animals studied, the number of observations per animal,
and the method used to induce fetal oxygen shortage.
Whether fetal ECG analysis is superior to the CTG in predicting hypoxemia
or acidemia during decelerations in the fetal heart rate pattern in human labor, can of
course not be concluded from the current data. Earlier animal studies showed that
short lasting acute hypoxia as occurring during decelerations is reflected in the
T/QRS ratio (7,8,9). However, in the present study slowly developing fetal acidemia
without major changes in heart rate or blood pressure was not adequately detected
by ST waveform analysis. The huge increase (up to 400%) in myocardial blood
flow during the developing acidemia (12), and the concomitant increase in oxygen
delivery to the fetal heart may have ensured adequate oxygen delivery to the
myocardial cells, thus not leading to ST-waveform changes.
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In conclusion, the present data show that during normoxemia there is a
large variation in T/QRS ratio in preterm fetal lambs. During severe asphyxia the
mean T/QRS ratio increased. However, the prediction of hypoxemia or acidemia
on the basis of the T/QRS ratio failed in the fetal lamb model used in this study.
Similarly, the correlations between the T/QRS ratio and arterial oxygen content,
arterial pH, and serum lactate levels were poor, implying that trends in individual
animals were of limited value.
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Abstract
During severe oxygen shortage the fetal brain resorts to anaerobic
metabolism and ATP becomes catabolized. High levels of nucleosides,
hypoxanthine and xanthine (ATP catabolites) in cerebrospinal fluid (CSF) may
therefore be associated with increased neonatal neurologic morbidity. In 22 fetal
lambs (3 to 5 days after surgery, gestational age 123.5 ± 3.5 days) arterial oxygen
content was progressively reduced to 35% of the baseline value with a balloon
occluder around the maternal common internal iliac artery. This resulted in a
1 hour lasting period of asphyxia, leading to a pH of 7.02 ± 0.03 and a BE of-17.0
± 1.0 mM. Mortality was 50%. CSF was sampled from the spinal cistern and
analyzed using HPLC. During reoxygenation hypoxanthine and xanthine may
serve as substrate for xanthine-oxidase with concomitant production of oxygen
derived free radicals, which may aggravate cerebral damage. The main difference
between surviving and non-surviving animals was the rate of the rise of ATP
catabolites in CSF: in the surviving group levels increased steadily, recovery
values being significantly elevated compared to asphyxia values, whereas in the
non-surviving group the rise was rapid and levels during asphyxia did not differ
from levels during recovery. We conclude (I) that catheterization of the spinal
cistern leads to increased levels of CSF hypoxanthine, xanthine, and inosine, and
(II) that during fetal asphyxia levels of these ATP catabolites and lactate in CSF
increase. (Ill) Maximum levels are reached during the recovery period and are
similar for surviving and non-surviving animals, but during asphyxia CSF levels
of hypoxanthine and lactate were higher in the non-surviving fetuses. (IV) The rate
of rise of ATP catabolites in CSF is higher in the non-surviving animals, and may
therefore be predictive for fetal demise.
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Introduction
Intrauterine oxygen shortage leads to anaerobic fetal metabolism. Due to
an increase of CBF (1) and preferential streaming of well-oxygenated blood in the
heart (2), the fetal cerebrum is provided with as much oxygen as possible. During
severe or sustained oxygen shortage however, the brain too resorts to anaerobic
metabolism. Lack of oxygen impairs mitochondrial functioning, leading to energy
shortage (3); ATP becomes degraded to AMP and after dephosphorylation, further
to adenosine, inosine and hypoxanthine. Serum levels of hypoxanthine are
considered a sensitive indicator of the hypoxic insult (4). Moreover, formation of
hypoxanthine and xanthine may aggravate outcome after such an insult, because
during reoxygenation hypoxanthine and xanthine may act as substrate for the
enzyme xanthine-oxidase, yielding oxygen derived free radicals and subsequent
damage in the newborn (5). This may explain bronchopulmonary dysplasia in the
preterm, since levels of pulmonary free radical scavengers are low in preterm
animals and reach peak values around term (6). Since the intestine is known to
contain large amounts of xanthine-oxidase (5), and the vitreous corpus of the eye
large amounts of hypoxanthine. necrotizing enterocolitis and retinopathy of
prematurity may be a result of oxygen derived free radical formation too (4).
Regarding the brain, oxygen derived free radical scavengers prevent the
secondary cerebral hypoperfusion after asphyxia in neonatal lambs (7), and limit
perinatal postasphyxiai brain damage in rats (8). We measured levels of lactate,
adenosine, inosine, guanosine, hypoxanthine, xanthine, and of uric acid in CSF of
fetal lambs during surgery, and before, during, and after severe asphyxia induced 3
to 5 days after surgery. We hypothesize that the level of ATP catabolites, and
especially of hypoxanthine, in the fetal lamb brain may affect outcome after
asphyxia, due to the subsequent oxygen derived free radical production. Therefore,
levels of ATP catabolites in CSF of surviving fetuses were compared with levels in
non-surviving animals.
Material and methods
Surgery
Surgery was performed in 47 pregnant Dutch Texel sheep under general
anesthesia. Gestational age varied between 110 and 128 days (mean ± SD = 119.9
± 2.7 days, term = 147 days). Instrumentation, handling, and care of animals was
performed as described previously (9). Briefly, a paramedian abdominal incision
was made, and an inflatable balloon occluder was placed around the maternal
common internal iliac artery. A hysterotomy was performed and the fetus partly
extracted. A midline incision was made in the dorsal surface of the fetal neck, and
the epidural cavity was opened (10). Epidural fat, containing small veins, was
carefully swept away with a cotton-tipped applicator and the spinal cavity was
opened with a needle. The appearing CSF was sampled. A polyvinyl catheter
(outer diameter 1.6 mm, inner diameter 0.8 mm) was inserted through the puncture
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hole into the spinal cavity and advanced 1.0 to 2.0 cm cranially until adequate CSF
sampling was possible. The catheter was fixed with tissue glue and sutured to the
fetal skin. The tip of the catheter was located in the spinal cistern. Furthermore,
catheters were inserted in the fetal axillary and femoral artery, the femoral vein,
and in the amniotic cavity. Electrodes to measure the fetal ECG and ECoG were
placed. Electrodes and catheters were exteriorized to the ewe's flank.
Measurements
The CSF catheter deadspace was reduced to approximately 0.2 mL. The
volume obtained per sample was > 0.6 mL, including the deadspace volume. All
CSF samples (included the ones obtained during surgery) were withdrawn with a 1
mL syringe, centrifuged (3 minutes at 13,000 revolutions/min), frozen in liquid
nitrogen, and stored at -73°C. After storage all samples were analyzed simul-
tanuously. Concentrations of lactate were measured using an enzymatic procedure.
Levels of nucleosides and bases were determined using high performance liquid
chromatography (11).
Blood gas values and pH from the fetal aortic arch were measured with an
automated analyzer (AVL, Radiometer, Copenhagen, Denmark) and corrected for
39°C. Hb saturation was measured with an hemoximeter (0SM2 Hemoximeter,
Radiometer). The [C^a was calculated as follows: [C^Ja (mM) = Hb concentration
(mM) x Hb oxygen saturation (%/100). During baseline, at the peak of asphyxia,
and twice in the recovery period 2 mL of blood were withdrawn from the axillary
artery and centrifuged (3 minutes at 13,000 revolutions/min). Serum was frozen in
liquid nitrogen and stored at -73°C to determine lactate concentrations.
Experiments
Fortyseven fetuses were instrumented with a CSF catheter. In 15 animals
CSF sampling could only be performed one to four times. Due to this low
frequency of sampling changes due to the experiment might be missed, and
therefore these fetuses were excluded, together with 10 preparations in which fetal
demise in the first 3 days following surgery occurred. Gestational age of the
remaining 22 fetuses during experiments varied between 113 and 132 days (mean
± SD = 123.5 ± 3.5 days). Baseline values for fetal metabolic parameters were
obtained during a period of 2 hours, in which fetal acid-base balance was analyzed
every 15 minutes.
Asphyxia was induced after 3 to 5 days recovery from surgery, by gradual
reduction of maternal uterine blood flow by stepwise inflation of the balloon
occluder around the common internal iliac artery. To maintain the fetus in a stable
hemodynamic condition, uterine blood flow was gradually reduced over a period
of 90 to 120 minutes until fetal [O^la reached approximately 35% of the baseline
value, during which period acidemia occurred. This latter asphyxiai condition was
maintained for 1 hour, referred to as se-vere asp/iyjt/'a (time= 0 to 60 min). At time=
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60 min the occluder was released and recovery monitored. The experiment was
ended when either the fetus had died or, in case of fetal survival, after 3 days.
When still alive after 3 days a relaparotomy was performed under general
anesthesia. The fetus was perfused /w v/vo with a fixative solution to perform
histologie analysis of the brain (12).
Calculations and data analysis
Because CSF levels of lactate, nucleosides, and purine bases may be
indicative for fetal survival after asphyxia, the 22 animals were divided into
survivors and non-survivors. Survival was established if the fetus was still alive 12
hours after asphyxia.
In both groups mean baseline values (from time= -240 min to time= -120
min) were determined, and compared with asphyxia values (from time= 0 min to
time= 60 min) and with recovery values (from time= 60 min to time= 180 min),
using a Wilcoxon matched-pairs signed-ranks test.
Differences between survivors and non-survivors were tested with the
two-tailed Mann-Whitney U test. Within one animal differences between
parameters obtained at surgery and during baseline were tested with a paired t-test.
For all statistical tests a p<0.05 was accepted as level of statistical significance.
Results
Eleven of the 22 fetal lambs (50%) survived longer than 12 hours after
asphyxia. The limit of 12 hours was arbitrarily chosen. Since only one animal
survived in the range from 6 to 20 hours, a change of this limit would not result in
major shifts from one group to another. The mean (median) ± SD surviving time
was 62.2 (72) ± 22 hours and 2.4 (2) ± 1.7 hours, for the surviving and the non-
surviving group, respectively.
Figure 8.1 shows the time course of the metabolic condition of both
groups. During occlusion mean [C^Ja decreased, leading to anaerobic fetal
metabolism and acidemia with a mean pH of 7.02 ± 0.03 at time= 60 min. This
was associated with a decrease of BE to -17.0 ± 1.0 mM. After release of the
occluder the [C^la steadily increased in surviving animals (o/?e« c7/r/e.y) leading to
pH and BE values returning to baseline levels. This was in contrast with non-
surviving animals (/;//«/ c/rc/es): release of the occluder resulted only temporarily
in an increased [C^Ja, whereas pH and BE did not return to baseline levels. No
differences between both groups were demonstrated before and during asphyxia,
whereas from time= 150 min onwards [C»2]a, pH and BE values were higher in the
surviving group compared with the non-surviving group (p<0.05, two-tailed
Mann-Whitney U test).
Table 8.1 summarizes the effect of surgery on CSF lactate, hypoxanthine,
xanthine, and inosine levels. Mean concentrations of these parameters at surgery
were compared with mean values 3 to 5 days later at baseline measurement. For
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hypoxanthine, xanthine, and inosine, CSF concentrations during surgery were
significantly elevated compared to baseline values in the experiment, whereas CSF
lactate levels were not elevated during surgery. Values of adenosine, guanosine,
and uric acid are not shown in Table 8.1 since these concentrations were not
elevated due to surgery.
Table 8.1. Effect of surgery on CSF lactate. hypoxanthine, xanthine, and inosine levels
Surgery
Baseline
Lactate
2.59 ± 0.31
2.66 ± 0.94
Hypoxanthine
15.09 ± 6.43
9.80 ± 2.83#
Xanthine
5.85 ± 1.86
4.08 ± 2.46*
Inosine
15.66 ± 7.97
3.53 ± 2.60#
Values are depicted as mean ± SD, lactate in mM. hypoxanthine, xanthine, and inosine in (iM, n=22.
• p<0.01 (surgery verms baseline, paired t-test)
#p<0.001 (surgery verms baseline, paired t-test)
Serum lactate levels were measured at four moments in the experiment,
indicated with asterisks in Figure 8.1. Results are shown in Table 8.2. During
asphyxia serum lactate levels increased 7 to 8 fold, and a slow decrease of serum
lactate levels was observed during recovery. Differences between survivors and
non-survivors did not reach significance.
Table 8.2. Serum lactate levels (mM)
Survivors
Non-survivors
Baseline
1.33 ± 0.46
1.86 ± 0.73
Asphyxia
time=60 min
14.04 ± 2.81
13.24 ± 5.21
Post-1
time= 90 min
13.27 ± 2.47
12.68 ± 5.00
Post-2
time= 180 min
10.66 ± 1.56
11.80 ± 6.08
Values are depicted as mean ± SD, n= 11 for both groups. No differences between groups.
Due to sampling difficulties withdrawal of CSF was not performed on
standardized moments in the experiment. Besides the sample obtained during
surgery, another 5 CSF samples were considered the minimum in order to be sure
that changes induced by asphyxia were adequately measured. Figure 8.2 shows all
individual CSF levels of lactate, hypoxanthine, and xanthine from surviving
animals (opevi c/rr/es, 11 animals, 73 samples, 5 to 10 samples per animal) and
non-surviving animals (////<?rf tm7ey, 11 animals, 75 samples, 5 to 11 samples per
animal).
In Figure 8.3, CSF levels of adenosine, inosine, guanosine, and uric acid
are depicted for surviving animals (optvi cm/es, 11 animals, 73 samples, 5 to 10
samples per animal) and non-surviving animals (////erf circ/es, 11 animals, 75
samples, 5 to 11 samples per animal).
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Figure 8.1. Time course of [C>2]a (mM), pH, and BE (mM). Values are means ± SEM.
Surviving animals (n=ll) are depicted as open ci/rfes, non-surviving animals (n=ll) as
./?//«/ circ/es. Time -180 to -120 min= baseline period; time -120 to 0 min= progressive
reduction of uterine blood flow; time 0 to 60 min= 1 hour period of severe asphyxia; time
60 to 210 min= recovery period. Bar, period of occlusion. Atfer/sib in the upper panel
represent serum lactate measurements.
Statistical analysis of the scattergrams of Figures 8.2 and 8.3 is
complicated by the different number of samples per animal obtained at unequal
time points. Therefore, mean values of individual animals were calculated in
thebaseline period (from time= -240 min to time= -120 min), in the period
ofasphyxia (from time= 0 min to time= 60 min), and in the recovery period (from
time= 60 min to time= 180 min). The means ± SD of these values are presented
for both surviving and non-surviving groups in Table 8.3. During asphyxia and
especially during recovery levels were elevated compared with baseline values
(p<0.05 and p<0.01, Wilcoxon matched-pairs signed-ranks test). During asphyxia
the levels of hypoxanthine and lactate in CSF were higher in the non-surviving
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group compared with the surviving animals (p<0.01, 2-tailed Mann-Whitney Li-
test). During recovery the same levels were reached in both groups. The major
difference between both groups was the rate of rise of ATP catabolites in CSF. In
the non-surviving animals the levels during recovery were not significantly higher
than concentrations during asphyxia, in contrast with the surviving fetuses: levels
were elevated during asphyxia, but increased even further during recovery
(p<0.01, Wilcoxon matched-pairs signed-ranks test).
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Figure 82 . CSF levels of lactate (mM, upper panel), hypoxanthine (^M, middle panel),
and xanthine (nM, lower panel). Time (min) is depicted on the X-axis. Time 0 to 60 min=
I hour period of severe asphyxia. All individual values are shown; open c/rc/es represent
surviving fetuses,_/!//«/c/rc/es represent non-surviving animals. Bar, period of occlusion
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Discussion
Purine nucleosides and bases (e.g., hypoxanthine, xanthine, inosine) are
able to move freely between the inside and the outside of cells, whereas
nucleotides (e.g., ATP, ADP, AMP) are larger and mainly confined in the cell
interior. It is evident that extracellular levels of nucleosides and bases reflect
thebreakdown of intracellular nucleotides, and are therefore indicative for cellular
energy shortage or even for cellular damage (11). Because serum hypoxanthine
levels during asphyxia mainly originate from fetal heart and liver (13), we decided
to determine nucleoside concentrations in CSF, moreover since high levels of CSF
hypoxanthine and xanthine after hypoxia have been associated with evidence of
brain damage or subsequent death (14).
Table 8.1. stresses the importance of recovery after instrumentation.
Complications during anesthesia can lead to oxygen shortage and ATP depletion,
but in the present study CSF lactate levels were low, indicative for normal aerobic
fetal metabolism. Surgery to expose the spinal cavity and the spinal tap were
associated with cellular damage to such an extent that CSF hypoxanthine,
xanthine, and especially inosine concentrations were significantly elevated
compared with baseline levels 3 to 5 days after surgery. This trauma of
instrumentation is in agreement with studies in rats in which placement of a
subdural catheter resulted in transient elevation of neuron-specific enolase levels
in CSF (15). Since levels of CSF lactate, hypoxanthine, and xanthine at time= 60
min were higher than during surgery, the asphyxiai event will have induced more
cellular damage than the trauma of surgery.
Table 8.3CSF levels of nucleosides. purine bases and lactate during the experiment
Lactate
Hypoxanthine
Xanthine
Adenosine
Inosine
Guanosine
Uric acid
Baseline
2 61 ±
8 52 ±
4.11 t
0 85 ±
3.70 ±
0 80 l
4 16 ±
0 9 4
1.84
2 3 7
0 3 8
3 4 2
0 7 8
2.99
Survivors
Asphyxia
4 49
20.0
6 8 0
1 48
5 6 3
1.07
6.16
i 1.29 ®$»
± 7.80 *$#
± 1.33 *$
± 1 25 $
l 2.59 $
± 0.72 *
± 3.72 •$
Recovery
8 70
38.1
12.7
1.96
8.10
1.14
8.61
±
±
±
±
±
2.02 @$
3.7 ®$
5.7®$
1.41 @$
2.55 @$
0.87 '
4 16 ®S
Baseline
3.04
126
5.06
0.95
3.33
0.86
5.70
± 1.14
± 5 6
± 3 18
± 0.68
± 1.17
± 0.63
i 2 38
Non-survivors
Asphyxia
6 16
3 3 3
11.4
1.36
6.97
1.35
7.39
± 1.24 ®$#
±10 9 @#
i 8.2 ®
i 0.92
± 3.15*
± 1.11
± 5.48
Recovery
923
41 3
136
1.60
8.20
1.46
8.08
±
±
±
±
±
±
±
1.83*$
12.2*
6 2 *
089
3.72 *
1.00
7 13
Values are depicted as mean ± SD. lactate in mM, all other values in ^ M . n = 11 for both groups. Baseline values are obtained
dunng time= -240 to -120 min. asphyxia values from time= 0 to 60 mm. and recovery values from time = 60 to 180 min.
* p < 0.05 (asphyxia or recovery versus baseline. Wilcoxon matched-pairs signed-ranks test)
® p < 0.01 (asphyxia or recovery versus baseline. Wilcoxon matched-pairs signed-ranks tesi)
$ p < 0.01 (asphyxia versus recovery. Wilcoxon matched-pairs signed-ranks test)
# p < 0.01 (survivors versus non-survivors, 2-lailed Mann-Whitney U-test)
Oxygen shortage leads to catabolism of ATP, ADP, and AMP and to
formation of adenosine. Adenosine is of great interest because it possesses strong
biological activity, dependent on the 6-amino group (11). Adenosine causes
coronary vasodilation and protects the myocardium after hypoxia-ischemia (9,16).
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Removal of the 6-amino group of adenosine to form inosine is a fast process.
Levels of CSF inosine increase during asphyxia and reach maximum values during
recovery (Table 8.3). These peak values however were lower than levels obtained
immediately after surgery (Table 8.1). We hypothesize that the difference observed
is explained by the time needed for metabolism. Due to the short interval between
the spinal tap and storage of CSF in liquid nitrogen during the surgical procedure,
the metabolism of inosine to hypoxanthine has not yet happened. During asphyxia
however, the energy depletion has a more chronic character and inosine is
metabolized to hypoxanthine.
Values of hypoxanthine, xanthine, and inosine obtained in the current
study are comparable with human data from newborns after hypoxia (14). A
microdialysis technique showed similar hypoxanthine and xanthine levels in the
extracellular compartment of the brain of severely asphyxiated exteriorized fetal
lambs. These results however were obtained in anesthetized lambs with their head
fixed in a stereotactic frame (17). In the present study CSF hypoxanthine levels are
shown to rise during asphyxia. This is in agreement with the net cerebral efflux of
hypoxanthine measured in plasma during severe asphyxia in fetal lambs (18).
Maximum CSF hypoxanthine and CSF xanthine levels were reached in the hours
following occlusion. The time lag between nadir of asphyxia and peak
hypoxanthine and xanthine levels may be caused by damage to the blood-brain-
CSF barrier after 1 hour of severe asphyxia, by delayed neuronal damage (19), or
by methodological errors. Chances of the latter were small due to minimization of
deadspace of the sampling catheter, careful handling of samples, use of the
recommended HPLC to determine nucleoside levels (11), and presence of this time
lag in the majority of animals. The elevated level of CSF hypoxanthine and
xanthine during the recovery period, in which availability of oxygen was almost
normal, is considered important because both bases act as substrate for the enzyme
xanthine-oxidase in the production of oxygen derived free radicals (4,5,11).
Xanthine-oxidase is released during hypoxia from the fetal liver (4) and is present
in the brain of fetal lambs (17). Indeed asphyxiated fetal lambs with the highest
CSF hypoxanthine and xanthine levels had the most extensive histologie brain
damage (12). In this respect the significant (p<0.01) higher levels of CSF
hypoxanthine in non-surviving animals compared to surviving fetuses during
asphyxia may be of importance, and may even predict fetal demise. In the
presence of elevated levels of cerebral hypoxanthine and xanthine a large amount
of oxygen administered during resuscitation after peripartal asphyxia may provide
adverse effects. In newborn pigs resuscitation after asphyxia with 100% oxygen
was not shown beneficially when compared with a group resuscitated with 21%
oxygen (20). It may therefore be worthwhile to consider using 21% instead of
100% of oxygen during resuscitation after peripartal asphyxia.
CSF lactate levels also reached maximum values during the recovery
phase. Concentrations were lower than serum lactate levels (Table 8.2), which is in
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agreement with the net influx of lactate into the fetal lamb brain during severe
asphyxia and recovery (18). Serum lactate measured during asphyxia originates
from a variety of organs as placenta, myocardium, and muscles, and used in the
brain as an energy source both during hypoxia (21) and during reoxygenation (18).
The rise of CSF lactate in the recovery period is of less importance than CSF
hypoxanthine and xanthine levels since involvement of lactate in oxygen derived
free radical production does not seem likely (5).
A remarkable difference between survivors and non-survivors is the rate
of rise of ATP catabolites (and especially of hypoxanthine) in CSF. Whereas in the
surviving group the levels at recovery were similar to the ones in non-survivors,
the increment during asphyxia in non-survivors was twice the value in survivors.
A similar tendency was observed for all parameters except guanosine. We have no
clear explanation for this difference, nor why it is most pronounced for
hypoxanthine. It could be argued that during asphyxia in the non-survivors ATP
catabolism proceeds much faster, but why does the difference persist during
recovery? A second possibility may be the ability of the survivors to salvage
hypoxanthine more efficiently. Third, it should be kept in mind that changes in
CSF reflect an equilibrium between many processes, including formation and
release from a variety of cells, uptake and catabolism in scavenging cells and
exchange with blood in the vasculature. Vascular efflux of ATP catabolites from
CSF is guaranteed due to extensive fetal metabolism and placental diffusion. This
implies that at a certain moment an equilibrium of maximal levels will be reached
in CSF. This equilibrium may be reached during asphyxia in the non-surviving
animals, in contrast to the surviving fetuses where maximal levels are reached
during recovery. The difference observed could be due to the larger amount of
cellular damage in those fetuses that will not survive the asphyxiai insult. Which
one of the theoretical explanations makes the difference between survivors and
non-survivors cannot be decided from the present data. It may also be questioned
whether the difference contributes to fetal demise.
In summary catheterization of the spinal cistern in preterm fetal lambs can
be performed adequately and results in elevated CSF levels of inosine,
hypoxanthine, and to a lesser extent xanthine. Experiments regarding CSF levels of
nucleosides and purine bases should therefore preferably be performed in
chronically instrumented animals. Three to 5 days after surgery fetal anaerobic
metabolism was initiated, CSF levels of lactate, hypoxanthine, and xanthine,
increased, whereas peak levels were reached in the recovery period. CSF
hypoxanthine (and lactate) levels during asphyxia were higher in the non-surviving
animals. The level of hypoxanthine may be related to oxygen derived free radical
production, which aggravates brain damage. A second difference between both
groups was the rate of rise of the ATP catabolites in CSF, which was higher in the
non-surviving fetuses. Finally, CSF adenosine, guanosine, and uric acid seemed to
increase in the survivors due to asphyxia, in contrast to the non-survivors.
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The incidence of perinatal asphyxia depends on gestational age and
definitions used, and varies around 2.0%. Clinically, asphyxia refers to a condition
following impaired gas exchange. Before it is concluded that cerebral damage
results from perinatal asphyxia, both biochemical and clinical asphyxia should be
present. A// of the following criteria should therefore be at hand: (I) profound
umbilical cord metabolic or mixed acidemia (pH <7.00 in the umbilical artery),
(II) persistence of an Apgar score 0 to 3 longer than 5 minutes, (III) neonatal
neurologic sequelae, e.g., seizures, hypotonia, or coma, and (IV) multiorgan
system dysfunction (cardiovascular, gastrointestinal, hématologie, pulmonary, or
renal). Chapter 1 describes various methods for fetal surveillance and detection of
asphyxia in the newborn. These techniques however increased medical
intervention but failed to improve neonatal outcome. To develop beneficial
therapeutical strategies, research should be directed upon basic understanding of
factors playing a role in fetal asphyxia. The latter explains the objectives of the
present study.
In chapter 2 the literature regarding fetal asphyxia is reviewed concen-
trating on heart and brain. Pathophysiology is discussed, fetal adjustments to
asphyxia are explained, and the mechanisms by which oxygen shortage lead to
fetal damage are summarized. Main issues are the role of oxygen derived free
radicals, of calcium, and of excitatory neurotransmitters.
The present study is designed to evaluate effects of fetal asphyxia on
cardiovascular parameters, on the ECG, on appearance of lactate and ATP
degration products in cerebrospinal fluid, on recovery after asphyxia, and on
histologie brain damage due to asphyxia. We used chronically instrumented fetal
sheep, well known in perinatal research. This model offers the opportunity to
investigate the fetus for a prolonged period, while still //i M/era. The sheep fetus is
3 to 5 kg in weight when born, allowing extensive instrumentation of fetuses
without premature onset of labor or fetal demise. Surgery was performed in 47
fetal lambs. Mean gestational age was 120.0 ± 2.8 days, term is 147 days. Fetal
instrumentation involved placement of catheters in axillary and femoral artery,
femoral vein, spinal cisterne (to obtain CSF), trachea, and amniotic cavity.
Electrodes were placed biparietally to measure the electrocorticogram, and on
cardiac apex and both forelimbs to measure the ECG. Three to 5 days after surgery
fetal asphyxia was induced by inflation of a balloon occluder around the maternal
common internal iliac artery, which reduced uterine perfusion causing fetal oxygen
shortage, the onset of anaerobic metabolism and acidemia. Reduction of uterine
perfusion was performed gradually in a period of 60 to 90 minutes, until the fetal
arterial oxygen content was approximately 35% of baseline level. At that moment
mean fetal pH had decreased to 7.15. The arterial oxygen content was maintained
at this level for 1 hour, during which the mean pH decreased to 7.03. After this
period the occluder was released and recovery was monitored. Immediately after
each step of increased occlusion fetal heart rate decreased and arterial blood
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pressure rised. Within a couple of minutes however fetal heart rate and arterial
blood pressure normalized. During sustained asphyxia fetal tachycardia developed
in combination with a normal blood pressure. Fetal blood flow (measured with
radioactive microspheres) was redistributed toward myocardium and cerebrum.
After release of the occluder the distribution of fetal blood normalized in the
normoxemic surviving animals, in contrast with fetuses that remained hypoxemic
and did not survive the asphyxiai event.
The influx of calcium into neurons after oxygen shortage is considered of
major importance during cell death. Calcium channel blocking agents (as, e.g.,
flunarizine) are shown to be neuroprotective in a variety of experiments when
given fee/ore the period of oxygen shortage. Chapter 4 describes the effect of
flunarizine treatment a//er fetal asphyxia. In the current study severity of asphyxia
was considerable: only five of the 15 fetuses survived the asphyxia, four
flunarizine-treated and one out of the control group. Influences of flunarizine on
regional cerebral blood flow, fetal heart rate or arterial blood pressure could not be
demonstrated. The latter is important since studies on calcium channel blockers
have been reported where treatment of severely asphyxiated newborns resulted in
dramatic hypotension leading to discontinuation of treatment.
Adenosine is formed during catabolization of ATP during energy shortage.
Adenosine is considered to possess beneficial pharmacological activities after
oxygen shortage, leading to vasodilation, reduced platelet and thrombocyte
activation, and reduction of afterload. Furthermore, adenosine acts
cardioprotective due to its antiadrenergic and antiarrhythmic properties. Since
myocardial pump failure may contribute to the fetal demise observed after
asphyxia, we pretreated 50% of a group of 14 fetal lambs with R-75231, an
adenosine transport inhibitor (chapter 5). If transport of adenosine is inhibited, its
catabolism is inhibited, and adenosine can perform beneficial activities for a
prolonged period. Although myocardial blood flow itself did not differ between
groups, the R-75231-treated animals had an enhanced increase of myocardial
blood flow during asphyxia. Furthermore, treated animals recovered faster, and
survived longer: all of the R-75231-treated animals recovered after asphyxia,
whereas in the control group only three of the seven fetuses recovered and
survived, the difference being significant. These results however were based on
small numbers and levels of significance were only marginally reached. Since
interanimal variation is large the experiments were repeated in a double blind
randomized controlled trial. With this setup however, the beneficial effects of R-
75231 could not be confirmed.
Delayed neuronal death is observed for several days after oxygen
shortage. Furthermore, it can take up to 72 hours before neurons show histological
features characteristic for asphyxiai damage. Therefore, the time lag between
asphyxia and fixation prior to histologie evaluation of brain damage should be at
least 72 hours. This implicates that only those animals that survived longer than 72
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hours could be used for /n v/vo fixation (replacement of fetal blood by a fixative
solution) and histologie evaluation. Microscopic analysis of eight cerebral areas
demonstrated brain damage mainly confined to the Purkinje cells of the
cerebellum (chapter 6). These cells are large and have a high level of metabolism:
oxygen and energy shortage may lead to irreversible damage in these cells at first.
Brain damage however was not extensive. There appeared to be a narrow border
zone between intrauterine fetal death due to asphyxia, and survival without any
histologie sign of brain damage. This may be due to the fact that after severe
asphyxia primarily the myocardium denominates survival. The clinical situation is
different. Birth of a severely asphyxiated infant which would have died due to
myocardial failure leads to active resuscitation, cardiac support, and mechanical
ventilation. Due to this therapy the infant may survive, thus widening the narrow
border zone between death and survival without deficits after asphyxia. Neonates
in this border zone are at greater risk for severe morbidity.
Myocardial dysfunction in adult cardiology leads to changes in the ECG.
In the fetus therefore, asphyxia might also cause ECG changes due to anaerobic
myocardial metabolism. In some studies fetal hypoxemia is indeed associated with
changes in the T-top of the ECG expressed as an elevated T/QRS ratio, suggesting
a possible use of the T/QRS ratio as a parameter in fetal surveillance. A CTG
monitor is designed in which the CTG is combined with an on-line analysis of all
T/QRS ratio. Clinical trials with this Sr-ana/yzer are not unequivocal. Analysis of
the T/QRS ratios from the 47 fetal lambs of the current study before, during and
after asphyxia reveals that the T/QRS ratio is inappropriate to predict fetal oxygen
shortage or fetal acidemia (chapter 7). The T/QRS ratio was not correlated
properly with fetal serum lactate levels or survival either. The T/QRS ratio was not
able to identify compromized fetuses that died /« wtero. Elevated myocardial blood
flow may have resulted in an adequate oxygen supply to myocardial cells, without
ST waveform changes. Based on the present research in fetal lambs therefore, its
use in clinical practice as another method of fetal surveillance seems disputable.
During neuronal oxygen shortage anaerobic metabolism is initiated, ATP
is degraded and ATP catabolites such as hypoxanthine and xanthine are released.
Both substances are not only considered the result of cellular cerebral damage, but
may also aggravate brain damage, since they act as substrates in the formation of
oxygen derived free radicals during reoxygenation after asphyxia. We measured
levels of CSF hypoxanthine and xanthine, purine bases and lactate during the
experiment in 22 fetuses (chapter 8). Surgery itself increased CSF hypoxanthine,
xanthine, and especially inosine levels. CSF levels of adenosine, guanosine or uric
acid were not influenced by surgery.
During asphyxia levels of these ATP catabolites in CSF increased.
Maximum levels were reached during the recovery period and were similar for
surviving and non-surviving animals. During asphyxia however CSF levels of
hypoxanthine and lactate were higher in the non-surviving fetuses. The rate of rise
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of ATP catabolites in CSF was higher in the non-surviving animals, and may
therefore be predictive for fetal demise.
In summary, the fetal lambs had a tachycardia and a normal blood pressure
after prolonged oxygen shortage, in combination with an increased cerebral and
myocardial blood flow and a raised T/QRS ratio. These cardiovascular parameters
were not predictive for recovery, nor were they influenced by R-75231 or
flunarizine. The severity of asphyxia is indicated by the intrauterine mortality rate
of 53%. In surviving animals microscopic brain damage was mainly confined to
the large cerebellar Purkinje cells, known to possess a high level of metabolism.
Histologie brain damage however was not extensive. The present experiments
confirm the narrow margin between lethality and survival without any damage
after fetal asphyxia. This is in agreement with the absence of detectable neurologic
sequelae in the majority of severely asphyxiated neonates. The brain sparing effect
during oxygen shortage is attributable to a variety of factors, including increment
of cerebral perfusion and reduction of cerebral metabolism. Accumulation of
hypoxanthine and xanthine in the brain, known to act as substrate in the oxygen
derived free radical production during reoxygenation after asphyxia, may have an
adverse effect on final outcome. Indeed CSF hypoxanthine levels during asphyxia
were elevated in non-surviving animals compared to surviving animals, and the
rate of rise of the increment of ATP catabolites was higher in the non-surviving
fetuses.
The current thesis summarizes the inadequate methods of fetal surveil-
lance, discusses pathophysiology of fetal asphyxia, and denotes various mecha-
nisms potentially leading to cerebral damage after asphyxia. Furthermore, in the
fetal sheep severe asphyxia is studied, and several protective cardiac and cerebral
aspects are discussed. Although intrauterine demise was considerable, the amount
of histologie damage in the adequately preserved group was not extensive. It
should however be kept in mind that abnormalities of function do not necessarily
have to be microscopically detectable.
Fortunately, fetal asphyxia is not always fatal asphyxia. Future research is
continued, and directed upon the immature brain, prior to myelination.
Furthermore, an arterial blood pressure below the limit of autoregulation seems to
be associated with cerebral damage. During hypotension the fetus will suffer from
reduced cerebral perfusion, leading to diminished cerebral oxygen delivery.
Another important observation concerns the role of growth factors in brain
development. Experimentally induced lack of growth factors mimics secondary
neuronal damage after asphyxia, which may offer possible therapeutic strategies in
the first days after oxygen shortage.
We have to conclude that the brain is complex. But if cerebral processes
occurring during asphyxia would be so simple that we could fully understand
them, we would be so simple that we couldn't.
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Aromf voor by on^eveer 2,0% van a//e
van de zwâng^ric/iap^^MMr en de geferMi&re dç/î/ii7ie. De
van z««r5/o//e/:or/ mer de daarop vo/gende verzuring wordr asp/ryjtie genoemd.
Voordar er geconc/Maeera" itan worden dar een gecons/aree/ï/e nersenfeesc/iad/ging
/ier gevo/g « van asp/iyxie rondom de geftoorfe, dienr er zowe/ 5pra/:e re zyn van
W/ni'sc/ie asp/ryxie a/s van bioc/iemiscne asp/ryx/e. De vo/gende cr/rer/a d/enen
a//en aanwez/g /e zi/'/i om a"eze gevo/g/reM/ng fe mogen ma)ten: f/J ern^r/ge
(p// <7,00J /n ner 5/agaa*e/-///'Â:e nave/s/rengb/oea' ), (//J Apgar icore van
nj/n/waa/ 5 ni/nu/en, f///j newro/og/^cne a/Wyit//ige/i è// a"e
pa^gefeorene, zoa/j t.v. ep//eprwc/ie acr/v/re/f, %pofo/j/e o/cowa, (/Vj a/vvy/t/ngen
i/i ana*ere orgaansy^rewen. A/noewe/ rf/ver^e f/n noo/a'5?M)t / fee^cnrevenj
/ecnn/eÂren worden roegepa^r /er ^»vaA:i/ig van a*e /oefa/e co«rfi7ie en op^por/ng
van asp/iyjrie in pa^ge^orenen w /ier aa/i/a/ a"oor z«Mr5/o/>eÂ:orr èe5cnaa"/gde
fo'nrteren n/er a/genomen. f/ef doe/ van deze 5/ud«e w een be/er /nz/c/ir re A:ri/ge/i in
de/ac/oren die een ro/ 5pe/en è///oe?a/e a^pn^ie, o/n zo evenrwee/ benande/ings-
/noge/ylneden re Âri/nnen onmi^^e/en.
/n noo/dsrwA: 2 wordr de //rerarwwr over /oera/e ajpnyjc/e sa/nengevar,
vvaarèy mer name de ejQfecfe/i op Ziarr en ner^enen fte^cnreven worden. De
par/iopn^i/o/ogie wordr tedi5CM55i'eerd,/oera/e aanpa55/ng5moge///7:neden uorden
fee^pro/cen, en de mecnan/smen d/e /e/den ror/oera/e besc/iad/ging worden
^amengevar. £en 6e/angr//A:e ro/ nier/n 15 wegge/egd voor vri/e ZMMr^ro/rad/ca/en,
voor ca/c/wm, en voor ejcc/rerende neMrorran^m/rreri.
De e/gen ^rwd/e werd opgezer om de eyjecren re eva/Meren van /oeraa/
Z«Mr5ro/re/:orr op card/ova^fw/a/re paramerer^, op ner £CG, op ner verscni/nen
van /ac/aar en i4TP a/èraaÂ:prodMcren in ner ner^envoc/ir fde //ai/or
cere6ro5p/na//5j, op ner ner^re/ na een per/ode van asp/iyx/e, en op de
m/cro5copi5cne ner^en^cnade veroorzaa/cr door de a^pnyjr/e. Vbor de srnd/e zyn
cnronwcn gein^rrwrnenreerde sc/iapen geftrMiÂ:r. D/r maa/tr èe^ruder/ng van ner
/oera/e /am gedwrende een /a/igere ryd moge/yA:, rerwy/ ner z/c/i nog in de
baarmoeder èei'/ndr. //er /am weegr by de gefeoorre rw s^en de i en 5 A:i7o, zodar
een grao/ aanra/ car/ierers en e/ecrrode^ operar/e/aangeoracnr /can worden zonder
dar vroegrydige weeenacrivire/r o//oera/e ^rer/re oprreedr. £r werden 47/oera/e
/ammeren geopereerd oy een gem/dde/de zwanger5c/iapsd«Mr van /20,0 ± 2,8
dagen (een /am w vo/dragen fey /47 dagen^. Car/ierer5 werden gep/aatar in/oera/e
ader/iy'A:e en s/agader//yA:e fe/oedvaren, in de 5pi'na/e rw/mre fom /lawor
cereferojp/na/i5 re verfcrygen,), in de /ivcnrpyp, en in de amnion/io/re. Vérvo/gen5
werden e/ecrrodes gep/aar^r rer reg/^rrar/e van e/ecrrisc/ie ner^en^cnor^ acri\ire/r
en rondom ner Ziarr r.fe.\'. de £CG reg/srraft'e. Drie ror vyr" dagen /arer werd/oera/e
asp/ryj/e gei'ndi/ceerd door een fea//on re v«//en waardoor de s/agader/yfce roevoer
naar de oaarmoeder verminderd werd. ///erdoor onwrond/oeraa/ ZM«rsrq e^Â:or/,
rrad een anaerobe/oera/e 5ro/wi's5e/ing en verzwring op. De roevoer van
moeder/y'Â: fe/oed naar de baarmoeder werd /angzaam verminderd in een per/ode
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van 60 tor 90 m/nuten, fofdar /j^r/oefa/e zi/urs/o/gena/Ze ongeve^r J5% van
norwaa/ focdro^^. GedM/rncte *fez£ zy'd c/aaWe de s/agackT///&e /oe/a/e p / / naar
7,/5. Daarna werd d// zwwrs/o/gena//e ge^wren^ / wwr op ongeveer 35% van
norwaa/ ^e/iOM^en. 7n d// «Mr daaWe de s/agader/y/:e p / / naar 7,03. //»>r/ja wérJ
de ba//o/J ^^/ee^(/ en ner /oe?a/e /i^me/ geoèsenrer£/. D/reA7 na e/fce stop van
vw///ng van de foa//on /raa" e^n a"a//ng van de /oefa/e nar//reaMenf/e op mer
van de/oera/e e/oeddrw/:. Afa /angdwr/g zwMrjro/re/:orr onrirond ecnfer
van de/oera/e nar(^-eaMenn'e waarfoy de 6/oeddrwA: con.v/an/ &/ee/. 77/dens
de a^pn^/e /rad een verandenng /n/oera/e dooro/oed/ng op f^eme/en m.o.v.
rad/oac//eve m/crospnerenj, /en gwnsre van nar/ en ner^enen. A/a ne/ /eegma&en
van de oa//on norma/ïseerde de /oe/a/e dooro/oed/ng van nar/ en nervenen /n de
d/eren die de a^pnyx/e over/ee/den.
De /nj/room van ca/c/wm /n zen«wce//en na z«ur5/o//e/:or/ word/
a/s een fee/angr(/Jte 5/ap m ne/ procès van ce/dood. Van se/ec//eve
van deze ca/c/um ms/room fzoa/5 ft.v. /7wnar/z/nej /.v dan ooA: /?erxen-
fcescnermende wer/t/ng aange/oond, /ndj'en ne/ wed/camen/ vôdora/ nerd
/oeged/end. //oo/d.y/M)t 4 ôe5cnr///r ne/ ej^ec/ van oenande//ng me/ /7wnan'z/ne na'
/oe/a/e aspnyx/e. /n de nutd/ge 5/«d/'e werd een ern^Z/ge a^pnvx/e veroorzaa^:/:
5/ecn/5 5 van de /5/oe/a/e /ammeren over/ee/den de aspnvjc/e, 4/7«nan'z/ne
èe/iande/de d/eren en 7 con/ro/e d/er. F/Mnari'zme /ee& geen /nv/oed /e neèoen op
de reg/ona/e dooro/oed/ng, op de/oe/a/e nai7/re^Me/i//e o/de o/oeddrwA:. D/7
/aa/5/e w van i>e/ang daar s/Md/es oe/:end zy'n n-aar /oed/en/ng van ca/r/wm A;anaa/
fc/oc/ter^ aan asp/rycz/scne neona/en ge.v/aaA:/ d/ende /e worden /.v.m. ern.v//ge
fc/oeddrw/: da//ngen.
Gedwrende energ/e/e)tor/ nord/ ATP a/geôro^en en word/ adenos/ne
gevormd. Aan adenos/ne worden een aan/a/ oe^cnermende e/genscnappen
/oegescnreven na z«Mr5/o//e/cor/, zoa/^ vaarverH'//d/'ng, geredt/ceerde ar/Zva/ze v'an
fc/oedp/aaz/e5 en w/ZZe t/oed//cnaamp/e5, en verm/nder/ng van oe/a.vZ/ng voor ne/
rtar/. 7evens ZOM adenos/ne èe^cnermend werA:en door z//n dempe/ide en an//-
arry/nm/scne e/gen^cnappen. Daar nar//a/en een feydrage zoi< ^wnnen /everen aan
de/oe/a/e i/er/'e na a^pnyjc/e, nerd 50% van een groep van /4/oe/a/e /ammeren
oenande/d me/ /?-752i7, een adenos/ne-/ranspor/ remmer fnoo/di/w/: 5j. /nd/en ne/
/ran^porZ van adeno^/ne geremd wordz, v/ndz eveneen.v remm/ng van de a/foraa&
p/aa/5 en &an adeno^/ne de oe^cnermende wer<:/ng gedwrende /angere //yd
M//oe/enen. Â/noewe/ de nar/doorWoed/ng op z/c/i n/'eZ verscn/7de /i/s^en oe/de
groepen, /rad er /ydens de axpnyx/e in de me/ fl-7523/ fcenande/de d/eren een
s/er/cere /oename i'an de nar/doorb/oed/ng op dan /n de on6enande/de d/eren.
Teven^ ners/e/den de oenande/de d/eren 5ne//er en over/ee/den ze 5/gn//i'can/
/anger: a//e /Î-75237 oenande/de d/eren ner^/e/den na de aspnyx/e, in
/ege«5/e//ing /o/ 5/ecn/5 i van de 7 onoenande/de d/eren. Daar deze re.yM//a/en
gevonden werden oy een We/ne groep d/eren en marg/na/e 5/gn//?can//e ftere/^/
werd, is de s/wdie ai/ge^reid. 7n een s/wdie me/ meer dieren en een duooe/ o//nd
156 Fetal asphyxia, a study in preterm lambs
ecn/er de fee^c/iermenrfe writing van /?-7523/ me/
&eves//gd worden.
G^dwreni/e een per/ode van en/ge dagen na ne/ zMwrs/o/ze&or/ A:an nog
zenuwce/ />escnad/g/ng oprrea"en. Daarnaas/ A;an ne/ /o/ 72 H«r a"Hren voorda/
onners/e/baar bescnad/gde zen«wce//en a/5 zoaVin/g neDtenfeare vorwen
aannemen. Derna/ve d/en/ Je per/ode /wssen de asp/ryjc/e en de/uca/Ze /en fee/ioeve
van m/croscop/scne 6eoorde//ng minimaa/ 72 «wr /e fterfragen. D/r wnp/icem da/
5/ecnW de d/eren d;'e ra/n/maû/ 72 M«r over/ee/den gebru//:/ /conden norden voor /n
v/vo y?jca//e («e/ ver\'angen van /oe/aa/ ft/oed door een /?j:a//e/) en m/croscop/scne
Z?eoorde//ng. A//croxcop/5cne ana/_y5e van een acnf/a/ ner^engeô/eden /oonde
zenwwce/ èe^cnad/g/ng aan d/e voorname/y/: ge/oca/Zseerd wa^ in de Puriti'^'e
ce//en van de ^/e/ne nervenen (noo/ds/M/: 6j. DiV z/)'n gro/e ce//en me/ een noog
5/q/vvj5je//ngsgena//e; /ejfcor/ aan z««r5/o/ en andere voed/ngss/o/fen ZOM /n deze
ce//en ne/ eer^/ /o/ fte^cnad/g/ng aan/e/d/ng /:wnnen geven. De ner^en^cnade na5
ecn/er n/e/ M/7gefere/d. D// ZOM dee/s ver/:/aarfeaar ^«nnen zyn M// ne/ /e// da/
/ydeni a^pnyx/e me/ name ne/ nar/ de over/ev/ng /?epaa/r. /i/in/.vcn /ig/ de .v/7wa//e
en/g.vz/n.9 anderi . De geèoor/e van een aspn_yc//sc« A:/nd /e/d? /o/ ac//eve
rean;ma//e, onder^/ewn/ng van ne/ nar/ en èeadem/ng. Door d/7 ingri/pgn /tan een
Â:;'nd over/even, en ni'ermee za/ ne/ ™o//f gren^ge^/ed /«55en dood en
genezen wyder vvorden. Pa^getorenen «// d// gren^ge^/ed /open een gro/ere
op ern5//ge fte^cnad/gi/jg.
5/ecn/ /wnc/ioneren van ne/ /i«/7 /e/d/ Z7/7 vo/wa\5enen /o/ £CG
verander/ngen. F«e/a/e aspn^jcie zow door ne/ anaeroofe norden ian de
•s/q/H7s.ïe//ng in ne/ nar/ eveneen^ aan/eiding /:«nnen geien /o/ £CG q/vi'yit/ngen.
/nderdaad zi/'n er een aan/a/ 5/Md/e5 Z?e/:end waarfey /oe/aa/ zwMrs/o//e&or/
gea^^oc/eerd is me/ verander/ngen in de 7-/op van ne/ £CG, ne/geen nord/
Mi/gedrw/:/ a/s een ges/egen 7/0/?5 ra//o. 7neore//5cn zow deze 7/Q/Î5 ra//o
der/ia/ve gebr«/À7 Awnnen vvorden a/5 een parame/er ^y'/oe/a/e èevva/t/ng. £en
CTG mon/7or is on/wi7:^e/d u'oan'/i ne/ C7G gecomfti'neerd vvord/ me/ de
/ege/y'Â:er/yd vveergegeven 7/^/?5 r«//o. A'/zn/scne s/«d/e.v me/ deze zg« 57-
zyn n/e/ eens/w/dend. Ana/vse van de r/0/?5 ra//o's l'an de 47/oe/a/e
M// de /luid/ge .v/«d/e voor, /ydens, en na de aspnyx/e /oonde aan da/ de
77(2/?S ra//o ongescn//:/ ;s o/n een /aag ZM«rs/o/gena//e o/verzwr/ng van ne//oe/a/e
s/flgader/yA:^ o/oed /e i'«o/"spe//en f/100/d.y/MA: 7). De 77(2/?S ra/1'0 HUÏ eien/n/n
goed gecorre/eerd me//oe/aa/ serwm /ac/aa/ gena//e o//oe/a/e over/eving.
Langzaam verergerende /oe/a/e verzwr/ng zo^der ôe/angryAre verander/ngen in
nar//reai<en/ie o/6/oeddruA: A:on n/e/ gede/ec/eerd worden m.fc.v. 5r-ana/yse. De
enor/?ie /oename in de doorè/oed/ng van ne/ nar/ gedwrende aspnvjr/e (/o/ 400%j
en /»e/ daarmee eveneen.v /oegenomen z«Mrs/o/aanèod aan ne/ /oe/a/e nar/ zo«
geresw//eerd Arwnnen ne^ften /n een adeo//aa/ zM«rs/o/aan6od aan de
nar/sp/erce//en, waardoor 57 verander/ngen n/e/ op/reden. Der«a/ve A:an op foas/s
van /ie/ nw/d/ge onderzoeA; /n /oe/a/e /ammeren geen goede grond vvorden
Hoofdstuk 9: Samenvatting en conclusies fS7
gevonJen Je 7/0/Î5 ra//o Ar///mc/j /e gaan /oepassen a/5 niewwe
7i/Jens ZMwr^ ro/refcorr freeJr anaerobe/oe/a/e sro/vvwie/mg op, worJ/ A7P
verorw/À/ en bm?n A7P a/ibraa/cproJwc/en a/5 Ay/?oA:anr/j/ne en jcanf/j/ne vny.
/Vjpoxan/rt/ne en jran/n/ne worJen n/e/ a//een ^eac/i/ ne? gevo/g \'an ce//w/a/re
scnaJe re zi/n, maar /even* Je oorzaaA: van nog meer scnaJe, Jaar Jeze 5/oj^ en m
Je /ase van wee/ye/reoxygenar/e aan/e/aVng geven /o/ Je vormi/ig van vri/'e
zw«rs?o/raJ/ca/en. De concen/ra//e5 /i^poxan/Zi/ne, jco/irn/we, pwnne ftasen en
/ac/aa/ vverJen /'n Je //ai/or cere^ro5p/na//5 geme/en /n 22 /oe/a/e /am/neren
fnoo/Jifw :^ 8). De operar/e ze//vernoogJe ne/ gena/fe nypoxan/«/ne, xanf/3/ne en /n
ne/ /7//'zonJer /noft/ie /n Je //awor cerefero^p/nafo. De concen/ra//e5 aJeno^/ne,
gwano5/ne en wr/nezwwr /n Je //awor iverJen n/e/ èe/nv/oeJ Joor Je opera//e.
TyJens Je a5p«_yx/e namen Je conce«fra//e5 A7P a/&raaÂ:proJMC/e/i foe. A/ajc/mu/n
concen/ra//es werJen m Je ners/e//a.ye èereto, en waren me/ ver*cn///enJ voor Je
over/even Je en Je m'e/-ove/7evenJe J/eren. 7ï/Jen5 Je aspnyx/e ecn/er waren Je
nypoxan/nme en /ac/aa/ gena//e5 /n Je m'er-over/evenJe /ammeren noger Jan m Je
J/eren J/e we/ over/ee/Jen. fîovenJ/en wa5 Je s/ie//?e/J vvaarnzee Je concen/ra//e
i47P a/&raaA:proJ«c/en in Je //awor cere/?ro5p/na//5 /oenam vee/ noger in Ji'e
J/eren J/e w/fe/nJe/(/& n/e/ zowJen oi'er/even. De nogere concen/ra//e n^po-
xan/n/ne en Je 5ne//ie/J van /oename van Je A77* a/feraaA:proJMC/en /y'Jen*
asp/ryx/e ZOM gea55oc/eerJ /cwnnen zyn me/ meer wee/5e/foe.stnaJ/g/ng en ZOM
Jerna/ve voor.ype//enJ /cwnnen zi/n voor Je/oe/a/e over/ev/ng.
5amenva//enJ naJJen Je /oe/a/e /a/nmeren na /angJwrig zwwn/o//e/:or/
een /oegeno/nen nar//reawen//e en een norma/e /j/oeJJrwÂ:. 7i?ven.v >va.v er .vpra/ce
van een /oegenoAwen Joorè/oeJ/ng van nar/ en nersenen. Deze parame/erj waren,
evena/i Je 7/(2/?5 ra//o, n/e/ voor5pe//enJ v.vv.è./oe/aa/ «er.y/e/, en evenm/n
werJen ze oe/nv/oeJ Joor /?-752i/ o//7wnar/z/ne. De ern.y/ van Je asp/iyjrie is goeJ
weergegeven Joor Je 5/er//e van 53%. /n Je over/even Je J/eren wa.s Je
m/cro5cop/5cne nersenscnaJe voorname////: beperitz /o/ Je Pnr)t/n/e ce//en; gro/e
ce//en me/ een noog s/o/H'/.?se//ng.vn/veaw. M/cro5Cop/5cne 5cnaJe wa* ecn/er n/e/
ig aanvvez/g. De nw/J/ge exper///zen/en èeve5//gen ne/ fcei/aan i>an een
marge /W55en /oe/a/e 5/er//e en ner5/e/ zonJer aanw//5oare m/croscop/scne
icnaJe. D// is in overeens/emm/ng we/ Je q/ivez/gneiJ van zenwwce/.vcnaJe in Je
/«eerJerne/J van Je erns//g a.vpnvc//.yc77 geftoren /:/nJeren. /Ve/ ner.ven.yparenJe
ej^ec/ ///'Jeni' zwMri/o//e/:or/ 15 fte/ gevo/g i'an ver.vcn/7/enJe/ac7oren, H-aaronJer
/oegenomen cereèra/e Joorfe/oeJ/ng en verminJm/ig van ne/ ner.venme/a/jo/i.sme.
Opnop/ng van «ypoxan/n/ne en xan/n/ne in Je //awor cere/jro5p/na//.y nee// H'e///cn/
een nega//e/ eT/er/ op Je w//e/nJe///'/:e « / f t a i l Joor Je vorm/ng van vrye zwwr.s/o/
raJ/ca/e/i in Je per/oJe van reoxygena//e. D// is in overeens/emm/ng me/ ne//e//
JaZ ///Jens asp/i^x/e ne/ nypoxan/n/ne gena//e in Je //aiior cereèrosp/na/i's ne/
noogs/ was in Je /ammeren J/e n/e/ zowJen over/even. 7evens was Je sne/ne/J
waarmee Je concen/ra//e AFP a/&raa/cproJwc/en in Je //owor /oenam noger in Je
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d/eren d/e M//e//zde///fc n/e/ zowden over/even.
D// proe/jcnr//lr oespree/:/ de /nadegwa/e /oe/a/e oewafc/ngswe/noden,
èed/scuss/eer/ de pa/nopnys/o/og/e van /oefa/e aspnyjt/e en gaa/ /n op de
versrn///ende wecnan/swen d/e po/en//ee/ tor nersenscnade na asp/ryjc/e &Knnen
/e/den. Verder word/ /n «ef cnron/\cn gein^frw/nenfeerde/oera/e scnapewode/
ern^^'ge /oe/a/e aspnjjc/e ^e^/wdeerd, en worden verscn/7/ende feeicner/nende
wecnanwmen ^edwcMSi/eerd v.w.fe. narf en nersenen. A/noewe/ er een aanz/en/j/Jte
5/er/re op/rad /n de fcaarwoeder è/eeÂ: er /n de nersfe/de d/eren n/e/ vee/ w/cro-
jcop/5cne nerien^cftade aanwez/g. £en a/Vv//&ende «er5en/Mnc//e noe// ecn/er n/ef
a/ryd m/cro5cop»5cn defec/eer&aar fe z(/n.
Ge/nifcifc/g /5/oe?a/e a^pnyx/e n/e/ a////d /a/a/e aspnyx/e. //ef onderzoeit
word/ voor/#ezer, roege5p//5f op de onnype ner^enen. 7even5 ///Â:f een s/agader////:e
t/oeddrwA: onder ne/ a«toregM/ar/en/veaM geassoc/eerd /e z//n wef ner^enicnade.
Gedwrende d/e /age o/oeddrt<A: za/ 61/ de /oe/M5 een verw/nderde nersen-
doorfe/oed/ng i»e5/aan, ne/geen /e/df to/ een ver/aagd zMwrsto/aanbod. £en andere
fee/angr/y'^e o/?5erva//e no«d/ veroand we/ de ro/ van groej/ac/oren 0//
ner5enon/H';Me//ng. £jcpenmen/ee/ opgeweÂ:/ /eA:or/ aan groet/actoren nee// ve/e
overeen^conii/en we/ secwnda/re zenMwce/feeicnad/g/ng na ZMW /^q^ efcorf. Di/ èzed/
we//icn/ woge//y/:neden to/ 6enande//ng /n de eery/e dagen na aspnyx/e.
De ner^enen vorwen een cowp/ex genee/. A/5 ecn/er de cere6ra/e
proce55en eenvoud/g /e £egrypen zowden z(//i, zowden w(/ zo eenvowd/g zy/i da/ we
ze n/e/ /ronden oegr//pe/i.
159
Publications
160 Fetal asphyxia, a study in preterm lambs
Publications
In the course of the studies, presented in part in this thesis, the following publications
were elaborated: , j <
Papers
1. de Haan HH, Van Reempts JLH, Borgers M, de Haan J, Vies JSH, Hasaart THM 1993
Possible neuroprotective properties of flunarizine infused after asphyxia in fetal lambs
are not explained by effects on cerebral blood flow or systemic blood pressure. Pediatr
Res 34:379-384
2. de Haan HH, de Haan J, Van Reempts JLH, Van Belle H, Hasaart THM 1993 The
effect of adenosine transport inhibition on cardiovascular function and survival after
severe asphyxia in fetal lambs. Pediatr Res 33:185-189
3. de Haan HH, Van Reempts JLH, Vies JSH, de Haan J, Hasaart THM 1993 Effects of
asphyxia on the fetal lamb brain. Am J Obstet Gynecol 169:1493-1501
4. de Haan HH, Uzermans ACM, de Haan J, Hasaart THM 1994 The T/QRS ratio of the
electrocardiogram does not reliably reflect well-being in fetal lambs. Am J Obstet
Gynecol, in press
5. de Haan HH, Uzermans ACM, de Haan J, Van Belle H, Hasaart THM 1994 Effects of
surgery and asphyxia on levels of nucleosides, purine bases, and lactate in
cerebrospinal fluid of fetal lambs. Pediatr Res, in press
Scientific abstracts
1. de Haan HH, Van Reempts JLH, Borgers M, de Haan J, Hasaart THM. Flunarizine
does not affect regional cerebral blood flow in severely asphyxiated fetal lambs.
Abstract no. 62, presented at the 38th annual meeting of the Society for Gynecologic
Investigation, San Antonio, Texas, USA, march 1991
2. de Haan HH. de Haan J. Hasaart THM. Inhibition of adenosine transport may improve
fetal survival in severely asphyxiated fetal lambs. Abstract no. 4, presented at the 18th
annual meeting of the Society for the Study of Fetal Physiology, De Eemhof, the
Netherlands, may 1991
3. de Haan HH, Wijffels MCEF, Hasaart THM. Adenosine transport inhibition does not
alter the changes in ST waveform of the fetal lamb electrocardiogram during severe
asphyxia. Abstract no. 17, presented at the SEOHS, Groningen, the Netherlands,
november 1991. Winning abstract for the Collegium Chirurgicum Neerlandicum
Award 1991
Publications 161
4. de Haan HH, Van Reempts JLH. Borgers M, Van Belle H, de Haan J, Hasaart THM.
Severe asphyxia in preterm fetal lambs does not result in extensive histologie brain
damage. Abstract no. 104, presented at the 39th annual meeting of the Society for
Gynecologic Investigation, San Antonio, Texas, USA, march 1992
5. de Haan HH, Wijffels MCEF, de Haan J, Hasaart THM. Adenosine transport
inhibition and cardiovascular effects in asphyxiated fetal lambs. Abstract no. 554,
presented at the 39th annual meeting of the Society for Gynecologic Investigation,
San Antonio, Texas, USA, march 1992
6. de Haan HH, Van Belle H, de Haan J, Hasaart THM. The increase in cerebrospinal
fluid (CSF) hypoxanthine concentration after severe asphyxia in fetal lambs. Abstract
no. El , presented at the 19th annual meeting of the Society for the Study of Fetal
Physiology, Niagara-on-the-Lake, Ontario, Canada, august 1992
7. de Haan HH, Van Reempts JLH, Borgers M, de Haan J, Hasaart THM. Histological
brain damage and electrocortical changes after severe asphyxia in fetal lambs.
Abstract no. D6, presented at the 19th annual meeting of the Society for the Study of
Fetal Physiology, Niagara-on-the-Lake, Ontario, Canada, august 1992
8. de Haan HH, de Haan J, Van Belle H, Hasaart THM. Release of hypoxanthine in
cerebrospinal fluid (CSF) during severe asphyxia in fetal lambs. Dutch Physiological
Society, Young Physiologists Meeting, Amsterdam, October 1992. Pfliigers Arch
1992;421:R38
9. de Haan HH, de Haan J, Van Belle H, Hasaart THM. The elevated level of
nucleosides in CSF after asphyxia may facilitate oxygen free radical formation and
brain damage. Abstract no. PI69, presented at the 40th annual meeting of the Society
for Gynecologic Investigation, Toronto, Canada, march-april 1993
162 Fetal asphyxia, a study in preterm lambs
"
163
Curriculum vitae
28 juli 1963 Geboren te Drachten (Frl)
1969-1975 Lagere school te Drachten (Frl), Huizen (NH), en Willemstad,
Curaçao (NA)
1975-1981 Atheneum, P.C.S.G. Doetinchem (Gld)
1981-1989 Studie Geneeskunde, Rijks Universiteit te Groningen
1986 Doctoraal examen
1986-1987 Werkzaam in het Holy Family Hospital, Berekum, Ghana
1987-1988 Co-schappen op Curaçao, Bonaire en Saba (NA)
1989 Aanvullend co-schap Obstetrie en Gynaecologie,
Academisch Ziekenhuis Maastricht
1989 Artsexamen, Cum Laude, Rijks Universiteit te Groningen
1989-1991 Assistent Geneeskundige Niet in Opleiding, afdeling Obstetrie
en Gynaecologie, Academisch Ziekenhuis Maastricht
1991 Collegium Chirurgicum Neerlandicum Prijs 1991
1992-heden Assistent Geneeskundige in Opleiding, afdeling Obstetrie en
Gynaecologie, Academisch Ziekenhuis Maastricht
Opleider: Prof. Dr. J. de Haan
1995-1996 Onderzoeksjaar
Onderzoekscentrum voor Ontwikkelingsgeneeskunde & Biologie,
Universiteit van Auckland, Nieuw Zeeland
Begeleider: Prof. Dr. P.D. Gluckman
Fetal asphyxia, a study in preterm lambs
The publication of this thesis was financially supported by:
• Accountantskantoor H. de Haan
• Hoechst Holland N.V.
• Janssen Research Foundation
• Organon Nederland B.V.
• Pfizer B.V.
• Pie Medical Benelux B.V.
• Sanofi Winthrop
• Schering Nederland B.V.
• Serono
• Syntex B.V.
• WyethB.V.

ISBN 90-9007452-X
